Alternations in the Splenic Marginal Zone with Age by Birjandi, Shirin Z.
Loyola University Chicago
Loyola eCommons
Dissertations Theses and Dissertations
2011
Alternations in the Splenic Marginal Zone with Age
Shirin Z. Birjandi
Loyola University Chicago
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in
Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 2011 Shirin Z. Birjandi
Recommended Citation
Birjandi, Shirin Z., "Alternations in the Splenic Marginal Zone with Age" (2011). Dissertations. Paper 164.
http://ecommons.luc.edu/luc_diss/164
 
 
 
 
 
 
                                          LOYOLA UNIVERSITY CHICAGO 
 
  ALTERATIONS IN THE SPLENIC MARGINAL ZONE WITH AGE 
 
                                         A DISSERTATION SUBMITTED TO  
                                 THE FACULTY OF THE GRADUATE SCHOOL 
   IN CANDIDACY FOR THE DEGREE OF 
                                                DOCTOR OF PHILOSOPHY 
 
PROGRAM IN CELL BIOLOGY, NEUROBIOLOGY AND ANATOMY 
 
                                                                    BY 
     SHIRIN Z. BIRJANDI 
     CHICAGO, ILLINOIS 
              MAY 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                      Copyright by Shirin Z. Birjandi, 2011 
                                                   All rights reserved.
 
 
iii 
 
 
 
ACKNOWLEDGMENTS 
 
 I am grateful to the wisdom, support and guidance of my mentor Dr. Pamela 
Witte.   Dr. Witte allowed me to find my own scientific niche and gave me the freedom to 
answer my own questions.  Under her guidance, I became a more independent thinker 
and learned that there are multiple ways to interpret any given finding.   I am also 
thankful to each member of my dissertation committee:  Dr. Richard Schultz, Dr. Phong 
Le, Dr. John Callaci, and Dr. Dennis Lanning.  Their suggestions and expertise added 
greater depth to the body of my work.    
 I am thankful to the members of my lab, both past and present, for their friendship 
and technical guidance.  I am particularly grateful to Jill Ippolito and Anand Ramadorai 
for the many years of support that they have given me.  Both Jill and Anand were of 
tremendous technical help throughout the course of this work.    
I would like to thank my parents, fiancé, sister, aunt, and friends for the much 
love and support that they have given me through the years.  Graduate training tests ones 
confidence and perseverance, and each one of you were there to remind me that I held in 
me what it takes to be successful within my craft.  The many friends I’ve met through the 
course of my training have each inspired me and given me much to look up to.  My 
fiancé, a fellow academic, has been a great friend, cheerleader, and colleague these last 
few years.  Lastly, I am most thankful to my parents, both my role models, who have 
 
 
iv 
 
always seen nothing but genius in me.  I hope their dreams of success for their daughter 
has come true.     
 
 
 
 
 
 
 
 
 
 
 
                              
 
 
v 
 
 
 
 
 
 
 
 
 
To my parents, Nahid Zahedi and Hossein Birjandi
 
 
vi 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS                iii 
LIST OF TABLES                 xi 
LIST OF FIGURES                xii 
LIST OF ABBREVATIONS                xv 
ABSTRACT                xvi 
CHAPTER I: STATEMENT OF THE PROBLEM                 1          
 CHAPTER II: LITERATURE REVIEW                5 
 Overview of the micro-architecture of the spleen              5 
 MZM and MZ B cell interactions and its functional importance            8 
 Marginal zone macrophages               12 
  Function of the MARCO receptor on MZM            13 
  Function of the SIGN-R1 receptor on MZM            14 
 Binding of S. pneumoniae to murine SIGN-R1            15 
 Phagocytosis                 16 
  Receptor mediated phagocytosis             17 
  Phagocytic compartments              18 
 The marginal zone B cell               19 
 Marginal zone B cell production in young and old mice           23 
 MAdCAM1+ marginal zone sinus and metallophilic macrophages          26 
 Survey of relevant age associated declines in immune function          28 
            Goals of my experiments                                31 
CHAPTER III: MATERIALS AND METHODS             32 
 Animals                 32 
 Tissue histology                32 
 Tissue specific scoring of MZ architecture             33 
 Tissue specific scoring of MAdCAM-1
+
 MZ sinus lining cells          34 
 Immunocytochemistry               34 
 Tissue specific scoring of MZM              35 
 Immunofluorescence and confocal microscopy            36 
 In vivo uptake of dextran by MZM              37 
 
 
vii 
 
 Flow-cytometry-revisited               37 
  Analyzing data gathered              39 
 Flow cytometric staining for identification of MZ B cells, FO B cells,  
   MZM, CCR7+ MZM, dextran+ MZM, pHrodo+ MZM, CD4+ T cells         40 
Adoptive transfer of mature B cells to young and old recipient mice         42 
Real-time PCR Analysis of expression of the chemokine CCL21          43 
pHrodo treatment and analysis via microplate reader           44 
Ex vivo treatment of pHrodo               45  
Statistical analysis                46 
 
CHAPTER IV: THE ANATOMICAL AND CELLULAR CHANGES IN THE                 
   MARGINAL ZONE OF YOUNG AND OLD MICE            47 
 
 Morphological disruption of the splenic MZ areas in old mice          48 
Alterations in the cells of the MZ region in spleens of old mice revealed by          
   immunofluoresence staining              52 
A reduction in MZM in the spleens of old mice revealed by  
   immunocytochemical staining             56 
A reduction in MZM in the spleens of old mice revealed by  
   flow cytometry                59 
Decrease in the frequency of MZ B cells in old mice           65 
 
CHAPTER V: THE MICRO-ANATOMICAL FACTORS THAT 
    MAY CONTRIBUTE TO DECREASES IN MZM AND  
   MZ B CELLS IN OLD MICE               70 
 
 Decrease in the frequency of MZ B cells in old mice correlates  
   with the decrease in MZM               71 
Adoptive transfer of MZ B cells to evaluate extrinsic factors in age  
   for the maintenance of MZ B cells to the MZ            76 
Evaluation of the chemokine CCL21 and its importance for  
   MZM homing to the MZ               85 
CCR7 levels in young and old mice              91 
 
CHAPTER VI: EVALUATION OF THE FUNCTIONAL  
   DIFFERENCES BETWEEN MZM OF OLD AND YOUNG MICE          95 
 
 Functional differences in capture of blood-borne dextran  
   particles by MZM in old mice              96 
Measuring dextran positive MZM by  
 f  low cytometry – pitfalls and potentials           100 
 
 
 
 
viii 
 
Evaluation of functional differences in the phagocytosis of  
  pHrodo bioparticles by MZM in old and young mice     
               using flow cytometry             103 
Phagocytosis of pHrodo bioparticles by a heterogenous  
   culture of adherent splenocytes measured via a microplate reader        104 
Establishment of concentration, time and inhibitor of  
   pHrodo treatment in vitro for flow cytometry analysis         107 
Phagocytosis of pHrodo bioparicles revealed by flow cytometry        111 
Summary of the functional studies on MZM (part I)          116 
Measuring the phagocytic differences of MZM from young and  
   old mice using live cell confocal microscopy          116 
Establishment of the concentration and time of the in vitro  
   pHrodo treatment of dextran marked MZM           118 
Imaging pHrodo
+
dextran
+
 MZM            121 
pHrodo phagocytic compartments over time           124 
Quantification of pHrodo in dextran
+
 MZM           126
 Percent pHrodo
+
 of the dextran
+
 MZM           132
 Comparison of dextran-FITC captured by MZM from young and  
   old mice in vivo as revealed by confocal microscopy         134 
Summary of the functional studies on MZM           137 
 
CHAPTER VII: DISCUSSION             138 
 
Alteration in the structure of the splenic marginal zone         140 
Decreases in marginal zone macrohages in old mice          141 
Decreases in marginal zone B cells in old mice          143 
The marginal zone sinus and metallophilic macrophages in old mice       146 
No differences in marginal zone macrophage function in old mice        147 
Chronic inflammation in age             148 
Significance               150 
 
REFERENCES               151 
 
VITA                                       163
 
 
ix 
 
 
                                              
LIST OF TABLES 
 
 
Table 1.  Depletion of MZM or MZ B cells and the effects on the  
      MZ compartment                           10 
 
Table  2 . Splenic B-lineage subpopulations and phenotypes            22 
 
Table 3. Number of MZM and MZ B cells in the spleens of  
       young and old mice                          67 
 
Table 4. Presence of MZ B cells in secondary lymphoid organs of  
     wild type BALB/c mice               80 
 
Table 5. Presence of MZ B cells in secondary lymphoid organs  
         following adoptive transfer of mature B cells isolated from  
       BALB/c mice into C.B17 mice               80 
 
Table 6. Presence of CCL21 in splenic sections of young and old mice          88 
 
Table 7. Average MFI of adherent splenocytes treated with or without  
         pHrodo for 2 hrs via microplate            105 
 
Table 8. Average Z-stack vs standard image of MFI of pHrodo
+
  
         phagocytic compartments/MZM            122 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
x 
 
    
 
 
LIST OF FIGURES 
 
 
Figure 1.  Schematic representation of the splenic marginal zone             7            
Figure 2.  Functional interaction of MZM and MZ B cells            11 
Figure 3.  MZ B and FO B cell development in young mice            24 
Figure 4.  Factors important for the production of MZ B and FO B cells in 
         young and old mice                                                                                         25 
 
Figure 5.  Morphological comparison of the MZ architecture of  
         young and old mice                          50 
 
Figure 6.  Representative images of H&E stained splenic sections  
         from young and “young-like” old mice             51 
 
Figure 7.  Morphological comparison of disrupted  
           MAdCAM-1+ MZ sinus lining cells in young and old mice                     54 
 
Figure 8.  Immunofluorescence of cellular compartments of  
       the MZ region of young and old mice             55
       
Figure 9.  Semi-quantitative assessment of MZM disruption  
       in spleens from old mice               58 
 
Figure 10.  Quantitative assessment of the frequencies of MZM in  
            spleens from old and young mice by flow cytometry     61-63 
     
Figure 11.  FACS cell sort of CD11b positive and negative populations          64    
 
Figure 12.   Representative profiles of MZ B and FO B cells from  
                     young and old mice                          67
            
Figure 13.  Comparison of frequencies of MZ B and FO B cells in  
              young and old mice                          69 
 
 
 
 
xi 
 
Figure 14.  Comparison of frequencies of MZ B cells in young and  
           old mice and correlation with abundance of MZM                      74 
 
Figure 15.  Adoptive Transfer of B cells              79 
 
Figure 16.  Adoptive transfer of B cells from young C.B17 mice  
         into young and old BALB/c mice                         80 
 
Figure 17.  Representative profile of MZ B population in the  
         spleen of young and old mice               82 
 
Figure 18.  Representative profile of MZ B population in the  
             bone marrow of young and old mice              83 
 
Figure 19.  Representative profile of MZ B population in the  
         lymph node of young and old mice              84 
 
Figure 20.  CCL21 distribution in spleens from young and old mice                          87-88 
 
Figure 21. Expression of CCL21 protein and mRNA                                                        90
      
Figure 22.  Flow cytometry profiles reveal the percentage  
         of CCR7+ MZM of young and old mice              92 
 
Figure 23.  Flow cytometry profiles reveal the percentage  
           of CCR7+ CD4+ T cells of young and old mice             93 
 
Figure 24.  Percentage of CCR7
+ 
MZM of young and old mice           94  
 
Figure 25.  Intravenous injections of dextran-FITC into young and old mice                  98 
 
Figure 26.  Binding of dextran by MZM of old versus young mice           99 
 
Figure 27.  Flow cytometry of MZM from young and  
           old mice injected with dextran-FITC           102 
 
Figure 28.  Percent net effect of pHrodo by adherent  
        splenocytes from young versus old Mice                     106 
 
Figure 29.  Experimental paradigm of pHrodo treatment  
         for flow cytometry analysis            109 
 
Figure 30.  Titration of pHrodo for use in flow cytometry          110 
 
 
xii 
 
 
Figure 31. Representative flow cytometry profile of MARCO  
        upregulation on splenic adherent cells upon treatment with pHrodo      113 
 
Figure 32. Representative flow cytometry profiles of  
            SIGN-R1+ MZM upon treatment with pHrodo          114 
 
Figure 33.  Experimental paradigm of pHrodo treatment of  
         dextran-FITC marked MZM                       120 
 
Figure 34.  The MFI of pHrodo
+
 phagocytic compartments over time        125 
 
Figure 35.   Comparison of the phagocytosis of MZM isolated  
              from old and young mice            128 
 
Figure 36.  Quantification of pHrodo in dextran
+
 MZM             129-131 
  
 
Figure 37.  The percentage of pHrodo
+
 cells of the dextran
+
 MZM         133 
 
Figure 38.  Quantification of Dextran-FITC in MZM  
             from young and old mice as revealed by confocal microscopy                  136 
 
Figure 39.  Model of the Microenvironmental alterations  
           of the Splenic Marginal Zone                       149
                                                                                                                                                                                                                                                 
xiii 
 
 
 
 
LIST OF ABREVATIONS 
BCR      B cell receptor 
DC        Dendritic cell 
FDC      Follicular Dendritic Cell 
FO B     Follicular B cells 
MARCO     Macrophage Receptor with Collagenous structure  
MMM      Metallophilic Macrophages 
MZ       Marginal Zone 
MZ B     Marginal Zone B cells 
MZM      Marginal Zone Macrophages 
PALS      Periarteriolar lymphoid sheath 
PC       Phosphorylcholine 
pHrodo      pHrodo™ S. aureus bioparticles 
SIGN-R1 Specific intracellular adhesion molecule-grabbing nonintegrin receptor 1 
TD       T-dependent 
TI       T-independent   
 
 
xiv 
 
 
 
 
ABSTRACT 
Splenic marginal zones are architecturally organized to generate a rapid response 
against blood- borne antigens entering the spleen. The marginal zone is a distinct 
anatomical micro-environment whose main components include the marginal zone 
macrophages, the marginal zone B cells, the marginal zone sinus, and the metallophilic 
macrophages. Marginal zone macrophages, in partnership with marginal zone B cells, are 
particularly important in host defense against T-independent pathogens and are crucial 
for the prevention of diseases such as Streptococcus pneumonia. It has been widely 
reported that with the advancement of age there is a higher rate of mortality as a result of 
bacterial pneumonia when compared to the young. My objective here was to determine if 
there are age related changes in the cellular components of the marginal zone in old 
versus young mice. Gross architectural changes in the  marginal zones of old mice when 
compared to young mice were found and that disruptions were observed among the many 
components of the marginal zone, including: marginal zone macrophages, marginal zone 
B cells, the marginal zone sinus lining cells, and the metallophilic macrophages.  The 
reduction in marginal zone macrophages in individual old mice also statistically 
correlated with reduced frequency of marginal zone B cells. These findings further 
strengthen a partnership of marginal zone macrophages and marginal zone B cells. 
Furthermore, the phagocytic properties of marginal zone macrophages were examined 
live on a per cell basis and no differences in phagocytosis of old marginal zone 
 
 
xv 
 
macrophages when compared to young were found, demonstrating that it is this reduction 
in the marginal zone macrophage population that contributes to the decline in the T-
independent immune response reported with age. Results obtained from these studies can 
provide insight for the proper response needed to clear pathogens that have been shown 
to be detrimental in the old. 
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CHAPTER I 
                                        STATEMENT OF THE PROBLEM 
More than 12.9 % of the U.S. population is over the age of 65 (1) and life 
expectancy continues to make rapid gains as a result of advancements in modern 
healthcare.  However, older people suffer greater risks of long-term complications and 
are still more susceptible to diseases than young and middle-aged individuals because of 
the effects of a weakened immune system. One of the leading causes of death in persons 
65 years and older is invasive pneumococcal disease (2, 3). Vaccines for the prevention 
of invasive pneumococcal disease show a decline in immune protection in the elderly 
when compared to the young (4, 5). This is possibly due to the reduced ability of the aged 
immune system to deal with bacteria load and mount an immune response to the T-
independent (TI) antigen components that make up the vaccine. Therefore, understanding 
how the immune system changes with age is critical for implementing better therapies 
and vaccines for the prevention of age related disease.   
 Blood-borne antigens enter the spleen prior to circulating to other immune organs 
(6).  Blood-borne bacteria, viruses, parasites and other antigens enter a 
compartmentalized area of the spleen, the marginal zone (MZ), where they are 
sequestered by marginal zone macrophages (MZM) and marginal zone B cells (MZ B) 
[reviewed in (7, 8)].  MZM are highly phagocytic cells and are responsible for rapid 
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clearance of blood-borne TI antigens and debris (7-9).  MZ B cells are also well known 
for their ability to respond to TI antigens by rapidly generating an IgM specific antibody 
response (10)[reviewed in (11, 12)].  It is believed that the pathogen degradation products 
shed by MZM are taken up by MZ B cells (8). Notably, the antigen components of 
vaccines important for the prevention of bacterial pneumonia are TI (13). Thus, 
examining the MZ compartment, especially MZM and MZ B cells, in the old may 
provide an explanation for the increased susceptibility and decreased efficacy of vaccines 
for bacterial diseases in the elderly.    
MZM are capable of binding TI antigens through specific cell surface receptors. 
Two important MZM cell surface receptors are: Macrophage Receptor with Collagenous 
structure (MARCO) and Specific Intracellular adhesion molecule-Grabbing Nonintegrin 
Receptor 1 (SIGN-R1) [reviewed in (7)]. MARCO binds to Staphylococcus aureus (14, 
15) and Escherichia coli [reviewed in (15)]; SIGN-R1 [homologue of human DC-SIGN 
(16)] binds the capsular polysaccharide of Streptococcus pneumoniae and also to the 
polysaccharide dextran (17-20). Once MZM bind an antigen, they will introduce it to 
closely associated MZ B cells (21).  MZM and MZ B cells have a direct intercellular 
interaction via the scavenger receptor, MARCO, expressed on MZM with an 
undetermined ligand on MZ B cells (22-24).  MZM and MZ B cells are positioned around 
the outer border of the MZ sinus, facing the red pulp of the spleen (7).  Positioned around 
the inner border of the MZ sinus are the metallophilic macrophages (MMM), which face 
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the white pulp of the spleen (7). The anatomical micro-architecture of the MZ can be seen 
as critical for the proper binding and clearance of blood-borne pathogens.  
Previous studies of the lymphoid architecture of old mice focused on disruption of 
the white pulp areas, T cell-rich periarteriolar lymphoid sheath (PALS) and B cell 
follicles, when compared to young mice (25-29).  My initial observations of the splenic 
tissue of most old mice suggested an overall alteration in the micro-architecture of the 
MZ.  Little is known about changes in the structure and cellular components of the MZ 
with age, my investigation proposes that there is an alteration in the cellular 
components that make up the MZ, specifically the MZM and MZ B cells, in old mice 
when compared to young mice.  This cellular alteration may impinge on the 
functional ability to capture and phagocytize blood-borne antigen.  Results of my 
studies revealed decreased frequencies of MZM and MZ B cells and disruptions in 
positioning of the mucosal adhesion cell adhesion molecule (MAdCAM-1
+
) sinus-lining 
cells and MMM. The consequence of altered MZM in old mice was reflected by 
reduction in binding of blood-borne dextran particles by the MZM.  One explanation for 
the decreases in MZM and MZ B cells observed with age could be due to alterations in 
the aged microenvironment.  The factors important for MZM and MZ B cell homing to 
the MZ were examined.  In individual animals decreases in MZM in old mice were found 
to be correlated with decreases in MZ B cells. The chemokine CCL21 and its receptor 
CCR7, chemotactic factors important for MZM homing were also found to be reduced in 
old mice when compared to young mice.  In cell transfer experiments, mature B cells 
isolated from young recipient mice had ~50% fewer young donor MZ B cells in old 
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spleens when compared to young spleens.  Lastly, the function of MZM was examined 
using a novel approach to measure MZM phagocytosis to determine if there were cell-
intrinsic alterations in age.  On average, the phagocytic function of individual MZM 
isolated from old mice was found to be unaffected upon administration of S. aureus 
bioparticles, suggesting that a decrease in the MZM compartment rather than cell-
intrinsic defects in age is the primary factor for the decreased immune response to TI 
antigens reported with age.     
 In this thesis, I will first provide a comprehensive review of the components that 
make up the MZ.  The MZM and MZ B cells will be emphasized as these cells are crucial 
for the efficient clearance of TI antigens. The origin of MZM and the receptors expressed 
on its surface will be discussed as well as a general overview of phagocytosis.  MZ B cell 
development in young adults will be reviewed and compared to MZ B cell development 
in old mice.  The MZ sinus as well as the MMM will also briefly be discussed.  The 
reminder of the literature review will discuss a survey of the relevant alterations in 
immunity with age.  The chapter following the literature review will give a complete 
description of the experimental approaches performed followed by the results (divided 
into 3 separate chapters).  Lastly, I will discuss the significance of my findings and the 
possible therapies for elderly patients to mount effective immune responses to life-
threatening pathogens such as S. pneumoniae.
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CHAPTER II 
LITERATURE REVIEW 
Overview of the micro-architecture of the spleen  
 The spleen houses many of the cells important for an efficient immune response. 
Histological examination of the spleen reveals a red pulp region and a white pulp region 
(Fig 1). The red pulp is traditionally known as the region where red blood cells are 
degraded by the red pulp macrophages that reside in the cords of the red pulp (30). The 
white pulp is organized into specific zones (Fig. 1): a T cell zone [(periarteriolar 
lymphoid sheath (PALS)], a B cell zone (follicle), and a marginal zone (MZ).  The T cell 
zone contains T cells that interact with dendritic cells (DC), stromal cells and B cells that 
pass through.  The B cell zone contains the follicular (FO) B cells, follicular dendritic 
cells (FDC), and stromal cells.  FDC and stromal cells secrete the chemokine CXCL13, 
which is necessary for the FO B cells to home to this zone (31).  FO B cells, unlike MZ B 
cells, require interaction with T cells to mount an effective antibody response.  Once 
activated by T cells, FO B cells undergo immunoglobulin isotype switching, somatic 
hypermutation, and clonal expansion (11, 32), which can be observed in H&E splenic 
tissue sections as dark heavily nucleated areas known as germinal centers. The MZ is 
made up of several components including: the MZM, MZ B cells, MMM, the MZ sinus, 
natural killer (NK) cells, and DC (7, 8, 30).  MZM form the outer ring of the MZ and 
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interact with the MZ B cells. The DCs are also observed to be localized near the MZM 
and MZ B cells.  MMM form the inner ring of the MZ and are found facing the white 
pulp of the spleen and are found to be in line with the MZ sinus.  
A hallmark feature of the spleen is that it is the site where blood-borne antigens 
are first detected by cells of the immune system (6).  Antigens and recirculating 
lymphocytes enter the spleen at the MZ.  Recirculating lymphocytes enter the MZ from 
the bloodstream similar to the process by which leukocytes transverse inflamed 
endothelium (33).  Once lymphocytes have re-entered the spleen each cell will position to 
its corresponding zone as a result of chemotactic signals (31, 34, 35).  Antigens will filter 
through the porous MZ sinus (36) and depending on the nature of the antigens, will 
initiate an immune response.  Traditional FO B cells are activated by thymus-dependent 
(TD) antigens and MZ B cells are activated by thymus-independent (TI) antigens (37, 
38).  TD antigens consist of soluble proteins and peptides that associate with MHC 
molecules on the surface of antigen presenting cells (APC).  The APC in the context of 
MHC class II molecules will then interact with the T cell receptor on the surface of T 
cells.  Activated T cells will recruit and have direct contact with B cells that will produce 
an immunoglobulin specific antibody response.  TI antigens are generally large in 
molecular weight, have repeating antigenic epitopes, and are able to activate the 
complement signaling pathway.  TI antigens are not able to stimulate MHC molecules on 
the surface of APC.  Therefore, TI antigenic components are able to elicit an antibody 
response in the absence of MHC class II restricted T cell help.  
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Figure 1.  Schematic representation of the splenic marginal zone 
Top left image is an H&E cross section of a young mouse (10x magnification).  The 
spleen is organized into a red pulp (RP) region and numerous white pulp (WP) areas.  
The boundary of the MZ is depicted by the white arrow.  Bottom left is a cartoon 
depiction of the spleen narrowing in on the cellular organization of the MZ.  The white 
pulp region is divided into specific zones: marginal zone, B cell zone, and T cell zone. 
The MZ is comprised of different cell types. The most notable cell types are the MZM 
and MZ B cells. MZM and MZ B cells are seen interacting throughout the MZ. The MZ 
sinus-lining cells are capillary extensions of the central arteriole and are the site where 
blood-borne pathogens first enter the spleen. The MMM are tangentially positioned next 
to the marginal sinus-lining cells facing the white pulp region. 
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MZM and MZ B cell interactions and their functional importance 
In the context of TI antigen responses in the spleen, MZ B cells and MZM are 
important players in initiating an efficient immune response.  At normal basal levels in 
mice, MZ B cells home to the MZ due to an interaction with MZM (22) (Fig. 2).  MZ B 
cells and MZM interact via the scavenger receptor, MARCO, on MZM with an 
undetermined cell surface receptor/ligand on MZ B cells (15, 22-24).  In vivo studies 
where anti-MARCO antibody was injected intravenously (i.v.) into mice resulted in 
disruption of MARCO and MZ B cell interactions with displacement of MZ B cells to the 
white pulp area and MZM retained in the MZ (15).   MZM-MZ B cell interactions are 
important functionally because MHC class II molecules, which are necessary for antigen 
presentation, are not expressed on MZM.  Therefore, it has been postulated that upon 
binding and phagocytosis of microbes, the pathogen degradation products shed by MZM 
are taken up by MZ B cells (Fig. 2) (15, 17).  This functional interaction between MZM-
MZ B cells is another avenue aiding in the clearance of foreign pathogens.    
Studies involving depletion of either MZM or MZ B cells in young adult mice 
report loss of the corresponding cell population as well as morphological disruptions of 
the MZ (Table I) (21, 39-41).   A report by Kraal et al. studying MZM kinetics in the 
spleen observed that depletion of macrophages, including MZM, by in vivo liposome 
treatment lead to a subsequent loss of the B cells in the MZ (39).  Recovery of MZM 
correlated with full restoration of the MZ B cell population of these mice.  More recently, 
studies using SIGN-R1
-/-
 mice, which have reduced MZM, reported decreases in MZ B 
cell numbers when compared to wild type mice (21).  On the other hand,  reports in 
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which MZ B cells were initially depleted in young adult mice by overexpression of CD70 
(a TNF family member), which leads to a gradual loss of the splenic B cell pool, reported 
a subsequent gradual loss of the MZM pool (40).   This same study also found that MZM 
failed to develop in BCR
-/- 
mice lacking B cells.  Similar studies have also found that 
CD19 (determined here to be important for MZ B cell differentiation) deficiency in B 
cells leads to a loss in MZ B cells by a mechanism believed to inhibit differentiation from 
precursor B cells to MZ B cells (41).   This study reported that absence of MZ B cells 
corresponded with absence of MZM.  Furthermore, adoptive transfer experiments were 
performed in which mature purified B cells from wild type mice were able to reconstitute 
the MZM pool after 17 days.    
Investigators have also found the functional importance of MZM-MZ B cell 
interactions.  Studies have found that upon infection with S. pneumoniae, SIGN-R1
-/-
 
mice have a reduced ability to mount an IgM specific antibody response against the 
phosphorylcholine (PC) epitope of S. pneumoniae when compared to wild type mice, 
which show elevated anti-PC IgM levels upon infection (20, 21).  Similar experiments 
done in vitro where B cells derived from  
SIGN-R1
-/-
 mice showed reduced anti-PC IgM levels upon stimulation when compared to 
B cells derived from wild type mice (21).   It is therefore predicted in age that if either the 
MZM or MZ B pool is decreased, this will have an impact on the other cell type.    
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Table 1.  Depletion of MZM or MZ B cell populations and its effects on the MZ 
compartment.  Survey of experiments that depleted either MZM or MZ B cell 
populations in the spleens of mice.  Symbols correspond to lack (- -) or presence (+ +) of 
MZM or MZ B cells in the spleen.   
 
 
 
 
 
 
 
 
Report MZM MZ B cell MZ 
Morphology
MZ B cell 
Position
Reference
Effect
Liposome 
depletion of 
splenic
macrophages
- - - +
MZM, MMM 
absent
80% 
reduced 
in MZ
Rooijen et al., 1989
CD70 Tg
Mice
- - - -
MZM, MZ B 
cells, and 
MAdCAM1+ 
cells absent 
after 8 wks
Completely 
absent after 
8wks
Nolte et al., 2004
BCR -/- - - - -
Completely 
absent
MZM, MZ B 
cells, & MMM 
absent
In vivo blocking 
of MARCO
+ + + + MZM Present White  pulp 
area
Nolte et al., 2004
Karlsson et al., 2004
CD19 -/- - - - -
MZM, MZ B c 
absent.  
MMM & 
MAdCAM1+ 
cells present
Completely 
absent
You et al., 2010
You et al., 2010
CD19 -/-
reconstituted 
with purified B 
cells
+ + MZM (17d) & 
MZ B cells 
(7d)
MZ
Table 1.  Depletion of MZM or MZ B cells and the effects on the MZ compartment
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Figure 2.  Functional interaction of MZM and MZ B cells.  MZM and MZ B cells are 
components of the MZ of the spleen.  MZM have a physical interaction with MZ B cells 
via the scavenger receptor MARCO located on the surface of MZM.  (1) MZ B cells 
recognize TI antigens via the BCR and generate a rapid IgM antibody response.  (2) 
MZM bind TI antigens predominantly through the cell surface receptors SIGN-R1 
(depicted above) and MARCO.  The antigen will then be phagocytized by the MZM.  
(3)When antigen has bound MZM it is believed that the pathogen degradation products 
shed by MZM are taken up by MZ B cells.  
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Marginal zone macrophages 
 MZM are a type of macrophage population in the MZ that appear as a band of 
cells forming the outer ring of the MZ.  MZM begin to populate the MZ about 10 days 
post-birth in mice (42).  MZM are derived from monocytes that home to the MZ as a 
result of the chemokines CCL19 and CCL21 that are expressed by gp38
+
 stromal cells 
known to be important for T cell homing to the PALS (43).  The exact origin of MZM 
has not been determined, but earlier studies examining macrophage kinetics in the spleen 
found that after liposome-mediated elimination of MZM, MZM did not repopulate the 
MZ until after 1 month (39).  In this study upon liposome treatment, the red pulp 
macrophages (RPM), MMM, and MZM were eliminated simultaneously 24 hr post 
treatment.  After 1 wk the RPM were found to repopulate, followed by the MMM in 2 
wks, and finally MZM after one month (39).  This sequence of repopulation suggested to 
the authors that MZM development may be under the influence of other splenic 
macrophage subtypes.  Interestingly, in this same study an absence of B cells that reside 
in the MZ was also observed and did not start to re-emerge until after 16 days (39).  
Although this study shows that MZM can be generated, it is not clear if the MZM 
established 10 days post birth survives throughout the lifetime of the animal or if MZM 
are constantly replenished as is the case with other white blood cell populations.  
MZM are known for their ability to be highly phagocytic and in fact have been 
referred to as “real scavenger cells” (8). MZM express on their surfaces a variety of 
pattern recognition receptors capable of inducing phagocytosis. Three main receptors 
have been characterized: Scavenger receptor A (SR-A); MARCO, a member of the SR 
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family of receptors;  the C-type lectin SIGN-R1 (the mouse analog of the human 
dendritic cell-specific intercellular adhesion molecule [ICAM-3 grabbing nonintegrin) ( 
DC-SIGN)] [reviewed in (8)]. 
Function of the MARCO receptor on MZM 
The MARCO receptor is expressed constitutively on MZM and is a member of 
the scavenger receptors (7).  Scavenger receptors are traditionally known for binding a 
wide range of ligands such as polyribonucleotides, lipopolysaccharides, and silica 
particles (44).  Studies in mice have shown that after ligand binding to MARCO, MZM 
are observed to traffic to the red pulp and MZ B cells displaced to the white pulp areas 
(15).  To demonstrate this, investigators injected the bacterial pathogen, S. aureus (a 
known ligand for the MARCO receptor) i.v. into mice (14).  Within 30 min of injection, 
S. aureus could be visualized exclusively on MZM (15).  At 18h after injection S. aureus 
positive MZM were found to migrate into the red pulp, and MZ B cells were found in the 
white pulp follicles (15). The migratory ability of MZM has been attributed to a 
downregulation in SH2-containing inosital-5-phosphatase 1 (SHIP) signaling upon 
binding antigen – as deletion of SHIP leads to displacement of MZM to the red pulp (15). 
Structurally, MARCO contains a long collagenous triple helix. The C-terminal 
region of MARCO has approximately 100 amino acids and has been recognized as the 
region where bacteria bind (45).  Although the downstream signaling pathways of 
MARCO have currently not been directly determined, over-expression of MARCO by 
other cell types has been shown to activate Rac1 (46).  Furthermore, it has also been 
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observed that MARCO over-expression results in cell shape changes that result in the 
formation of what is described as “large lamellipodia-like structures.” These cell shape 
changes have also been shown to be accompanied by rearrangement in actin cytoskelton.  
It is important to note that while MARCO has been shown to bind antigen, it is believed 
that this process of antigen internalization occurs as a result of co-receptor involvement 
by a process not yet identified (47). 
Function of the SIGN-R1 receptor on MZM 
SIGN-R1, another prominent receptor on the surface of MZM was identified as 
the murine homologue to human DC-SIGN.  DC-SIGN is a receptor found on the surface 
of dendritic cells in humans and is capable of binding the HIV-1 envelope glycoprotein 
(17).  DC-SIGN is a C-type lectin (recognize carbohydrates) (7, 47) that binds to the 
adhesion molecule ICAM-3/CD50 expressed on resting T cells and ultimately transmits 
the virus to T cells (17).  Notably, more recent studies have shown that DC-SIGN binds 
the gram-positive bacterium S. pneumoniae (16).  SIGN-R1 on MZM has also been 
shown to bind the capsular polysaccharide of S. pneumoniae (19, 20) as well as the gram-
negative bacteria such as Escherichia coli (48) and the polysaccharide dextran (18).  
Upon dextran binding, the SIGN-R1 receptor and antigen will internalize and this antigen 
receptor complex has been shown to localize to lysosomes (17).  Briefly, K562 cells were 
transfected with monoclonal SIGN-R1 and administered dextran-FITC for 45 min at 37ᵒ 
C.  Immunofluorescence microscopy revealed dextran-FITC internalized to the 
lysosomes.  It has also been shown that the SIGN-R1 receptor on MZM is capable of 
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interacting with the toll-like receptor 4 (TLR4), initiating the production of 
proinflammatory cytokines (48).  Transfection of SIGN-R1 into macrophage-like 
RAW264.7 cells resulted in enhanced TLR4 oligomerization.  Immunoprecipitation 
experiments also revealed a physical association between SIGN-R1 and TLR4 (48).  
TLR4 is important for the production of a wide range of proinflammatory cytokines (49-
51), which are important for proper immune function by inducing costimulatory 
molecules and other inflammatory mediators at the site of invasion (52).      
The binding of S. pneumoniae to murine SIGN-R1  
 In humans, S. pneumoniae is transmitted from an infected individual through 
direct contact with their respiratory secretions (53).  An estimated 10% of healthy adults 
are carriers of some serotype of S. pneumoniae, which are non-invasive and stay within 
the nasopharynx.  When S. pneumoniae enters lung tissue through passage from the 
nasopharynx, it is referred to as invasive, leading to the development of pneumococcal 
disease.  How does S. pneumoniae, a bacterium known to infect lung tissue, enter the MZ 
to bind the SIGN-R1 receptor?   S. pneumoniae crosses lung tissue and enters the blood 
using the host’s receptor for platelet-activating factor (PAF) (53). This receptor is known 
for the recognition of the phosphorylcholine (PC) determinant of the ligand PAF and is 
expressed on a wide variety of cells including but not limited to platelets, monocytes, and 
neutrophils found in the blood [reviewed in(54)].  S. pneumoniae express PC in their 
bacterial cell wall and therefore are recognized by the host’s receptor.  Once in the 
bloodstream, S. pneumoniae will filter to the spleen and bind to SIGN-R1
+ 
MZM.  Mice 
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that are SIGN-R1-deficient are more susceptible to pneumococcal infection (20, 21).  
Once S. pneumoniae has bound SIGN-R1
+ 
MZM, antigen is then believed to be presented 
to the MZ B cells, which produce anti-PC IgM antibodies (21).  Recently, studies done on 
the human DC-SIGN have shown that this receptor also binds to S. pneumoniae.  DC-
SIGN, a receptor expressed on DC that reside in mucosal tissue, was shown to 
specifically bind to S. pneumoniae serotypes 3 and 14 in vitro (16).  Yet, DC were not 
observed to have any immunomodulatory effects.  Therefore, further investigation needs 
to target human DC-SIGN and determine the mechanism involved in initiating an 
immune response after binding S. pneumoniae.  Examining the murine homologue SIGN-
R1 can lead to a better understanding of the immunomodulatory role of human DC-
SIGN.   
Phagocytosis 
 After binding antigen such as S. pneumonia MZM, will begin the process of 
phagocytosis.  Phagocytosis is a form of endocytosis (the process by which cells engulf 
particles, molecules, and/or fluids) [reviewed in(55)].  Phagocytosis occurs when 
particles are greater than 0.5 µm in diameter.  Phagocytosis of microbes is a complex 
process that involves multiple receptors, signaling molecules, and signaling pathways to 
effectively internalize the microbe. The receptors and endosomal compartments involved 
in the engulfment and clearance of microbes are discussed below.   
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Receptor-mediated phagocytosis 
Multiple receptors have been shown to bind microbes simultaneously [reviewed 
in (47)].  Briefly, immunoglobulin Fc receptors, complement receptors, integrins, lectins, 
and scavenger receptors are believed to directly bind the microbe or bind opsonins on the 
surface of the microbe.  Receptor binding induces many signaling pathways that use 
numerous molecules to undergo proper signaling that lead to a plethora of responses like 
microbial killing and the production of inflammatory cytokines and chemokines.  Fc 
receptors bind immunoglobulin-opsonized pathogens and complement receptors bind 
complement-opsonized pathogens.  Integrins are both adhesion and phagocytic receptors 
and have been seen to mediate both (55).  For example, the fibronectin receptor (αMβ1 
integrin) has been shown to bind ligand at the substrate-adherent surface of monocytes.  
This binding of ligand to receptor promotes the activation of the complement receptor 
CR3 (αMβ2 integrin), which mediates phagocytosis.   Lectins, such as SIGN-R1, 
recognize self and non-self carbohydrates often seen on the cell wall of microbes (7, 47).  
Studies with the lectin for receptor mannose have shown that ligation of receptor leads to 
particle internalization (47).  Scavenger receptors are well-known for their ability to bind 
and internalize modified lipoproteins.  The MARCO receptor is a member of the 
scavenger receptors.  Scavenger receptors are divided into two groups: SR-A and 
MARCO.  They bind diverse ligands such as polyribonucleotides, lipopolysaccharides, 
and silica particles (44).  It has been suggested that while scavenger receptors bind 
microbes, they do not contribute to the internalization; co-receptors are required for 
internalization (47). 
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Phagocytic compartments 
 Once a receptor has bound and internalized a microbe, the formation of a 
phagolysosome is initiated.  The phagolysosome will fuse with compartments of the 
endocytic pathway and will be degraded [reviewed in (56)].  The main compartments of 
the endocytic pathway are the early endosome, late endosome, and the lysosome (56-58). 
Each compartment of the endocytic pathway has been characterized based on the 
intracompartmental pH, luminal composition and morphology. 
The early endosome is often referred to as the major sorting station.  Here, 
organelle materials may get recycled to the plasma membrane, proceed to late endosome, 
or be targeted to secretory vesicles (58).  Using ratiometric measurements, the pH of the 
early endosome has been reported to be ~ 6 [reviewed in (58)].   The structure of the early 
endosome is described as multivesicular, consisting of cisternal regions with thin tubules 
(57).  The late endosome and lysosome are regarded by some authors as one 
compartment; however there are differences between late endosomes and lysosomes.  
Both contain acid hydrolases, lysosome-associated membrane proteins (LAMPS), and 
lysobisphosphatidic acid (a phospholipid that plays a role in glycolipid degradation and 
the transport of lipids and membrane proteins) [reviewed in (56)].  Differences between 
late endosomes and lysosomes include their function and morphology.  The late 
endosome functions as the main site for proteolysis and the lysosome functions as the 
main site for hydrolase by acid hydrolases.  At the ultrastructural level, late endosomes 
are observed to have a complex morphology with a multivesicular appearance containing 
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cisternal, tubular and vesicular regions similar to the early endosome (59, 60), whereas, 
lysosomes are observed to be spherical in shape and said to resemble vesicles (60).  The 
pH of the late endosome has been reported to be approximately 5.5 and the pH of the 
lysosome close to 4 (56).   The pH varies from cell to cell and is controlled by a complex 
system controlled by the luminal environment of each compartment.  A system of 
vacuolar ATPases (V-ATPases) and redox chains pump protons into the luminal 
compartments, which are regulated by Na
+
/H
+
 exchangers (early endosome) and Cl
-
 ion 
channels (late endosome and lysosome) (56). 
The marginal zone B cell 
The B cell population is comprised of several functional and phenotypically 
distinct subpopulations, including newly-formed immature (transitional and preMZ B 
cells), mature FO, B1 B cells, regulatory B cells, and MZ B cells (Table II). These 
subpopulations have been suggested to be a result of evolutionary pressures that allowed 
the host to defend against invading pathogens with and without help from T-cells (61, 
62).  
Recent attention has been given to MZ B cells because of their ability to provide a 
rapid defense against TI bacterial antigens – an attribute lacking in TD FO B cells, which 
can take up to 7 days to produce antibodies.  MZ B cells in normal adults make up ~5% 
of the total B cell pool in the spleen, and FO B cells comprise ~90%. Upon stimulation 
by TI antigens, MZ B cells differentiate rapidly into short-lived plasma cells and secrete 
IgM antibodies (10).  In addition, MZ B cells have been shown to mediate TD responses 
in vitro [reviewed in Allman et al (11)].  In humans, MZ B cells are found in the MZ of 
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the spleen, and B cells with the MZ B phenotype are also seen in lymph nodes in the 
outer extra-follicular rim (11). Yet in rodents, MZ B cells have only been demonstrated to 
reside in the MZ of the spleen.  
Once thought to be sessile, recent work has shown that MZ B cells shuttle 
between the MZ and follicles of the spleen, resulting from the balance of two main 
factors. The first is downregulation of the sphingosine 1-phosphate receptor (S1P1) that is 
present on MZ B cells (15, 63, 64).  S1P1, like MARCO, is also required for MZ B cells to 
remain lodged in the MZ, because in the absence of S1P1, MZ B cells are found displaced 
to the white pulp follicle (64, 65). The chemokine CXCL13 and its receptor CXCR5 that 
is present on MZ B cells are the second major factor important for MZ B cell shuttling.  
The white pulp follicle has high levels of CXCL13 and it is believed that MZ B cells 
naturally move toward this chemokine gradient (64, 65).  This shuttling occurs during 
homeostatic conditions (64) and in response to antigen (15, 63, 64).  Antigen that has 
entered by way of the MZ sinus is believed to be phagocytized by MZM and the 
pathogen degradation products are then taken up by MZ B cells (15, 17).  On the other 
hand, some believe MZ B cells are able to bind the antigen directly and transport it to the 
white pulp follicles (63).  Upon exposure to TI antigens, MZ B cells will bind the antigen 
via the BCR thereby initiating the BCR-mediated signaling pathway.  BCR aggregation 
results from antigen binding leading to phosphorylation of tyrosine residues on 
immunoreceptor tyrosine activation motifs (ITAMS) located on the cytoplasmic tails of 
the BCR co-receptors. Once phosphorylated, the tyrosine kinase Syk will facilitate the 
initiation of downstream signaling pathways that lead to the activation of phospholipase 
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C- (PLC-). In parallel to BCR aggregation, the complement receptor CD21/35 binds 
complement-coated antigens and enhances BCR signaling. Activation of CD21/35 leads 
to Bruton’s tyrosine kinase (Btk) signaling that causes further activation of PLC- and 
also causes activation of NFB, which are both components necessary for proliferation 
and clonal expansion of B cells [reviewed in (32)].      
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Table 2. Splenic B-lineage subpopulations and  phenotypes
B cell subset Phenotype Location Function                           Frequency
Transitional T1                B220
+a
CD23-bCD21/35lowIgMhighd IgDlowe              MZ                                   Immature B cell            3-5%
Transitional T2/T3          B220 + CD23+CD21/35low IgMhigh IgDhigh MZ/Follicle?                    Immature B cell                < 3%
preMZ B cells B220+ CD23+CD21/35high IgMint/high  IgDhigh Follicle Immature B cell <3%
Follicular B cells             B220 +CD23+CD21/35int IgMint/high IgDhigh
Follicle                              Mature B cell 
>90%
important in TD response
Marginal Zone B cells     B220+CD23 - CD21/35high IgMhigh IgDlow MZ 
Mature B cell
3-5%
important in TI response
B1 B cells                        B220+ IgMhigh IgDlow CD9f MZ?                         Mature B cell
-
<3%important in TI response
a B220/CD45 is belongs in the protein tyrosine phosphate family a nd is a major cell surface glycoprotein.  It 
primarily recognizes the proB cell stage through mature B cells.
b CD23 is a type II transmembrane glycoprotein present on resting follicular B cells. CD23 is also a low 
affinity receptor for IgE. 
c CD21/35 are expressed by mature B cells and CD21 is a receptor for complement component C3d and  
Epstein-Barr virus.
d IgM a class of immunoglobulin expressed on the surface of immature and mature B cells.
e IgD a class of immunoglobulin expressed on the surface of mature B cells.  
f CD9 is a cell surface glycoprotein important for cell adhesion and migration.
c
Regulatory B cells    CD1dhiCD5+ ?                         Produce IL-10 1-2%
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Marginal zone B cell production in young and old mice 
 In normal young adults, B cell development starts in the bone marrow.  B cells 
arise from common lymphoid progenitors (CLP) and through a series of gene 
rearrangements (V(D)J regions) develop into a pro-B cell, pre-B cell, and an immature B 
cell phenotype  (Fig. 3).  An immature B cell will leave the bone marrow and enter the 
spleen.  In the spleen, immature B cells will transition into T1, T2/T3 transitional B cells, 
and pre-MZ B cell before taking on the mature MZ B or FO B cell phenotype.  
Production of MZ B cells is influenced by several factors including but not limited to: 
interleukin-7 (IL-7) cytokine and receptor levels, B cell receptor (BCR) signal strength, 
the helix-loop-helix protein E2A, and more recently the adapter molecule SHEP1 (SH2 
domain-containing Eph receptor-binding protein 1) [reviewed in (11, 32, 66-68)].  For 
proper MZ B cell development, Notch 2 levels need to be high, and E2A protein activity 
and BCR signal strength need to be low.   An interesting observation is that in age 
decreases in IL-7 (69, 70), BCR signal strength (71-74), and E2A protein levels (75-77) 
have been observed (Fig. 4). Since these conditions favor MZ B cell development over 
FO B cell development, a shift towards MZ B cell differentiation at the expense of FO B 
cell production may be predicted.  However, increases in MZ B cell numbers in age have 
only been reported by the Cambier group using a BCR transgenic mouse model (78). 
Furthermore, results in this dissertation and the work by Frasca et al. (79) show a 
decrease in MZ B cells with age. 
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Figure 3.  MZ B and FO B cell production in young mice.  Figure depicts normal B 
cell development which arises in the bone marrow.  B cells arise from common lymphoid 
progenitors (CLP) and through gene rearrangement (V(D)J regions) will progress through 
a pro-B cell, pre-B cell, and an immature B cell phenotype.  An immature B cell will 
leave the bone marrow and enter the spleen.  In the spleen, immature B cells will 
transition into Transitional B cells before taking on the mature MZ B or FO B cell 
phenotype.  It has been suggested that MZ B and FO B cells also possess the ability to 
interchange, taking on the other’s phenotype depending on the environmental conditions.  
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Figure 4.  Factors important for the production of MZ B and FO B cells in young 
and old mice.  Immature B cells will develop into FO B cells as a result of the 
availability of high amounts of the transcription factor E2A and increased BCR signal 
strength induced by IL-7 secreted by bone marrow stromal cells.  MZ B cells will arise 
when there is less E2A available and the BCR signal strength is low.  Red text 
corresponds to the factors that are present in the aged microenvironment. 
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MAdCAM1
+
 marginal zone sinus and metallophilic macrophages 
The MZ compartment is also comprised of non-immune cells including the 
MAdCAM1
+
 sinus-lining endothelial cells, which line the site where pathogens and 
recirculating lymphocytes enter into the MZ (30).  MAdCAM1
 
is a homing receptor on 
the high endothelial venules (HEV) of gut-associated lymphoid tissue (80, 81).  
MAdCAM1 expressed on HEV has been shown to be responsible for lymphocyte traffic 
into these mucosal sites.  However, similar roles for the MAdCAM1 expressed on the 
endothelial cells that form the MZ sinus could not be demonstrated (82).  Recent studies 
have implicated the role of MAdCAM1 in the homing of bone marrow- derived 
hematopoietic stem cells into the spleen (83).  The MZ sinus is a capillary extension of 
the central artery.  Ultrastructurally, the MZ sinus of rats was found to have a basement 
membrane with discontinuous walls wider on the MZ side than the follicle side (36).  
Lymphocytes, macrophages, plasma cells, and occasionally polymorphonuclear 
leucocytes were found adjacent to these discontinuities; presumably these discontinuities 
are wide enough for the passage of cells as large as macrophages.    
The positioning of the MAdCAM1
+
 sinus-lining cells is thought to be under the 
influence of sphingosine-1-phosphate receptor 3 (S1P3).  S1P3 is a G-protein-coupled 
receptor belonging to a family of five different isotypes, S1P1-5, found ubiquitously on 
most cells including lymphocytes [reviewed in (7)].  The known ligand for the S1P1-5 
receptors is sphingosine-1-phosphate (S1P), which is a lysophospholipid found 
predominantly in peripheral blood and produced by many cells including macrophages 
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(7).  In a study by Girkontaite et al., S1P3- deficient mice showed morphological 
disruptions in the MAdCAM1
+
 sinus-lining cells that resembled multiple layers of 
MAdCAM1
+
 cells (84).  Disruptions in the MZ sinus most likely would lead to a 
hindrance in passage of cells and antigens through the discontinuities of the sinus. Studies 
presented in this dissertation will examine the MAdCAM1
+
 MZ sinus in old mice to 
determine if there are any gross morphology alterations, such as disruptions in cell 
positioning.       
 Situated along the inner border of the MZ sinus facing the white pulp area, MMM 
form a tight ring around the MZ sinus.  As seen with the MAdCAM1
+
 sinus, S1P3 has 
also been found to be necessary for the positioning of MMM (84).  MMM express the 
cell surface adhesion molecule Siglec-1 (sialoahesin) that can bind sialic acid containing 
molecules on the surface of pathogens and immune cells [reviewed in (7, 30)].  Siglec-1, 
however, is not involved in the internalization of antigen and requires other receptors for 
phagocytosis (7).  MMM produce the cytokines interferon-α and interferon-β after 
challenge with virus (30).  MMM have a high content of nonspecific esterase (85).  This 
enzyme is involved in the cleavage of fatty acids and removal of apoptotic cells.  In sum 
an alteration in MMM may impinge on the ability to remove dead cells that accumulate 
due to natural cellular turnover.  Furthermore, MMM positioning is continuous with the 
MZ sinus.  Therefore, it is also conceivable that disruptions in the sinus can indirectly 
cause damage to this pool of macrophages.      
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Survey of relevant age-associated declines in immune function 
 The elderly population 65 years and older has a greater susceptibility to infections 
than young adults.  Histological examination of splenic tissues with age have found 
reduced germinal centers (29) and disrupted T cell zone (PALS) of the spleen with visual 
changes in the MZ (26).  It has been well documented that aging is associated with a 
decline in cell-mediated and humoral immunity.  The thymus involutes and the naïve T 
cell pools decline with age while the memory T cell pool increases (86, 87).  In terms of 
the humoral immune response, the mature B cell pool (FO B cell phenotype) in the spleen 
has been reported to be similar in young and old mice (88); however, the pre B cell pool 
in the bone marrow has been reported to decrease when compared to young mice (88).  
The maintenance of the mature B cell pool in the spleen is thought to be due to an 
accumulation of long-lived mature B cells in the old and not a result of turnover with 
newly formed B cells (27).  Recent studies determined if B cells in old mice developed at 
similar rates when compared to B cells of young mice (89, 90).  BrdU labeling showed 
that the production rate of immature B cells is similar in young and old mice, yet newly 
made immature B cells of old mice were less frequent in the spleens of old mice when 
compared to young mice (89).  More recently, the migration of immature B cells to the 
spleens of old mice was examined by transferring immature B cells from young mice into 
old and young mice (27).  Results found that the number of donor immature B cells in old 
mice was significantly reduced when compared to the amount of donor cells recovered in 
young mice.   Together these data suggest that the reduced frequency of newly made 
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mature B cells observed in old mice is the result of alterations in the splenic 
microenvironment hindering newly formed B cells from populating the spleen.  
B cells are ultimately important for the production of antibodies against invading 
pathogens.  In age, levels of serum antibody against tetanus toxoid, plant mitogens and 
allogenic lymphocytes of older humans are reduced compared to young adults and are 
maintained for shorter periods (91-93).  Moreover, the antibodies produced by aged 
individuals have been reported to have reduced affinity and avidity when compared to 
antibodies of young adults (94-96).    Reports using mice have shown antibodies 
generated in old mice against PC, found in the cell wall of S. pneumoniae, are less 
protective when compared to the antibodies generated in young mice (73, 74).  PC-
specific hybridomas were generated from young and old mice and isolated RNA was 
used to determine which immunoglobulin VH and VL gene families (important for the 
variable region of the immunoglobulin) were utilized.  Results revealed that 12/13 of the 
hybridomas tested from young mice expressed restricted VH and VL gene families, 
whereas only 2/13 of the hybridomas from old mice expressed the same VH genes and 
none expressed the VL gene family seen in young.  Thus, the repertoire of 
immunoglobulin gene usage appears to change with age.  Furthermore, the antibodies 
generated against PC in old mice were able to cross react with a number of unrelated 
antigens (74).  In humans, the IgM antibody titers of elderly individuals vaccinated 
against S. pneumoniae or pneumococcal polysaccharides has also been reported to be 
reduced when compared to young adults (97).   Given that S. pneumoniae infection can 
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elicit a TI immune response these data suggest a breakdown in the TI immune response 
in the old.  As mentioned previously, MZM are key in the response to TI antigens.    
Although there are no reports on the immune response of MZM in age, whole 
splenic macrophages (13), peritoneal macrophages (98, 99), and alveolar macrophages 
(100) of aged rodents have been reported to decrease in function when compared to 
young rodents.  Studies by Chelvarajan et al. measured the cytokine profiles of whole 
splenic macrophages in vitro after treatment with the TI antigens trinitrophenol (TNP)-
LPS and TNP-Ficoll.  Results showed that aged macrophages secreted reduced amounts 
of the proinflamatory cytokines IL-6, TNF-α, IL-1β, and IL-12 and elevated amounts of 
the anti-inflammatory cytokine IL-10 when compared to young mice (13). Similarly, 
studies with peritoneal macrophages isolated from young and old mice found that after 
LPS stimulation, cultured macrophages  from old mice produced less IL-6 and TNF-α 
when compared to young mice (98).  It was further determined by Boehmer et al. that this 
decrease was due to decreases in p38 and c-jun NH2-terminal(JNK) mitogen-activated 
protein kinase (MAPK), which are transcription factors important for the production of 
IL-6 and  TNF-α.  Notably, this same study found no differences in the surface 
expression of TLR4 (recently shown to interact with SIGN-R1) between age groups.    
There is also a wide body of literature that has found heightened levels of 
proinflammatory cytokines with increasing age (101, 102).  This heightened 
proinflammatory state is termed “Inflam-aging” and is described as the underlying factor 
attributing to the immunosenescence observed in aging.  It has been suggested that 
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phagocytic cells such as macrophages and neutrophils are responsible for increased 
production of proinflammatory cytokines in age.  It is argued that this hyper-
proinflammatory state result in damage to neighboring immune cells and thereby 
contributes to immunosuppressive effects. Whether a hyper-proinflammatory state can 
lead to a hindrance in normal cell frequencies still, however, remains to be elucidated.   
Goals of my experiments 
The MZ of young mice is a highly organized region comprised of MZM, MZ B 
cells, the MZ sinus and MMM.  Since little is known about changes in the cellular 
components of the MZ with age, the goal of this dissertation is to compare the MZ 
compartment in old and young mice and to assess the age-associated alterations of 
the MZ.  Results presented in this dissertation first show that there is a morphological 
disruption of the MZ with age and decreases in MZM and MZ B cell frequencies are seen 
in old mice. Results have also determined the possible micro-environmental factors 
contributing to this loss of MZM and MZ B cells with age.  Lastly, the functional 
differences of MZM of young and old mice were investigated.  These results determined 
that the decline in the TI immune response reported in age is a result of loss in cell 
frequency/number and not a cell intrinsic defect.
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CHAPTER III 
MATERIALS AND METHODS 
Animals 
Female BALB/c mice were purchased from Harlan Laboratories (Indianapolis, IN) or 
Charles River (Wilmington, MA) through contract with the National Institute of Aging at 
17-18 mo of age and from Harlan Laboratories at 6-8 wks of age. Upon receipt, the 
animals were housed at the Animal Research Facility (Loyola University Medical Center, 
Maywood, IL) under specific pathogen-free conditions until sacrificed.  Old animals with 
any visual abnormalities such as enlarged spleens and presence of tumors were not used 
in these studies. 
Tissue histology 
Spleens were fixed in 10% buffered formalin and processed using an automatic tissue 
processor, dehydrated through graded alcohols, cleared in xylene and infiltrated with 
paraffin. Paraffin sections were cryosectioned on a microtome (4 µm) and applied on 
Superfrost
®
/ Plus microscope slides (Fisher Scientific, Pittsburg, PA). Sections were then 
treated with xylene to deparaffinize the tissue and rehydrated in successive decreasing 
grades of alcohol. The splenic sections were stained with hematoxylin and eosin (H&E). 
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Sections were cleared and mounted. Slides were viewed and photographed with a Leitz 
Diaplan microscope (W. Nuhsbaum, Inc., McHenry, IL).  
Tissue specific scoring of MZ architecture 
H&E stained slides were blinded and four well-oriented white pulp areas were chosen for 
each animal and scored independently by two investigators. In consultation with a 
pathologist, criteria were established to evaluate the morphology of the MZ.  The 
interface between the white pulp and MZ was evaluated subjectively for the percent of 
distortion around each white pulp area and given a score ranging from 0-4.  A score of 0 
corresponded to  75% distortion, 1 was  50% but  75%, 2 corresponded to  12.5% 
and  50% distortion, 3 corresponded to  12.5% distortion, and finally a score of 4 
corresponded to no evidence of interface distortion.  For each white pulp area, the extent 
of interface distortion was also evaluated by determining the percent of radius 
involvement. This was defined by taking the area that was distorted and evaluating the 
amount of distortion that protruded toward the center of the white pulp. As before, for 
each white pulp area, a score ranging from 0-4 was given. A score of 0 was  20%, 1 
corresponded to  15%, 2 corresponded to  10%, 3 corresponded to  5%, and finally 4 
corresponded to no distortion protruding inwards.  The summation of the interface 
distortion and percent of radius involvement per white pulp area was determined and 
given a total score ranging from 0-8.  The final distortion was characterized either as 
severe (0-2), moderate (3-4), mild (5-6), or minimal (7-8).  Finally, the average score of 
all four white pulp areas per animal was determined and reported for each mouse.  
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Tissue specific scoring of MAdCAM-1
+
 MZ sinus lining cells 
MZ sinus lining cells were revealed by immunofluorescence staining of spleen frozen 
sections from the middle 1/3 of the spleen. A tiled image (25x) of a complete cross 
section of spleen (6-8µm) from each animal was compiled using a Zeiss LSM 510 
confocal microscope (Carl Zeiss, Inc., Jena, Germany). Using LSM image browser 
software (Carl Zeiss, Inc), the lines of MAdCAM-1
+
 cells were outlined using the 
polyline drawing and measurement tools. Measurements of the length of MAdCAM-1
+
 
cells enveloping all white pulp areas in a single section were recorded. Disrupted lengths 
were then discriminated and measured by identifying dispersed, non-compact MAdCAM-
1
+
 staining. Relative proportion of the disrupted areas verses total length of the lines 
covered by MAdCAM-1
+
 cells was calculated. 
Immunocytochemistry  
One-third of each spleen was frozen in Tissue-Tek
®
 O.C.T. freezing medium (Sakura, 
Torrance, CA) and stored at -70
o
C. Frozen spleens were cryosectioned (6-8 µm) onto 
Superfrost®/ Plus microscope slides. Splenic sections were fixed in acetone for 10 min, 
blocked in 5% normal mouse serum (NMS) (The Jackson Laboratory, Bar Harbor, 
Maine) and then incubated for 1 hr with an unconjugated rat anti-mouse IgG2a anti-
MAdCAM-1 mAbs (MECA-367; BD Pharmingen, San Diego, CA) followed by a 30 min 
incubation with alkaline phosphatase conjugated mouse anti-rat IgG2a (2A 8F4; Southern 
Biotech, Birmingham, AL) to detect the MZ sinus lining cells. Positive cells were 
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revealed using Alkaline Phosphatase Substrate Kit III (Vector Laboratories, Burlingame, 
CA). For double immunocytochemistry, sections were then blocked with 5% NMS for 20 
min and subsequently incubated for 30 min with either unconjugated rat anti-mouse IgG1 
anti-MARCO mAbs (ED31; BMA Biomedicals, Switzerland) or unconjugated armenian 
hamster anti-mouse SIGN-R1 (ebio22D1; eBioscience, San Diego, Ca) followed by a 20 
min incubation with horseradish peroxidase (HRP) conjugated mouse anti-rat IgG1 (G1 
1C5; Southern Biotech) or rabbit anti-armenian hamster IgG HRP (Abcam Inc., 
Cambridge, MA), respectively, to detect MZM.  Positive cells were revealed using DAB 
Substrate Kit for Peroxidase (Vector Laboratories). All antibody incubations were at 
room temperature. Slides were counterstained with Nuclear Fast Red (Vector 
Laboratories) for 30-60 seconds, mounted with VectaMount (Vector Laboratories) and 
viewed and photographed with a Leitz Diaplan microscope. 
 Tissue specific scoring of MZM 
MARCO was revealed by immunocytochemical staining of spleen frozen sections. Slides 
were blinded and four well oriented white pulp areas were chosen per animal and scored 
independently by two investigators. Each area was given a score of 1, 2, or 3 for the 
abundance of MARCO
+
 MZM and the percent of the continuity of MZM encircling each 
white pulp area.  A score of 3 equated to a high abundance of MZM present that tightly 
encircled the MZ sinus. A score of 2 equated to a moderate abundance of MARCO
+
 
MZM that partially encircled the MZ sinus. Finally, a score of 1 equated to low or virtual 
absence of MARCO
+
 MZM that, if present, were found in patches along the MZ sinus.  
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An average score of the four white pulp areas graded was determined and reported for 
each individual animal. 
Immunofluorescence and confocal microscopy 
Cryosections of spleen were fixed in acetone for 5 min and incubated with Super Block 
(ScyTek Laboratories, Inc., Cache, UT) for 5 min according to manufacturer’s protocol. 
Sections were incubated at room temperature with primary antibodies for 1 hr followed 
by respective secondary antibodies for approximately 30-45 min. To identify MZ sinus 
lining cells, sections were stained with unconjugated rat anti-mouse MAdCAM-1 
followed by goat anti-rat Alexa Fluor
®
 633 (Invitrogen, Carlsbad, Ca).  For isotype 
control, rat IgG2a unlabeled with goat anti-rat Alexa Fluor
®
 633.
 
 To reveal MMM, 
sections were incubated with fluorescein isothiocyanate (FITC) conjugated rat anti-
mouse CD169 (MOMA-1; AbD Serotec, UK). For isotype control, rat IgG2a FITC.  To 
reveal MZM, sections were stained with unconjugated armenian hamster anti-mouse 
SIGN-R1, goat anti-armenian hamster IgG biotin (The Jackson Laboratory) and 
Streptavidin (SA)-Dylight
™
 549 (The Jackson Laboratory).  For isotype control, 
Armenian hamster IgG.  Sections were blocked with 5% normal armenian hamster serum 
for 20 min and stained for co-localization of MARCO using unconjugated rat anti-mouse 
MARCO followed by donkey anti-rat Dylight
™
 488 (The Jackson Laboratory).  Isotype 
control used, rat IgG1.  To reveal CCL21, sections were stained with goat anti-mouse 
CCL21 (R&D Systems) and donkey anti-goat Alexa 555 (Invitrogen).  For isotype 
control, goat IgG (Jackson Laboratory).  Sections were blocked with 5% normal rat 
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serum for 20 and stained for MZ sinus lining cells as a landmark using unconjugated rat 
anti-mouse MAdCAM1 followed by donkey anti-rat Alexa 488 (Invitrogen). For isotype 
control, rat IgG2a (AbD Serotec).  Slides were mounted with fluorescent mounting 
medium (Dako, Carpinteria, CA) and viewed using a Zeiss LSM 510 confocal 
microscope (Carl Zeiss, Inc., Jena, Germany). 
In vivo uptake of dextran by MZM 
Using a protocol previously described by Ato et al. (43), mice were injected i.v. in the tail 
vein with 200 µl of dextran-FITC (500,000 MW, Invitrogen) at 100µg/ml in sterile PBS. 
After 45 min, the mice were sacrificed and spleens harvested.  One third of the spleen 
was placed in Tissue-Tek® O.C.T. freezing medium for immunofluorescence analysis 
and the remaining 2/3 was used for flow cytometry analysis (as described below).  For 
co-localization of MARCO with dextran-FITC positive cells, cryosections were 
incubated with unconjugated rat anti-mouse MARCO followed by donkey anti-rat 
Dylight
™
 488 (as described above).  Slides were mounted with fluorescent mounting 
medium and viewed using a Zeiss LSM 510 confocal microscope.   
Flow cytometry – revisited 
Flow cytometry is a highly sophisticated instrument that can be used to gather a 
plethora of information about a cell population such as the cell size, cells 
frequency/number, and amount of protein expressed on the cells surface (103).  A cell 
can be identified via flow cytometry analysis through the use of fluorescently labeled 
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antibodies that recognize the cells antigens.  Current flow cytometry methods utilize the 
use of a multiple fluorescently labeled antibodies for the precise identification of cell 
populations.  After cells are stained with the appropriate antibodies they are run through 
the flow cytometer.  Cell samples are suspended in saline solution, and 1000 cells/second 
are passed through the flow cytometer like a stream.  At the integration point of the 
instrument each cell is hit with a laser beam and information about how the cell scatters 
light and the fluorescence of the conjugated antibodies bound to the cell is recorded.   
Light scattered in the forward direction is called the cells forward scatter (FSC).  
The FSC gives information about the size of the cell – small cells have low FSC and 
large cells have high FSC.  Light scattered in angular directions is called the side scatter 
(SSC).  The SSC gives information about the cells granularity.  Cells such as neutrophils 
have high SSC because they are highly granular due to high levels of lytic enzymes 
within the cell compared to lymphocytes that have virtually no lytic enzymes.  
The fluorophores conjugated to the antibodies each have a unique excitation and 
emission spectrum.  The simultaneous measurement of multiple fluorescently labeled 
antibodies on a cell will result in spectral overlap in the emission spectrums.  Special 
filters will correct for this overlap, however, compensation also needs to be utilized. 
Compensation is the process by which the spectral overlap of the interfering fluorophore 
is subtracted as a percentage of the signal.  For this subtraction to be achieved single 
fluorescently stained beads/cells for each fluorophore used to mark the cell need to be run 
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on the cytometer before the cell sample is run.  Once compensations are set the 
experimental samples are ready to be run through the flow cytometer.   
Lasers are used to excite the fluorophores and optical filters are used to separate 
emission of varying wavelengths.  Optical filters can be either high pass (for one 
fluorophore detection; allows light of high wavelengths to pass while attenuating low 
wavelengths), short pass (allows light of short wavelengths to pass while attenuating light 
of high wavelength), or band pass (for multiple fluorophore detection; a combination of 
low and high pass filters).  A blue 488 nm, red 633 nm (HeNe), and a violet 405 nm laser 
are in the FACSCanto™II cytometry used at the Loyola University Medical Center Core 
Facility.   
Analyzing data gathered  
For years the isotype antibody of the antibody used to target antigen was used as 
the control to determine where the positive cell populations of interest separated from the 
negative cell populations. In the last decade the use of fluorescence minus one (FMO) has 
become the standard for flow cytometry controls (104).  FMO employs all the 
fluorophores used to target a population except the one of interest to determine the 
positives and negatives of that particular population.  Once the gates are determined 
populations of cells can be revealed through recognition of protein determinants known 
to be associated with the cell.  Analysis of the data collected by the flow cytometer is 
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done using Tree Star FlowJo software version 7.5.5 (Becton Dickinson, Mountain view, 
CA).   
Flow cytometric staining for identification of MZ B cells, FO B cells, MZM, CCR7
+
 
MZM, dextran
+
 MZM, pHrodo
+
 MZM, and CD4
+
 T cells  
Splenocytes, from approximately 1/2 - 2/3 of each spleen, were obtained by 
gently pressing the splenic tissue between two frosted glass slides. The dispersed cells 
were collected in RPMI 1640 supplemented with 10% FBS, 1% L-glutamine, 1% 
penicillin/streptomycin, and 500 µl M β2-ME (referred to as media here on end), and 
small clumps were allowed to settle in a conical tube and discarded.  Erythrocytes were 
lysed with 0.8% ammonium chloride solution and incubated on ice for 4 min.  For four-
color analysis of MZ B and FO B cells, 1 x 10
6
 cells per sample were incubated with rat 
anti-mouse CD23-PE-CY7 (B3B4; eBioscience), rat anti-mouse B220-FITC (RA3-6B2; 
Southern Biotech), rat anti-mouse CD21/35-PE, and rat anti-mouse IgM-PE-Cy5.5 (II/41; 
eBioscience) for 20 min on ice, protocol modified from Won et al. (105). Cells were then 
fixed in 1% paraformaldehyde and the samples were analyzed using FACS Canto II with 
Tree Star FlowJo software version 7.5.5.  MZ B cells were identified as CD23
-
 B220
+
 
CD21/35high IgMhigh.  FO B cells were identified as CD23
+
 B220
+
 CD21/35int IgMint/high.  
 For MZM characterization, approximately 1/2 - 2/3 of each spleen was treated 
with Collagenase D (Roche Diagnostics, Indianapolis, IN) or without (as described 
above) for 1.5 hr at 37
o
C, and the single cell suspension was recovered after gentle 
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filtration of the minced tissue through a fine nylon mesh. The erythrocytes were lysed by 
0.8% ammonium chloride and the cells were washed and resuspended media.  For two-
color analysis to identify MZM, 1 x 10
6
 cells per sample were pretreated on ice with rat 
anti-mouse CD16/32 FcR-block (FCR4G8; AbD Serotec) and subsequently incubated 
with either allophycocyanin (APC)-Cy7 labeled rat anti-mouse CD11b (M1/70; 
eBioscience) or biotinylated CD11b (M1/70; eBioscience) with armenian hamster anti-
mouse SIGN-R1-Alexa Fluor
®
 647 (22D1; eBioscience) for 20 min on ice. Streptavidin-
peridinin chlorophyll protein (SA-PerCP; 16904; BD Pharmingen) was used as a second-
step reagent.  For isotype control to SIGN-R1, armenian hamster anti-mouse IgG-Alexa 
Fluor
®
 647 (22D1; eBioscience) was incubated for 20 min on ice. Cells were fixed in 1% 
paraformaldehyde, except in experiments using dextran; cells were resuspended in PBS 
and analyzed using flow cytometry.   
For characterization of CCR7
+
 MZM, 1 x 10
6
 cells per sample of dispersed splenocytes 
were incubated with anti-mouse CCR7-PE (eBioscience) for 30 min in 37
o 
C followed by 
pretreated on ice with rat anti-mouse CD16/32 FcR-block and subsequently incubated 
with antibodies to identify MZM (described above).  For isotype control to CCR7, Rat 
IgG2a (eBioscience) for 30 min in 37
o 
C.  For characterization of CD4+ T cells, thymus 
was removed and single cell suspensions were made and resuspended in media.  For one 
color identification of CD4
+
 T cells, 1 x 10
6
 cells per sample were stained with anti-
mouse CD4-PE (eBioscience).  Cells were fixed in 1% paraformaldehyde and 
resuspended in PBS and analyzed using flow cytometry.   
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For characterization of pHrodo
+ 
MZM splenocytes obtained from both young and 
old cells were harvested and allowed to adhere onto 35 mm culture plates for 1 hr in 
media.  Non-adherent cells were removed and 125 µl of 125µg/ml pHrodo were added 
and allowed to incubate in 37 C for 2 hrs.   Cells were collected using a policeman 
scraper, stained for to identify MZM, and analyzed using FACScanto, which records 
fluorescence of the phagocytized pHrodo in the PE channel. 
Adoptive transfer of mature B cells to young and old recipient mice 
 Spleen was prepared from young (IgM
b
) C.B17 mice and transferred into young 
and old (IgM
a
) BALB/c mice.  C.B17 mice differ from BALB/c mice in expression of the 
IgM allotype, allowing for donor cells to be identified from recipient cells.  Donor spleen 
cells were dispersed as described above, and then donor mature B cells were purified 
using a magnetic antibody cell sorting (MACS) B cell isolation kit (Miltenyi Biotech) 
according to the manufacturer’s protocol.    Each recipient mouse received an intravenous 
injection of 20 x 10
6
 donor purified mature B cells in 200 µl PBS.  Spleens from recipient 
mice were harvested 6 hr post-transfer. Donor MZ B and FO B cells were analyzed by 
flow cytometry stained with antibodies previously mentioned for the identification of MZ 
B and FO B cells (note: anti-allotype IgM biotin was used in place of rat anti-mouse IgM 
PE-Cy5.5 for identification of donor cells). 
 For detection of MZ B cells in bone marrow, lymph node and blood cell 
preparation was performed as follows: Bone marrow was harvested by flushing the tibias 
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and femurs from one leg of each mouse using a 27-gauge needle and a 10 ml syringe 
filled with media.  Aggregated cells were separated by pipetting up and down with a 5 ml 
pipette.  Cells were centrifuged and the cell pellets were resuspended in 5 ml media.  
Inguinal, axial, and cervical lymph nodes were removed from each mouse and single cell 
suspensions were made by rubbing the nodes between two frosted glass slides.   Cells 
were pelleted and resuspended in 3ml media.  Blood was collected by cardiac puncture 
after mice were CO2 asphyxiated.  To prevent blood coagulation blood is drawn from the 
cardiac chamber using a 10 ml syringe containing 1 ml citrate to yield a total volume of 
1.5-2 ml blood + citrate.  Blood suspensions were diluted with 2 ml of PBS and 3 ml 
lymphocyte separation medium was added.  The preparation was centrifuged for 30 min 
at room temperature at a speed of 1500 rpm.  Lymphocytes were recovered by gentle 
pipetting. Media was then added to the cell suspension and centrifuged for 7 min at 4°C.  
Cells were pelleted and resuspended in 1 ml media.     
Quantitative RT-PCR analysis of expression of the chemokine CCL21 
 Quantitative RT-PCR analysis was performed on spleen from young and old 
mice.  Spleens were frozen in liquid nitrogen for homogenization at a later date.  
Homogenization was done using a rotor-stator homogenizer.  Total RNA was isolated 
from whole homogenized spleen using the Qiagen RNeasy Kit (Valencia, CA) according 
to the manufacturer’s suggested protocol.  Complementary DNA (cDNA) was 
synthesized using the Amersham First Strand cDNA synthesis kit (Buckinghamshire, 
UK) and real-time PCR analysis was performed using a GeneAmp 2400 thermal cycler 
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(PerkinElmer, Wellesley, MA).  Primers were as follows:  CCL21: forward 5’ –
AAAGAAAGGAAAGGGCTCCAA-3’ and reverse 
5’TGCGCTCATCTTAGGCTTTGT-3’.  The real-time PCR thermal cycler profile was 
run as follows: one cycle at 50°C for 2 min, one cycle at 95°C for 10 min, 40 cycles of 
denaturing at 95°C for 15 seconds, and annealing and elongation at 60°C for 1 min, 
followed by a dissociation protocol run to test the melting temperature of the product.  
The data were analyzed using GeneAmp 5700 SDS software (Applied Biosystems).  The 
relative expression levels for each sample were calculated by determining the ratio of the 
number of copies/µl for CCL21 to the number of copies/µl of HPRT.  
pHrodo treatment and analysis via microplate reader 
Splenocytes were harvested as described above from young and old mice and 
allowed to adhere onto a 96 well plate at 1 x 10
6
 cells/well.  Non-adherent cells were 
washed after 1 hr and 100µl of 100µg/ml pHrodo were added per well and allowed to 
incubate in 37 C for 2 hrs.  After 2 hrs, the 96 well plate was placed in a microplate 
reader and cells were excited using a 550 nm laser and the emission was recorded at 600 
nm.  The percent net effect was determined by using the manufacture suggested formula.  
Ex vivo treatment of pHrodo   
Young and old mice were injected with dextran-FITC (as described above).  Splenocytes 
were harvested and 4 x 10
6
 splenocytes were allowed to adhere onto 1 ml chamber slides 
(Nunc Labtek) for 1 hr at 37°C incubator.  After 1 hr non-adherent cells were removed 
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and pHrodo™ S. aureus BioParticles® (pHrodo) (Molecular Probes™ Invitrogen) were 
given at 100 µg/ml in Hank’s balanced salt solution HBSS (GIBCO® Invitrogen) 
containing 20 mM Hepes (GIBCO
®
 Invitrogen) for 1.0-1.5 hr.  After 1.0-1.5 hr cells were 
viewed using a Leica TCS SP5 confocal microscope (Leica) remaining incubated at 
37°C.  Each chamber containing cells from one animal was examined for 15 min.  The 
following exceptions were made with time lapse experiments: pHrodo was administered 
and 10 min after administration, MZM were imaged once every min (for total of 60 min) 
or once every 2 min (for total of 120 min).  For each animal sample dextran
+ 
pHrodo
+
 
MZM were located and approximately 10-15 MZM were imaged/animal live at 5000x 
magnification.  Three criteria were needed to qualify as an MZM: first, cells needed to be 
dextran
+
; second, cells needed to be pHrodo
+
; and lastly, cells needed to have 
macrophage morphology. 
 Phagocytosis of pHrodo by MZM was measured using ImageJ version 1.43u.  For 
each animal sample, single images of dextran
+
 pHrodo
+
 MZM were evaluated for the 
mean fluorescence intensity (MFI) of pHrodo and dextran within MZM, and the number 
of phagocytic compartments/MZM.  For young mice approximately 7-10 MZM images 
were analyzed and for old mice 4-5 MZM images were analyzed. The average value was 
reported for each measurement assessed.          
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Statistical analysis  
Statistics were calculated using Graphpad Prism software (version 5.01). To compare 
compared differences in cells populations between young and old mice Mann-Whitney 
test or Unpaired t-test was used.  To determine if there was a direct correlation between 
changes in one cell type to another Pearson Correlation was applied where appropriate.
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CHAPTER IV 
THE ANATOMICAL AND CELLULAR CHANGES IN THE 
MARGINAL ZONE OF YOUNG AND OLD MICE 
  This chapter provides a survey of the morphological and cellular 
alterations of the MZ with age.  Initial observations revealed visual disruptions of the MZ 
with age.  These disruptions were first observed on H&E cross sections of mice spleens, 
which could not identify specific cell population involved in the alterations.  By 
examining the various cell components that make up the MZ in young and old mice, the 
populations responsible for these morphological disruptions were determined.  Given that 
the cells that comprise the MZ are vital for the proper immune response to TI antigens, 
establishing which cells are altered with age would provide insight into the reported age 
associated declines in immunity.  
Previously established methods, as well as novel methods using flow cytometry 
and tissue histology, were used to identify and properly assess MZ cells and to determine 
if alterations were present in old mice.  Results showed gross alterations in the structure 
of the MZ with age are attributed to decreases in the MZM and MZ B cells pools and 
disruption in the positioning of the MAdCAM-1
+
 lining cells and MMM.  Results also 
showed that in ~20% of old mice, a “young-like” phenotype persist within the MZM and 
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MZ B cell compartment.  Therefore, unless animals fall into this 20th percentile 
of having young-like cell frequencies, a consequence of a reduction in cells of the MZ 
with age can have an impact on an efficient immune response.   
Morphological disruption of the splenic MZ areas in old mice  
The morphological organization of the MZ region in young animals is well 
defined (7, 8, 106).  In consultation with a pathologist, two morphological criteria were 
selected to discriminate the degree of morphological disruption in the MZ areas of aged 
spleens.  Sections of H&E stained spleens from young and old mice were scored 
independently by two investigators, “blinded” to the identity of the specimens.  The 
criteria used were (1) the interface distortion (defined as the boundary between the white 
pulp area and the inner edge of the MZ) and (2) the percent radius involvement (defined 
as the percentage of interface distortion protruding towards the center of the white pulp 
(Fig.5).  Each criterion was given a score ranging from 0-4 (severe to minimal).  Four 
MZ areas were scored for each spleen.  A sum of scores for both criteria was calculated 
for each MZ area, and this sum was averaged to yield a value for each individual spleen 
(Fig.5B) (detailed in material and methods).  The MZ from young mice (2-6 months, 
Fig., top panels) uniformly encircled the white pulp areas.  However, the MZ of old mice 
(18-23 months, Fig.5A, bottom panels) showed a great deal of variability and many had a 
high degree of distortion around the white pulp compared to spleens from young mice.  In 
many old mice, the splenic MZ areas were diffuse and some were even difficult to 
discern.  Figure 5B shows that on average, the morphology of splenic MZ from old mice 
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could be histologically discriminated from those of young mice.  Of note, the splenic MZ 
from some old mice retained a “young-like” morphology, in which the MZ areas appear 
to have intact organization by the criteria assessed (Fig. 6).  
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Figure 5.  Morphological comparison of the MZ architecture of young and old mice. 
(A) Fixed, paraffin-embedded cross-sections of spleens stained with H&E demonstrating 
the range of disruption in the MZ of young and old mice.  The top panels are a 25x and 
50x magnification of a white pulp area from one representative young mouse.  At 50x 
magnification the interface distortion (depicted by the inner line) is uniform and the 
percent radius involvement (arrows point to minimal protrusion of cells inward) is ≤ 5%.  
The lower panels are a 25x and 50x magnification of a white pulp area from one 
representative old mouse.   At both low and high power magnification the interface 
distortion is severe and the percent radius involvement is ≥ 20% (arrows point at cells 
protruding into the white pulp area).  (B) Qualitative scoring of MZ histology as detailed 
in Materials & Methods.  The average score for four white pulp areas from each of six 
young (2-6 mo), filled circles and six old (18-23 mo), open squares is shown.  The 
horizontal bars indicate the average and SEM for each group.  p = 0.0021 determined by 
Unpaired t-test . 
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Figure 6.  Representative images of H&E stained splenic sections from young and 
“young-like” old mice. The top panel is a 50x magnification of a white pulp area from 
one representative young mouse.  The boundary of the MZ is visible and the interface 
distortion is uniform and the percent radius involvement is ≤ 5%. The bottom two panels 
are 50x magnification of white pulp areas of old mice that exhibit “young-like” MZ.  The 
interface distortion and percent radius involvement are similar to that of which is 
observed in young mice. 
Old
Old
Young
MZ
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Alterations in the cells of the MZ region in spleens of old mice revealed by 
immunofluorescence staining  
The MZ is a compartment composed of different types of macrophages and B 
cells that are highly organized for the function of detecting and clearing antigens from the 
blood.  Therefore, any changes in these cells or their position within the MZ of old mice 
could account for the decreases in clearance of TI antigens with age.  Staining was 
included for MAdCAM-1
+
 MZ sinus lining cells to provide a landmark, since both MZM 
and MMM relate in position to the MZ sinus. Similar to numerous reports of spleens 
from young mice, MAdCAM-1
+
 MZ sinus lining cells (red or purple) showed continuous, 
thin rings surrounding white pulp areas (Fig. 7A top panel).  In contrast, the MAdCAM-
1
+
 cells from old mice exhibited a less even, more diffuse distribution and often appeared 
as multiple layers of cells oriented toward the white pulp (Fig. 7A bottom panel).  Figure 
6A shows an assessment of MAdCAM-1
+
 disruptions in young and old mice.  In spleens 
from young mice, MMM (green) were closely aligned with the MAdCAM-1
+
 cells and 
formed a continuous line of cells on the follicular side of the MZ sinus (Fig. 8A top 
panel), similar to published examples (7).  In the spleens from old mice, the MMM were 
aligned along the MZ sinus but were highly diffused into the white pulp/follicle area (Fig. 
8A bottom panel).   The diffused distribution of MAdCAM-1
+
 cells and MMM was 
consistently observed in old mice. 
 The most pronounced difference between old and young spleens was in the 
distribution of the MZM (marked by expression of either MARCO or SIGN-R1). MZM 
in young spleens formed continuous rings on the outer edge of the MZ sinus (Fig. 8B top 
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panel), similar to numerous published reports (18-21, 40).  However, in many old 
spleens, MZM appeared to be reduced in abundance and aligned in discontinuous patches 
along the MZ sinus (Fig. 8B lower panel).  In summary, with age there are several 
disruptions in the positioning of cells specific to the MZ region, including the MAdCAM-
1
+
 sinus lining cells, MMM, and MZM.  It appeared that with age the variability in MZM 
was greater than that seen in the MAdCAM-1
+
 cells and MMM.  The degree of alteration 
in the MZM population within individual old animals was next assessed.  MZM bind and 
phagocytize blood-borne bacteria (7, 20), thus changes in the number of MZM with age 
can affect the clearance of blood-borne bacteria as less MZM are available to 
phagocytize.  
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Figure 7.  Morphological comparison of disrupted MAdCAM-1
+
 MZ sinus lining 
cells in young and old mice.  Representative photos are shown of frozen sections (6-
8µm) stained for MAdCAM-1
+
 MZ sinus lining cells. (A) Left are representative images 
(25x tiled magnification) taken from cross sections of whole mouse spleens with the 
MAdCAM-1
+
 MZ sinus lining cells (purple) observed encircling numerous white pulp 
areas. Images to the right (50x magnification) are the MAdCAM-1
+
 MZ sinus lining cells 
of one white pulp area from a representative young (top) and old (bottom) mouse spleen..  
(B) Relative linear proportion of disrupted MAdCAM-1
+
 cells in five young mice (2-3 
mo, filled circles) and five old mice (18-23 mo, open squares). Each symbol indicates an 
individual animal. The horizontal bars indicate the average and the SEM for each group. 
p = 0.0001 determined by unpaired t-test  
B
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Figure 8.  Immunofluorescence of cellular compartments of the MZ region of young 
and old mice.  Representative photos are shown of frozen sections (6-8 microns) stained 
for cells within various compartments of the MZ and analyzed by confocal microscopy 
(all images taken at 50x magnification).  (A) The continuous, tight ring of MAdCAM-1
+
 
MZ sinus lining cells (red) typical of young and the diffused distribution observed in old 
mice (examples from 2 mice of each age).  Young MOMA
+
 macrophages MMM (green) 
contrast with aged MMM which appear diffuse and infiltrated into the white pulp in old 
tissue.  Right panels show representative photos of isotype controls.  (B) Shows a 
representative example of the changes in distribution of MZM (indicated by staining for 
MARCO (red) and SIGN-R1 (green)) found in spleens of many old mice.  MZM showed 
a continuous line encircling the white pulp in young animals in contrast to a patchy, 
discontinuous distribution in many old mice.  Right panels show representative photos of 
isotype controls.   
MAdCAM-1 MOMA1 MERGE
Young
Young
Old
Old
MARCO SIGN-R1 MERGE
Controls
Controls
MARCO Hamster IgG
Rat IgG1 SIGN-R1
Rat IgG2  MOMA
A
B
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A reduction in MZM in the spleens of old mice revealed by immunocytochemical 
staining   
 Sections of young and old spleens were stained using antibody to MARCO 
(brown) to mark MZM and antibody to MAdCAM-1 (blue) to mark the MZ sinus lining 
cells.  Figure 9 top panel shows the typical, consistent pattern observed in young spleens: 
the MZM population was present in a continuous line of cells adjacent to the sinus lining 
cells.  However, the distribution of MZM in spleens of old mice was highly variable, 
ranging from a young-like distribution of MZM to negligible stain for MZM.  Many 
spleens from old mice had notably decreased staining for MARCO (Fig. 9A middle 
panel, representative of intermediate reduction).  In these spleens, the expression of 
MARCO was localized in patches rather than in a continuous line of cells around the MZ 
sinus.  A semi-quantitative scoring was devised in order to compare the MZM 
distribution in young vs. old spleens.  For each spleen, four well oriented white pulp areas 
were graded “blind” for (1) the relative abundance of MARCO+ MZM present and (2) the 
continuity of MARCO
+
 MZM positioning around the MZ sinus (detailed in Materials and 
Methods).  Scores ranging from 1-3 were given for each criterion graded (worst to best; 
Fig. 9A shows representative tissue sections for each score).  An average of scores was 
calculated and shown for individual animals (Fig. 9B).  Expression of MARCO
+
 MZM 
showed a statistically significant decrease in old tissue compared to young (n = 13 young 
and n = 15 old, p = 0.0012).  Using serial sections, immunocytochemical staining for 
SIGN-R1, although less intense than for MARCO, also reflected reduced abundance and 
patchy pattern (representative examples in Fig. 8B middle panel and data not shown) 
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confirming that reduction of MARCO expression reflected a decreased presence of 
MZM. 
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Figure 9.  Semi-quantitative assessment of MZM disruption in spleens from old 
mice.  (A) Immunocytochemistry of frozen sections (6-8 microns) stained to reveal 
MAdCAM-1
+
 MZ sinus lining cells (blue) and MARCO
+ 
MZM (brown).  Left panels are 
images taken at 10x and right panels are images taken at 50x magnification.   MZM were 
semi-quantified for the (1) abundance of MARCO
+
 stain present and (2) the continuity of 
MARCO
+
 MZM positioning around the MZ sinus.  Four separate white pulp areas were 
graded “blind” per animal and given a score from 1-3 (worst to best).  Shown are 
representatives from each grade.  Top panel represents a grade of 3 showing the typical 
abundant and continuous stain for MARCO
+
 MZM surrounding the MZ sinuses.  The 
middle panel corresponds to a grade of 2 showing moderate abundance of MARCO
+
 
MZM that moderately encircled the MZ sinus with patches.  The lower panel corresponds 
to a score of 1, which equates to low or virtual absence of MARCO
+
 MZM that, if 
present, were found in patches along the MZ sinus.  (B) Semi-quantitative scoring of 
MZM for the criteria above.  Each symbol represents an average of the summation of the 
four scores for each animal.  Horizontal bars indicate the average and SEM for each 
group. p = 0.0012 as determined Mann-Whitney test (n = 13 young mice (2-3 mo), filled 
circles; n = 15 old mice (18-23 mo), open squares).    
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A reduction in MZM in the spleens of old mice revealed by flow cytometry 
To further explore the interpretation that MZM appeared reduced in many aged 
mice, MZM were quantified using flow cytometry analysis.  Many reports agree that 
MZM express MARCO and SIGN-R1 (7).  Although anti-MARCO antibody worked well 
in immunocytochemistry, anti-SIGN-R1 antibody more clearly distinguished a 
subpopulation in flow cytometry.  MZM comprise a minor subset of dispersed spleen 
cells; therefore, another marker was used to aid in gating the population.  Published 
reports indicate that MZM lack expression of the typical macrophage marker F4/80 (18) 
and express negligible CD11b (107).  By flow cytometry, the SIGN-R1
+
 population were 
consistently identified within a population of large cells that expressed very low levels of 
CD11b (Fig. 10A).  Based on previous reports that dextran particles bind to SIGN-R1 and 
are rapidly cleared from the blood by MZM (17, 18), FITC-labeled dextran administered 
i.v. was used to verify the identity of the SIGN-R1
+
, CD11b low subset as MZM.  Figure 
10B shows that the SIGN-R1
+
, CD11b low cells bound dextran within a short time, 
confirming that these cells were MZM. To confirm that the MZM are within the CD11b 
low population FACS was used to isolate the CD11b high, CD11b low, CD11b negative 
subsets (Fig. 11), which were then H&E stained for morphological examination.  The 
CD11b low subset contained cells that were large and macrophage like in morphology, 
while the cells in the CD11b high subset appeared to be largely neutrophils and cells in 
the CD11b negative subset were lymphocytes.   Attempts to enrich for MZM via column 
isolation were unsuccessful, as the column enrichment population had the same 
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frequency of MZM as the unenriched population.  Therefore, the frequency and number 
of MZM of total splenocytes was determined and reported for individual young versus 
old animals.  Figure 10C shows that there was a significant decrease in the average 
frequency of MZM in old mice when compared to young mice (n = 30 young and n = 22 
old, p = 0.0001).  Table III shows that the number of MZM in old mice also declines 
when compared to young mice.  The frequency of MZM in some old mice was equivalent 
to the frequency of MZM in young mice.  Overall, the results indicate a decline in 
frequency and positioning of MZM in the marginal zones of aged splenic tissue.  It is 
possible that the decrease in MZM frequency with age is due to a decrease in the levels of 
the SIGN-R1 receptor; however, there was a significant increase in SIGN-R1 expression 
on MZM from old mice compared to young (p = 0.0088) (Fig. 10D).  To determine if this 
increase in SIGN-R1 is attributed to an increase in MZM size with age, flow cytometry 
was used to examine the FSC of MZM in young and old mice.  MZM from old mice had 
a higher FSC value when compared to young MZM, suggesting that MZM from old mice 
are larger in comparison to MZM from young mice, a possible explanation for the 
increase in SIGN-R1 expression on MZM from old mice (p = 0.0006) (Fig. 10E).   
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Figure  10.  Quantitative assessment of the frequencies of MZM in spleens from old 
and young mice by flow cytometry.  (A) Identification of SIGN-R1
+
 cells (MZM) in the 
CD11b low splenic fraction.  Contours shown are representative of young spleen cells. 
(B) Contour plots from a separate experiment demonstrating that a majority of the CD11b 
low/SIGN-R1
+
 cells took up FITC-labeled dextran within 45min after i.v. delivery, as 
expected of MZM (43). (C) Comparison of the frequencies of MZM present in spleens 
from young and old mice.  Each symbol represents an individual animal.  Horizontal bars 
indicate the average and SEM for each age group.  Old mice have approximately on 
average a 45 percent reduction in MZM when compared to young mice.  p = 0.0001 
determined by Mann-Whitney test (n = 30 young mice (2-3 mo), filled circles; n = 22 old 
mice (18-23 mo), open squares).  (D) Comparison of the MFI of SIGN-R1 of MZM from 
young and old mice (p = 0.0088).  (E) Comparison of the forward scatter of MZM from 
young and old mice (p = 0.0006).  Data presented in (D) and (E) are represented using the 
ratio of sample value over the average value of all young mice taken within each 
experimental group.  Data is expressed as mean ± SEM and are representative of four 
separate experiments (n = 10 young mice (2-3 mo); n = 10 old mice (19-23 mo).   
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Figure 11.  FACS cell sort of CD11b positive and negative populations.  FACS was 
utilized to separate the CD11b high, low, and negative populations (represented in the left 
image as P2-P7; P2 = lymphocyte fraction, P3 = the CD11b low fraction, P4 = CD11b 
high fraction, P5 & P = 7 cell doublets, P6 = large macrophages) for visualization of cell 
morphology.  The cells were cytospun onto microscope slides and H&E stained.    
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Decrease in the frequency of MZ B cells in old mice 
Knowing that MZM have a direct interaction with MZ B cells I next determined if 
there were differences in the MZ B cell compartment with age.  For flow cytometry, 
gating on MZ B cells was adapted from Won et al. (105).   Spleen cells were initially 
gated on the B220
+
, CD23
-
 population followed by gating on the CD21/35 high and IgM 
high fraction (Fig. 12).  The frequency (Fig 13A) and number (Table III) of MZ B cells of 
the total B220
+ 
cells was then determined and reported for individual young versus old 
animals.  Figure 13A shows that there was a significant decrease in the average frequency 
of MZ B cells in old mice when compared to young mice (n = 30 young and n = 41 old, p 
= 0.0001).  Furthermore, as seen with MZM, MZ B cells also have a decline in total cell 
numbers in old mice when compared to young mice (Table III).  As observed with the 
MZM population, the frequency of MZ B cells in some old mice overlapped with the MZ 
B cell frequency in young animals.  Initially, an increase in MZ B cells was anticipated 
with age based on the factors present in age that favor MZ B cell development (69, 70) 
(71-74) (75-77), however, results showed that there was a significant decrease in the MZ 
B cell pool with age. 
Given that the MZ B cell population declines with age I next determined if there 
were any alterations to the FO B cell population with age.  Using flow cytometry, the 
frequency (Fig.13B) of FO B cells of young and old mice was determined.  Spleen cells 
were gated on the B220
+
, CD23
+ 
population followed by gating on the CD21/35int and 
IgMint/high fraction (Fig. 11).  The frequency of FO B cells was determined from the total 
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B220
+
 cells.  The data show no differences in the FO B cell pool in young and old mice 
(n = 14 young and n = 16 old mice, p = 0.3277)  These results support published reports 
that the mature B cell (FO B cell phenotype) pool in old mice is similar to that of young 
mice (88).  The distributions of FO B cells in old mice were also similar to that of young 
mice.  It has previously been reported that there is a decline in the pre B cell pool in the 
bone marrow of old mice; however, no differences  were present in the mature B cell 
pool in the spleens of young and old mice (89).   Using BrdU labeling Johnson et al. later 
reported that the production of newly formed immature B cells in old mice is similar to 
that of young mice.  However, this same study also reported that newly formed immature 
B cells of old mice were less frequent in spleens of old mice when compared to young 
mice, suggesting that the microenvironment of the aged spleen does not allow for the 
homing of newly formed B cells.  It has been suggested that the mature B cell pool of old 
mice are long lived and newly formed immature B cells of old mice are unable to home 
to the spleen because the niche is over crowed and does not require more cells (27).  The 
frequency of FO B cells determined here in old mice may be a reflection of the long lived 
mature B cell population  and not a result of newly formed FO B cells as previously 
discussed by Johnson et al (89).   Therefore, decreases in MZ B cells could also be a 
reflection of alterations present in the microenvironment of the MZ region of old mice.     
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Figure 12.   Representative profiles of MZ B and FO B cells from young and old 
mice. Flow cytometry was used to determine MZ B and FO B cell frequencies. The MZ 
B cell population was determined by gating on the B220
+
/CD23
-
 fraction followed by 
gating on the CD21/35 
high
/ IgM 
high
 fraction.  The FO B cell population was determined 
by gating on the B220
+
/CD23
+
 fraction followed by gating on the CD21/35 
int
/ IgM 
high
 
fraction.  
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Table 3. Representative absolute numbers of MZ B cells and MZM of young and old 
mice.  Flow cytometry was used to determine MZM and MZ B cell absolute numbers.  
Absolute numbers of MZM determined within all viable splenocytes and absolute 
numbers of MZ B cells within the B220
+
 population. **p = 0.0070 ; *p = 0.0081 
determined by Unpaired t-test.  Data is expressed as mean ± SEM and are representative 
of two separate experiments (n = 8 young mice (2-3 mo); n = 4 old mice (19-23 mo).   
 
 
 
 
              
Table 3.  Number of MZM and MZ B cells in the spleens of young and old mice
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Figure 13.  Comparison of frequencies of MZ B and FO B cells in young and old 
mice.  (A) Frequency of MZ B cells within the B220
+
 population.  p = 0.0001 determined 
by Mann-Whitney (n = 30 young; n =41 old mice).  (B) Frequency of FO B cells within 
the B220
+
 population.  p = 0.3277 determined by Unpaired-t test (n = 14 young; n = 16 
old mice).
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         CHAPTER V 
THE MICRO-ANATOMICAL FACTORS THAT MAY CONTRIBUTE TO  
     DECREASES IN MZM AND MZ B CELLS IN OLD MICE 
Chapter IV showed that there is a decrease in MZM and MZ B cell frequencies and 
numbers with age. However, what causes the decrease in these two important immune 
cell type is currently not known.  This chapter will explore possible factors that may 
contribute to the decline in MZM and MZ B cells with age.   
MZM and MZ B cells have a direct physical interaction that when disrupted leads 
to their displacement within the spleen (15).  Therefore, determining if there is a direct 
correlation between the reduction in MZM and MZ B cells observed in old mice could 
provide insight for the decreases in both immune cells.  Reduction in cell 
frequency/number can also be attributed to cell intrinsic or extrinsic factors.  The cell 
extrinsic factors important for MZM and MZ B cells were examined by looking at the 
microenvironmental factors important for the maintenance of these cells as components 
of the MZ of the spleen.   
The chemokine CCL21 and its receptor CCR7 are important for the localization 
of MZM within the MZ (43).  Therefore it is possible that changes in either chemokine 
and/or receptor with age could account for the decline in the MZM frequency found in 
old spleens. The decrease in MZ B cells with age could be due to the inability of MZ B 
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cells in old mice to be retained in the spleen. The microenvironment of old mice was 
examined by determining if it can attract young transferred MZ B cells.  Can young 
transferred MZ B cells home to the spleens of old mice that have reduced MZM, or do 
they aberrantly home to other lymphoid organs, such as the lymph nodes and bone 
marrow?   
Decrease in the frequency of MZ B cells in old mice correlates with the decrease in 
MZM    
It is well established that MZM directly interact with MZ B cells via the 
scavenger receptor MARCO located on the surface of MZM and an undetermined cell 
surface ligand on MZ B cells (22-24).  Furthermore Nolte et al. found that in young adult 
mice, loss of the B cell population corresponded with loss of MZM (40).  Therefore, it is 
possible that the decrease in MZM in old mice could correlate with the decline in MZ B 
cells also seen with age. The spleens were removed from young and old mice, and 2/3 of 
each spleen was prepared for flow cytometry analysis in which both MZM and MZ B cell 
frequencies were determined.  The remaining 1/3 of the spleen was frozen for 
immunocytochemistry staining to assess the MZM qualities described in Figure 9.  For 
flow cytometry, MZ B cells were gated as shown in Fig 12 (Chapter IV) and MZM were 
gated as shown in Figure 10 (Chapter IV).  Figure 14A shows a significant reduction in 
average frequency of MZ B cells in old vs. young mice (n = 17 old, n = 15 young;  
p = 0.0002).  Although the average reduction was statistically significant, a wide 
variation was again apparent in individual old mice.  Some spleens had extremely 
72 
 
 
reduced MZ B cells; whereas in other spleens, the MZ B cell frequencies were equivalent 
to the mid-range of the young group.  Furthermore, the reduction in MZ B cell 
frequencies appeared to correlate with reductions in MZM assessed by the semi-
quantitative tissue scoring method (Fig. 14B, r = 0.6429 and p = 0.0003) or by frequency 
determined in flow cytometry analysis (Fig. 14C, r = 0.4930 and p = 0.0320).  This 
correlation remained present within the correlation pairs of each individual old animal 
when the correlation pairs of young animals were removed (Fig. 14B, r = 0.5237 and p = 
0.0451; Fig. 14C, r = 0.7076 and p = 0.0330).   
 Although there is a significant correlation present between levels of MZM and 
MZ B cells in both young and old mice, the individual values in Figures 14 B and C can 
further be divided into 3 separate groups: Poor, moderate, and good.  The poor group 
corresponds to low MZM and MZ B cell populations in individual animals, the moderate 
corresponds to animals with moderate levels of MZM and MZ B cells, and the good 
corresponds to animals with frequencies of MZM and MZ B cells that are at levels 
normally observed in young mice.  It is possible that at some point all the animals will 
fall into the poor group and that the moderate group is a type of biomarker showing the 
beginning of the collapse in MZM and MZ B cell populations.  We are limited in the data 
interpretation because one cannot assess decreases in MZM and MZ B cells in an 
individual animal over time, therefore highlighting the importance of this analysis.  
The correlation present between MZM and MZ B cells frequencies suggests that 
the spleens of old mice with decreased MZM may also show a decline of the MZ B cell 
population as less MZM are available to physically interact with the MZ B cells (or vice 
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versa).  It is possible that MZM do not home to the MZ of old mice because of the 
decline in the MZ B cell pool present with age.  On the contrary, it is also possible that 
MZ B cells do not home to the MZ as a result of the decline in the MZM pool with age.   
Therefore, data here suggests that extrinsic microenvironmental factors important for 
both MZM and MZ B cells appear to be altered in old mice.  
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Figure 14.  Comparison of frequencies of MZ B cells in young and old mice and 
correlation with abundance of MZM.  (A) Frequency of MZ B cells within the B220
+
 
population.  The MZ B cell population was determined by gating on the B220
+
/CD23
-
 
fraction followed by gating on the CD21/35 
high
/ IgM 
high
 fraction.  Symbols represent 
individual mice and the horizontal bars indicate the average and SEM for each age group; 
p=0.0002 determined by Mann-Whitney test (n = 15 young; n = 17 old mice).  (B) 
Pearson correlation analysis was performed on 27 spleens from both age groups shown in 
panel A that were also sectioned, stained with anti-MARCO, and scored for MZM 
criteria; r = 0.6429 and p=0.0003.  (C) Pearson correlation analysis was performed in a 
separate experiment to compare frequency of MZ B cells versus frequency of MZM 
assessed by flow cytometry; r = 0.4930 and p = 0.0320 on 19 spleens from both age 
groups.  Symbols in A, B, and C represent young mice (2-3 mo), filled circles; old mice 
(18-23 mo), open squares.   
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Adoptive transfer of MZ B cells to evaluate extrinsic factors in age for the 
maintenance of MZ B cells to the MZ  
Decreases in MZ B cells with age can be due to failure of MZ B cells to be 
retained in the spleens of old mice.  Studies in aged animals have shown that the there is 
a gross morphological alteration in lymphoid tissues, including smaller germinal centers 
(29), and changes in the T cell rich PALS and MZ (26). Studies discussed earlier have 
also reported immature B cells of young mice have a reduced ability to home to the 
spleens of old mice when compared to young mice but old donor immature B cells had no 
homing defect (27).  On the other hand, mature follicular B cells (FOB) homed 
appropriately in either young or old recipients.  Cells enter the spleen at the MZ; the 
difference is that the FOB cells move quickly into the white pulp follicles but the 
immature B cells linger in the MZ for a period of further maturation.  It has been 
suggested that the aged defect is a result of alterations in the MZ microenvironment of 
old mice. Therefore, I tested the efficiency of the aged microenvironment to allow 
homing of young transferred MZ B cells can home to the spleens of old mice or if they 
were found in other lymphoid compartments such as the lymph nodes or bone marrow.    
MZ B cell homing to the spleen was examined by injecting total enriched splenic 
B cells isolated from young mice (of which MZ B cells were approximately 5%) into 
young or old mice (Fig. 15).  Mice were sacrificed 6 hrs post injection and the spleens 
were harvested for staining of donor cells via flow cytometry. The 6 hr time point was 
based on experiments done by Cyster and colleagues for homing of FO B cells to follicles 
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(108).  Results show a reduced frequency of donor MZ B cells in the spleens of old hosts 
compared to young, indicating old mice have reduced MZ B cell homing to the spleen 
when compared to young mice (Fig 16A, p = 0.0308) (27).  This type of experiment may 
suggest that some environmental factor such as a chemokine or its ligand is altered with 
age.  This analysis was performed in concert with experiments by others in the lab to 
assess homing of FO B cells to follicles.  Independently, I also examined the FO B cell 
population using the antibody staining paradigm adapted from Won et al. (105).  My 
results showed no statistical differences in FO B cell homing between age groups (Fig 
16B), which confirmed the now published work of Minges-Wols et al. from our group 
(27). 
 As previously discussed in the background section of this dissertation, skewing 
toward MZ B cell output in old animals might be predicted based on the environmental 
conditions that favor MZ B cell development over FO B cell development (69-77).  Yet, 
data presented in Chapter IV show decreases in MZ B cells in most old mice when 
compared to young mice (Fig. 13A).  Furthermore, results demonstrate that there is a 
direct correlation between the decreases in MZ B cells with the decreases in MZM in 
individual old mice.  Therefore, it may be possible that MZ B cells are being developed at 
normal or increased frequency in advanced age, yet the splenic microenvironment in old 
mice does not allow for effective homing to the MZ (in this case because absence of 
MZM).  Results obtained from adoptive transfer experiments found fewer donor MZ B 
cells in spleens of old host mice compared to young host mice.  To determine if MZ B 
cells in normal, unmanipulated mice could be displaced to other lymphoid organs in age, 
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lymph nodes, bone marrow and blood of old mice were examined for MZ B cells and 
compared to young mice.  Results showed that small populations in 2 of 7 old mice 
examined had an MZ B cell phenotype present in the bone marrow (Fig. 18) and lymph 
nodes (Fig. 19) (Table IV) that was similar to the MZ B cell phenotype observed in the 
spleen (Fig. 17).   Young mice had no MZ B cell phenotype present in any of these 
lymphoid compartments (Table IV).   Donor MZ B cells from young mice into old mice 
were also examined in the lymph node of the old and results show that 3 of the 6 old mice 
examined had characteristic MZ B cell profiles present in the lymph nodes of recipient 
mice (Table V).  Furthermore, based on previous reports that dextran particles bind to 
MZ B cells and MZM (17, 18), FITC-labeled dextran administered i.v. was used to verify 
the identity the MZ B cells (similar to the prior study done in Chapter IV, Fig 9B) .  
Figure 18 (lower left panel) shows that the MZ B cells bound dextran within a short time, 
confirming that these cells were MZ B cells. 
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Figure 15.  Adoptive Transfer of B cells 
Mature B cells isolated from the spleens of young C.B17 mice (2-3 mo) were injected 
into the tail vein of either young (2-3 mo) or old (19-21 mo) BALB/c recipient mice.  6 
hours post injection, spleens were removed and antibody staining with an antibody to the 
IgM
b
 allotype was performed for donor MZ B cells.  C.B17 mice express the IgM
b
 
allotype on the BALB/c background.   BALB/c mice are IgM
a
 allotype, so donor B cells 
can be distinguished from host B cells. 
 
 
Mature splenic B cells (including 
MZ B cells) were isolated from 
young C.B17 mice.
B cells were transferred 
into young and old BALB/c  
mice via tail vein 
injections. 
After 6 hours mice were sacrificed and 
cells from spleens were dispersed and 
stained for donor MZ B cells in both 
young and old mice.
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Figure 16.  Adoptive transfer of B cells from young C.B17 mice into young and old  
BALB/c mice.  Total splenic B cells, including MZ B cells, were isolated from young 
C.B17 mice (that have an IgM/D
b
 allotype) and injected into young and old BALB/c 
mice (that have an IgM/D
a
 allotype). Transferred cells were analyzed by flow cytometry 
using an antibody to the IgM
b
 allotype that is strain specific and stained for (A) donor 
MZ B cells; Unpaired t-test, p = 0.0308 (B) and donor FO B cells; Unpaired t-test, p = 
0.2603.   Data represent 7 young into young and 6 young into old transfer pairs. 
Statistical analysis was performed on the mean of 7 young host and 6 old host   SEM.                                               
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Table 4 and 5.  Evaluation for MZ B cells in secondary lymphoid organs of young 
and old mice.  In Table IV the spleen, lymph nodes, bone marrow, and blood of 6 young 
and 7 old BALB/c mice were evaluated for MZ B cells.  Each plus and minus sign 
corresponds to an individual mouse.  The plus signs indicate presence of the MZ B cell 
phenotype and a minus sign indicates an absence.  Table V evaluates the presence of the 
MZ B cell phenotype in the spleens and lymph nodes of 7 young and 6 old C.B17 mice 
after transfer of B cells isolated from young BALB/c mice.   
 
 
Animal Lymph Node Bone Marrow Blood
Young
Old
- - - -
- -
- - - - -
+ + - -
- - -
+ + - -
- - -
- -
Table 4.   Presence of MZ B cells in secondary lymphoid organs of wild type BALB/c mice
Spleen
++++
++
++++
+++
Animal Lymph Node
Young
Old
- - - -
- - -
Table 5.   Presence of MZ B cells in secondary lymphoid organs following adoptive 
transfer of mature B cells isolated from BALB/c mice into C.B17 mice
Spleen
++++
+++
++++
++
+++ -
- -
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Figure 17.  Representative profile of MZ B population in the spleen of young and 
old mice.  Shown are contours representative of young or old splenocytes.  Top panel is 
representative of splenocytes of young mice (4 mo).  Lower panel is representative of 
splenocytes from an old mice (21 mo). MZ B cell phenotype present in the CD21/35 
high
/ 
IgM 
high
 fraction of B220
+
 CD23
-
 splenocytes.   
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Figure 18.  Representative profile of MZ B population in the bone marrow of young 
and old mice.  Shown are contours representative of young or old bone marrow cells.  
Top panel is representative of bone marrow cells of young mice (4 mo).  No MZ B cell 
phenotype was present in the CD21/35 
high
/ IgM 
high
 fraction.  Lower panel is 
representative of bone marrow cells from an old mice (20 mo) that reveals a MZ B cell 
like phenotype in the CD21/35 
high
/ IgM 
high
 fraction.  Normal MZ B cell flow profiles of 
same mouse (young and old) in Fig. 17. 
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Figure 19.  Representative profile of MZ B population in the lymph node of young 
and old mice.  Shown are contours representative of young or old lymph node cells.  
Frequency of MZ B cells was determined within the B220
+
 population.  The MZ B cell 
population was determined by gating on the B220
+
/CD23
-
 fraction followed by gating on 
the CD21/35 
high
/ IgM 
high
 fraction.  Top panel is representative of lymph node cells of 
young mice (4 mo).  No MZ B cell phenotype was present in the CD21/35 
high
/ IgM 
high
 
fraction.  Lower panel is representative of lymph node cells from an old mice (21 mo) 
that reveals a MZ B cell phenotype in the CD21/35 
high
/ IgM 
high
 fraction, which took up 
FITC-labeled dextran within 45min after i.v. delivery, as expected of MZ B cells. 
 
 
 
  
 
B
2
2
0
-A
P
C
CD23-PE-Cy7
C
D
2
1
/3
5
-P
E
IgM-PE-Cy5.5
C
D
2
1
/3
5
-P
E
Dextran-FITC
Old
B
2
2
0
-A
P
C
CD23-PE-Cy7
C
D
2
1
/3
5
-P
E
IgM-PE-Cy5.5
Young
FSC
FSC
S
S
C
S
S
C
85 
 
 
Evaluation of the chemokine CCL21 and its importance for MZM homing to the 
MZ 
The cell populations that home to the MZ do so as a result of chemotactic factors 
that are secreted by neighboring stromal cells (31, 34, 35, 43).  I have shown that the 
distribution and frequency of MZM appears altered in many old mice.  Furthermore, 
fewer young MZ B cells appeared to home to the spleens of old mice compared to those 
of young mice, suggesting an extrinsic defect that could be related to the reduction of 
MZM.  One study suggests that MZM home to the MZ in response to the chemokine 
CCL21 and to a lesser extent the chemokine CCL19.  Ato et al. observed a decrease in 
MZM in plt/plt mice, which lack functional CCL21 and CCL19, (43);  furthermore, in 
vitro migration assays of enriched MZM demonstrated that CCL21 resulted in migration 
of MZM(43).   Examination of CCL21 at the protein level using anti-CCL21 antibody 
was revealed on splenic tissue sections (Fig. 20A).  CCL21 is secreted by the stromal 
cells important for T cell homing to the PALS of the spleen (43).  Results from young (n 
= 7) tissue sections revealed an abundance of CCL21 present in the PALS (T cell regions 
of the white pulp areas) (Fig. 20A, top and middle panels).  CCL21 was detected in 85% 
of the PALS regions examined in the tissues from 7 young mice (Table). However, in 
splenic tissue sections of old mice (n = 7) (Fig 20A, bottom panels) CCL21 appeared to 
be absent in 55% of the PALS regions examined (Table).  CCL21 was also present in the 
bridging channels of splenic tissue of both young and old mice (Fig. 20A, top right 
panels).  
CCL21 was also evaluated in the MZ areas of splenic tissue from young and old 
mice to determine if present near MZM. CCL21
+
 protein was observed to localize in 
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clusters adjacent to the outer edge, but not encompassing the MZ in 3/7 young mice 
examined. CCL21was also observed in clusters adjacent to the outer edge of the MZ in 
3/7 old mice examined.  To determine co-localization of CCL21 on MZM, anti-MARCO 
antibody was used to reveal the MZM (Fig. 20B).  Results revealed that there was no co-
localization of CCL21 on MZM in splenic sections from young and old mice.  Results 
also showed that animals with poor MARCO
+ 
MZM (2 old mice) appeared to have a 
heightened CCL21protein in the spleen (Fig.20 C); however, in this figure it was difficult 
to determine the amount of CCL21
+ 
PALS/total PALS, CCL21
+ 
protein adjacent to the 
outer edge of the MZ, and CCL21
+ 
bridging channels/total bridging channels in these 
splenic tissue sections.    
To determine if there were differences in mRNA levels of CCL21 in the spleens 
of young and old mice, spleens were isolated and homogenized and quantitative RT-PCR 
was performed.  Results showed no significant differences in CCL21 mRNA between 
young and old spleens (p = 0.4234 as determined by Mann-Whitney test; n = 9 young; n 
= 8 old) (Fig.21).  For some individual animals stained for CCL21 at the protein level, the 
level of mRNA was also determined. Results show no definitive correlations.  
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Figure 20.   CCL21 distribution in spleens from young and old mice.  (A) Sections 
are stained with antibodies specific for MAdCAM1
+
 MZ sinus lining cells (green) and 
the chemokine CCL21 (red).  Confocal microscopy was used to reveal localization of 
CCL21, which is found in the T cell rich PALS region of the white pulp follicle, bridging 
channels, and around the outer edge of the MZ. Top panel shows the distribution of 
CCL21 in young splenic sections from 2 separate animals (top right and left) 25x tile 6x6.  
Middle panel shows 2 separate MZ and white pulp follicles from 1 representative young 
mouse (25x). Bottom panel shows the distribution of CCL21 in old splenic sections from 
2 separate animals (lower right and left) 25x tile 6x6.  (B) Sections are stained with 
antibodies specific for MARCO (green) and the chemokine CCL21 (red). Top panel 
shows the distribution of CCL21 in one young splenic section (top left, isotype control 
top right) 25x tile 6x6.  Bottom left panel shows the distribution of CCL21 in one old 
splenic section 25x tile 6x6 (bottom left, isotype control bottom right). (C) Top and 
bottom panels are representatives of 2 separate splenic sections from old mice.  MARCO
+
 
MZM in both mice have a poor distribution and CCL21 appears to be abundant.   
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Table 6.  Distribution of CCL21 protein in splenic sections of young and old mice.   
The spleens of 7 young and 7 old BALB/c mice were evaluated to determine differences 
in CCL21 protein throughout the spleens.  The number of CCL21
+
 PALS/Total PALS, 
the presence of CCL21
+
 protein adjacent to the outer edge of the MZ, the number of 
CCL21
+
 bridging channels/ total bridging channels, and the amount of MARCO (where 
appropriate) was evaluated between age groups.  Splenic tissue sections were stained to 
reveal either CCL21 and MAdCAM-1
+
 MZ sinus lining cells or CCL21 and MARCO
+ 
MZM (*). 
 
 
 
Animal 
Number
CCL21+ PALS/Total PALS
CCL21+ Protein Adjacent 
to Outer Edge of MZ
CCL21+ Bridging Channels/
Total Bridging Channels
Y-330
* Y-470
3/3
Table 6.  Presence of CCL21 in Splenic Sections from Young and Old mice
Y-331
Y-334
Y-335
Y-462
* Y-469
O-332
O-333
O-336
O-450
* O-471
* O-472
* O-473
4/5
3/3
5/5
3/4
1/2
3/4
1/3
1/4
1/3
1/4
3/3
?
2/3
No
Yes
Yes
No
Yes
No
No
Yes
Yes
Yes
?
No
No
No
0/0
0/0
2/2
2/3
4/4
1/1
1/1
2/2
0/0
0/1
0/0
3/3
0/0
?
Good MARCO
Poor MARCO
Poor MARCO
Good MARCO
Good MARCO
Degree of MARCO 
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Figure 21.  Expression of CCL21 protein and mRNA   Quantitative RT-PCR on 
spleens from young (2-4 mo) and old (18-23 mo) mice showed no statistical differences 
between age groups. p = 0.4234 as determined by Mann-Whitney test (n = 9 young mice; 
n = 8 old mice).  
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CCR7 levels in young and old MZM 
 The receptor for CCL21 is CCR7, which is expressed on MZM (43).  In order to 
determine if CCR7 receptor levels on MZM are altered with age, the flow cytometry 
staining paradigm developed for MZM identification was implemented (Fig. 22).  The 
percentage of MZM that were CCR7
+
 was determined for both young and old mice, and 
results showed that there was a decrease in the percentage of CCR7
+
 MZM in old mice 
when compared to young mice (Fig. 24).  Yet, it is of interest to note that although there 
is a decrease in the percentage of CCR7
+
 MZM in old, the overall expression of CCR7
+
 
MZM of both young and old mice was low compared to what is normally observed with 
T cells (Fig. 23).  Work by Ato et al. first revealed that MZM express CCR7 weakly 
compared to naïve T cells and DCs (43).  This was determined by staining splenocytes 
isolated from dextran-FITC injected mice (used to identify MZM) with a recombinant 
CCR7 ligand, CCL19-Ig chimeric protein, which was generated by Manjunath et al. 
(109).  CCL19 like CCL21 is a chemokine for the CCR7 receptor (43).  MZM were 
identified as FITC
+
 SIGN-R1
+
  by flow cytometry and the level of CCR7 was determined 
from this pool and observed to be low (43).  
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Figure 22.  Flow cytometry profiles reveal the percentage of CCR7
+
 MZM of young 
and old mice.  The MZM population is determined from the CD11b low SIGN-R1
+
 
fraction and the percentage of CCR7 is revealed in the PE channel.  Top panels are the 
isotype control for CCR7 and representative profile from young mouse depicting the 
CCR7 positive MZM. The lower panels are the isotype control for CCR7 representative 
MZM profile and representative profile from an old mouse depicting the CCR7 positive 
MZM. 
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Figure 23.  Flow cytometry profiles reveal the percentage of CCR7
+
 CD4+ T cells of 
young and old mice.  The CD4+ population is determined from viable lymphocyte 
fraction and the percentage of CCR7 is revealed in the PE channel.  Top panel is a 
representative profile of the isotype control for CCR7.  Middle panel is a representative 
of young profile and the lower panel is representative of old profile. 
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Figure 24.  Percentage of CCR7
+ 
MZM of young and old mice.  The percentage of 
CCR7
+
 MZM in young and old mice was determined by flow cytometry.  Data show that 
old mice have significantly lower percentages of CCR7 expressed on MZM when 
compared to young mice.    p = 0.0314 as determined by Unpaired t test (n = 6 young 
mice; n = 7 old mic
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CHAPTER VI 
         EVALUATION OF THE FUNCTIONAL DIFFERENCES BETWEEN  
                                          MZM OF OLD AND YOUNG MICE 
Data presented in Chapter IV revealed that there are decreases in the MZM pool 
with age.  I next wanted to determine if loss in cell number alone or a combination of loss 
of number and decrease in cell function may contribute to the age related decline in the 
TI immune response.  The MZM from old mice were evaluated to determine if they are 
functionally different compared to MZM of young mice by measuring differences in 
phagocytosis by MZM.  
 In order to measure the phagocytic ability of MZM in young and old mice a 
number of experimental approaches were examined. The first experiment aimed to 
examine the functional differences of MZM in vivo through intravenous delivery of 
dextran. Analysis was done via confocal microscopy and flow cytometry.  The second 
series of experiments aimed to measure the phagocytic function of MZM in vitro after 
treatment with pHrodo ™ S. aureus bioparticles (pHrodo); analysis was done via flow 
cytometry.  Techniques established from the first two series of experiments helped build 
the next series of studies.  In these last experiments, MZM were successfully targeted for 
measurement of phagocytosis and live visualization of phagocytosis by MZM was 
revealed using a Leica TC5 SP5 confocal microscope.     
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Functional differences in capture of blood-borne dextran particles by MZM in old 
mice   
 Since an important function of MZM is the clearance of blood-borne antigens, I 
asked whether reduced capture of blood-borne antigen would be a consequence of the 
changes in MZM with age.  MZM have been shown to decrease in age; however, whether 
this decrease in cell frequency/number implied reduced cell function needed to be 
clarified.   SIGN-R1 [homologue of human DC-SIGN (16)] binds the capsular 
polysaccharide of Streptococcus pneumoniae and also to the polysaccharide dextran (17-
20).  For these experiments the rapid, in vivo binding of FITC-labeled dextran to SIGN-
R1 was used to mimic antigen (18, 43).  Dextran-FITC was administered i.v. into tail 
veins of young and old mice (Fig. 25).  It has been previously shown that dextran binds 
MZM in tissue in as early as 45 min and at later time points dextran is no longer 
visualized on MZM (18).  After 45 min, animals were sacrificed and the spleens removed 
and frozen in O.C.T for visualization of dextran binding to cells in tissue sections.  
Spleen sections were stained with anti-MAdCAM-1 to distinguish the MZ sinus lining 
cells as a landmark.  To confirm that dextran
+ 
macrophages were MZM, tissue sections 
were stained with anti-MARCO antibody for the expression of MARCO, found on the 
surface of MZM. (Fig. 26A).  As reported by Ato and colleagues for young mice (43), 
after 45 min dextran binds to MZM, appearing as a continuous ring on the outer edge of 
the MZ sinus.  Confocal microscopy revealed a clear “ring” of bound dextran-FITC 
adjacent to the MAdCAM-1
+
 cells in the MZ of young spleens (Fig. 26B).  In contrast, 
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the tissue sections from old spleens had less bound dextran-FITC in the MZ when 
compared to the young tissue and showed a patchy deposition similar to 
immunocytochemistry staining for MARCO (Chapter IV, Fig. 9A).  This patchy 
distribution could be a reflection of fewer MZM present in the spleens of old mice and 
less indicative of an alteration in cell function.   
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Figure 25.  Intravenous injections of dextran-FITC into young and old mice.  
Dextran-FITC was administered i.v. into young and old mice. After 45 min, mice were 
sacrificed and spleens were removed.  One half of the spleen was frozen in O.C.T for 
sectioning to evaluate the localization of dextran-FITC in the MZ via confocal 
microscopy. The second half of the spleen was dispersed and single cell suspensions were 
stained with anti-CD11b and anti-SIGN-R1 antibodies for flow cytometry analysis of the 
percent of dextran positive MZM. 
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Figure 26.  Binding of dextran by MZM of old versus young mice.  Confocal images 
of frozen splenic sections harvested 45 min after dextran-FITC (green) was given 
intravenously to female BALB/c mice.  (A) Co-localization of dextran (green) with 
MARCO
+
 MZM (red) is observed as yellow after staining dextran positive tissue from a 
representative young (top) and old (bottom) mouse.   (B) Photos show typical deposition, 
representing 2 of 18 young (2-3 mo, top panels) and 2 of 16 old (18-23 mo, bottom 
panels) mice.  In the spleens of most old mice, uptake of dextran appeared in 
discontinuous patches along the outer edge of the MZ sinus. MAdCAM-1
+
 MZ sinus 
lining cells (purple) are stained as a landmark.  (C) Representative young (top) and old 
(bottom) splenic sections from PBS injected mice. 
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Measuring dextran positive MZM by flow cytometry – pitfalls and potentials 
To determine if MZM of old mice are less efficient at capturing dextran, 
differences in the percentage of dextran positive MZM of young and old mice was next 
determined by flow cytometry.  As described above, mice were injected i.v. with dextran-
FITC in the tail veins and after 45 min, 1/2 of each spleen was dispersed for flow 
cytometry analysis.  The MZM population was identified in the CD11b low and SIGN-
R1
+
 fraction and the percentage of MZM that were dextran
+
 was revealed in the FITC 
channel.  PBS (no fluorophore) was delivered i.v. into the tail veins as a control.  From 
the flow cytometry profiles of PBS injected mice, it was determined that MZM have a 
high level of autofluorescence in the FITC channel (Fig. 27).  Based on this high level of 
background, the percentage of dextran
+
 MZM could not be adequately determined in 
young and old mice.  
In order to be able to use flow cytometry to determine binding of dextran-FITC by 
MZM, this background autofluorescence needs to be corrected.  To determine if the 
experimental design contributed to the high level of background fluorescence, the method 
of i.v. delivery of dextran-FITC or PBS delivery was first examined.  Delivery of 
dextran-FITC and PBS into the tails veins of mice, which requires warming the mice, was 
compared to intraocular delivery of dextran-FITC and PBS, a different i.v. route that does 
not require manipulation.   Results were not different between injection routes; therefore, 
I conclude that the autofluorescence of MZM in the FITC channel prohibited the 
101 
 
 
 
determination of differences in the percentage of dextran positive cells in young and old 
MZM.   
To correct for this autofluoresence in the future, either a fluorophore of a higher 
emission conjugated to dextran needs to implemented or more precise filters need to be 
used that correct for the observed spectral overlap.  MZM from PBS injected mice 
showed up positive in the dextran-FITC channel; this suggests that the spectral overlap is 
occurring with the natural autofluoresent properties of MZM with the low emission FITC 
fluorophore conjugated to the dextran.  To reveal dextran-FITC
 
positive MZM 
populations by flow cytometry, the use of multiple antibodies of which each is 
conjugated to a unique fluorophore is required. Therefore, a precise bandpass filter, 
which separates the emission of multiple wavelengths, would be needed to differentiate 
the emission of the cells autofluoresence from the FITC fluorphore emission.         
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Figure 27.  Flow cytometry of MZM from young and old mice injected with 
dextran-FITC. Dextran-FITC was delivered i.v. in the tail vein of young and old mice 
and analyzed for the percent of dextran-FITC positive MZM.  Top panel shows a 
representative flow cytometry profile of PBS injected control, the middle panel represents 
a dextran-FITC injected young, and bottom panel represents a dextran-FITC injected old 
mouse.  Far right top panel shows the MFI of PBS injected controls, which are similar to 
dextran-FITC injected mice (far right middle panel). 
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Evaluation of functional differences in the phagocytosis of pHrodo bioparticles by 
MZM in old and young mice using flow cytometry 
I next aimed to test the phagocytosis of MZM between age groups using a pH 
sensitive antigen that emits fluorescence in a higher channel (PE) using flow cytometry.  
Although MZM are known for their highly phagocytic properties (9), it is not known if a 
decline in the phagocytic function of MZM from old mice, compared to young, 
contributes to decreased TI immune response in age.  Here, pHrodo ™ S. aureus 
bioparticles (pHrodo) were used to specially aim to measure the phagocytosis of MZM.  
pHrodo consists of killed S. aureus conjugated to a fluorescent compound that is pH 
sensitive and emits fluorescence only under acidic conditions.  Binding of antigen by 
macrophages initiates phagocytosis, which consists of three essential compartments: early 
endosome, late endosome, and lastly, the lysosome.  These separate phagocytic 
compartments each have a specific pH (56).  Progression through early endosome (pH 6), 
late endosome (pH 5.5), and the lysosome (pH 4) leads to decreases in pH.  pHrodo 
bioparticles start to emit florescence at a pH of 6 and hit peak fluorescence at a pH of 4 
(56, 58). The fluorescence of pHrodo can be detected by a microplate reader, flow 
cytometer, or confocal microscope.  
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Phagocytosis of pHrodo bioparticles by a heterogeneous culture of adherent 
splenocytes measured via a microplate reader 
To measure phagocytosis of pHrodo by the manufacturer’s suggested protocol, a 
microplate reader was first used.  The concentration recommended by the manufacturer is 
100µg of pHrodo for 100,000 cells (Invitogen).  Splenocytes were harvested and 1 x 10
6
 
cells/well were cultured onto 96 flat bottom well plates for 1 hr.  The adherent cells 
(macrophages) in the spleen make up approximately 10% of the total splenocyte 
population. Therefore, non-adherent cells were removed to yield approximately100,000 
cells/well. 100µl containing 100µg pHrodo were added per well and allowed to incubate 
for 2 hrs at 37 C.  The 96 well plates were loaded in replicates of three for each animal as 
follows: cells + pHrodo, cells only, pHrodo only, and media only negative control.  After 
2 hrs the samples were placed in a microplate reader.  Excitation of pHrodo occurred at 
550 nm and emission at 600 nm.  The ratio of net experimental phagocytosis over net 
baseline phagocytosis x 100% gives a percentage of the net effect of phagocytosis of 
pHrodo by the adherent cells (Fig. 28).  To calculate the net baseline phagocytosis, the 
mean of the three replicates of cells only and the mean of the three replicates of pHrodo 
only were first added.  The mean negative control value (media only) was then subtracted 
from this value.  The net experimental phagocytosis was calculated by subtracting the 
mean negative control value from the mean of cells + pHrodo.   
Results showed no differences in the net effect of phagocytosis between old and 
young total adherent cells (Fig. 28) (n = 3 mice for both young and old, p = 1.0000).  
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These results did confirm that the pHrodo bioparticles work as the manufacturer 
suggested, but was not sufficient for specifically targeting MZM.              
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Figure 28.  Percent net effect of pHrodo by adherent splenocytes from young versus 
old Mice.  Results are reported by taking the ratio of net experimental phagocytosis x 
100% over net baseline control phagocytosis to give a percentage of the net effect of the 
adherent cells.   
  
The horizontal bars indicate the average and the SEM for each group. p=1.0000 
determined by Mann Whitney test (n=3 for each age group; young mice (2-3 mo), filled 
circles; old mice (18-23 mo), open squares).   Bottom table represents raw MFI values 
obtained from pHrodo + cells, cells only, pHrodo only, and media only of representative 
young and old animal samples. 
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Establishment of concentration, time and inhibitor of pHrodo treatment in vitro for 
flow cytometry analysis 
In order to use flow cytometry to measure phagocytosis of pHrodo the 
concentration, time, and inhibitor of pHrodo needed to be determined.  The manufacturer 
recommends 100µg of pHrodo for 100,000 cells, which are adhered to a 96 well plate 
that measures phagocytosis of pHrodo directly in the wells.  For flow cytometry, single 
cell suspensions are run through the flow cytometer in order to detect the amount of 
fluorescence associated with the cell.  The aim of these experiments was to specifically 
measure the amount of pHrodo phagocytized by MZM; therefore, MZM flow cytometry 
staining as well as pHrodo treatment was implemented.  In order to stain for MZM using 
cells treated with pHrodo, the cells needed to be adhered to a larger surface than the 96 
well plates to allow for collection of the cells.  35 mm culture plates were used and the 
optimal concentration of pHrodo for flow cytometry detection was determined to be 
125µg of pHrodo for approximately 200,000 adherent cells (Fig 29 and 30).  The 
suggested time for pHrodo incubation is 2hrs.  Phagocytosis, as measured by the use of 
latex beads, has been well established to occur in 30 min (55).  The 30 min time point for 
pHrodo, measured by flow cytometry, gave variable MFI when compared to the 2hr time 
point (Fig. 30).  It appears that after 30 min at increasing concentrations (62.5-1000µg), 
adherent cells are not able to take in additional pHrodo and the MFI decreased to lower 
values.  The use of beads to quantify phagocytosis does not distinguish between beads 
that bind on the cell surface from beads that are endocytosed.  pHrodo reveals 
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phagocytosis after the phagosome has been endocytosed,  which may require additional 
time to see its fluorescence via flow cytometry.  Therefore, it is possible that MZM have 
a threshold for the amount of pHrodo that can be taken in by the cell before additional 
bioparticles can be bound and endocytosed.
 
  
An effective control for pHrodo would be one that would inhibit its phagocytosis 
and therefore prove its efficacy.  To determine the best control for pHrodo reduced 
temperatures (-20C) was initially used to inhibit phagocytosis and found to be an 
ineffective, since a positive fluorescence was still detected (data not shown).  Subsequent 
experiments found that 1.0 % sodium azide, an electron transport chain inhibitor, was 
found to reduce the phagocytosis of pHrodo.  These series of experiments discussed in 
this section revealed the best concentration, time of pHrodo incubation, and inhibitor to 
pHrodo in vitro for flow cytometry analysis.  
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Figure 29.  Experimental paradigm of pHrodo treatment for flow cytometry 
analysis.  Heterogeneous suspension of fresh splenocytes from young and old mice were 
allowed to adhere onto 35 mm culture plates for 1hr in RPMI + 10% FBS.  Non-adherent 
cells were removed and 125µg of pHrodo at a volume of 125µl was added to 
approximately 200,000 adherent splenocytes and allowed to incubate for 2 hrs at 37C.  
After 2 hrs cells were gently scraped and stained with antibodies for identification of 
MZM by flow cytometry.  
 
 
 
Cells were collected using a 
policeman scraper, stained to 
identify MZM, 
and analyzed using 
FACScanto.
125µg/200,000 adherent 
splenocytes of pHrodo
added  for 2 hrs at 37C.
Experimental design of pHrodo treatment for  flow cytometry analysis  
Heterogeneous 
suspension of fresh 
splenocytes.
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Figure 30.  Titration of pHrodo for use in flow cytometry.  Top panel shows that at 
increasing concentrations of pHrodo incubated at 37 C for 30 min, there is a gradual 
increase in the MFI with a threshold at 500 µg/ml/200,000
 
splenocytes.  Bottom panel 
demonstrates that after 2 hr incubation with pHrodo, fluorescence can be detected starting 
at 60 µg/ml/200,000 splenocytes and stays steady with increasing concentrations.  Media 
only controls at both 30 min and 2hrs auto-fluoresced at an MFI of near 500. 
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Phagocytosis of pHrodo bioparticles revealed by flow cytometry 
To evaluate the differences in phagocytosis of pHrodo by MZM from young and 
old mice, differences in the percentage of pHrodo positive MZM between age groups 
were aimed to be determined by flow cytometry.  As previously mentioned, pHrodo is 
killed Staphylococcus aureus conjugated to a dye that emits fluorescence under acidic 
conditions.  MZM have been shown to bind Staphylococcus aureus via the surface 
receptor MARCO (15).  Adherent splenocytes from young and old mice were cultured 
and 125 µg of pHrodo was administered for 2 hrs at 37 C.  Adherent cells were collected 
and stained to identify MZM.  Initially MZM were stained using the antibodies to CD11b 
and MARCO.  Notably, a 2-3 fold increase in the percentage of CD11b low MARCO
+
 
cells after pHrodo treatment was found compared to media treated controls that exhibited 
typical MARCO
+ 
MZM phenotypes (Fig. 31).  This observation supports prior reports 
that have shown after LPS treatment, MARCO was upregulated on red pulp macrophages 
(110, 111). Therefore, I think that the 2 hr incubation with pHrodo induced expression of 
MARCO on red pulp macrophages and using the antibody to MARCO to identify MZM 
will not differentiate MZM from the red pulp macrophages.  Recent work by Kirby et al. 
examined if non-lymphoid splenocyte populations including red pulp macrophages, 
neutrophils, and dendritic cells upregulate SIGN-R1 after antigen exposure similar to that 
which is seen with MARCO (6).  Mice were infected with Leishmania donovani to 
specifically deplete MZM and were subsequently infected S. pneumoniae to determine if 
other splenocytes upregulated SIGN-R1 to bind and clear S. pneumoniae.  Their results 
showed minimal expression of SIGN-R1 on other splenocyte populations after infection 
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with S. pneumoniae in Leishmania infected mice.  As a result of these published findings, 
I elected to use the antibodies to CD11b and SIGN-R1 to identify pHrodo
+
 MZM.   
However, an increase in CD11b low SIGN-R1
+
 cells after pHrodo treatment was  
observed in both young and old mice after incubation with pHrodo for 2hrs in vitro from 
splenocytes obtained from wild type BALB/c mice (Fig. 32).  Due to this increase 
observed in the CD11b low SIGN-R1
+ 
cells after pHrodo treatment, it is unclear if MZM 
are exclusively responsible for the phagocytosis of the pHrodo bioparticles.  It is possible 
that the data obtained via flow cytometry includes other CD11b low splenocytes that 
have upregulated SIGN-R1 after encounter with antigen.  
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Figure 31. Representative flow cytometry profile of MARCO upregulation on 
splenic adherent cells upon treatment with pHrodo. Flow cytometry was used to 
distinguish pHrodo
+
 MZM from cultured adherent splenocytes from young and old mice 
after 2 hr in vitro pHrodo treatment. MARCO
+ 
MZM were defined using the antibodies to 
CD11b and MARCO. The CD11b low fraction was gated from all viable cells in the 
spleen and the MZM population revealed in the CD11b low and MARCO
+ 
fraction. The 
top panel shows media only controls with normal levels of CD11b low MARCO
+ 
MZM 
(18.0%); the lower panel shows > 3 fold increase in CD11b low MARCO
+
 after pHrodo 
treatment and approximately equal decreases in the CD11b low MARCO negative 
quadrant.   
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Figure 32. Representative flow cytometry profiles of SIGN-R1
+
 MZM upon 
treatment with pHrodo.  Flow cytometry was used to measure phagocytosis of pHrodo
 
by MZM from whole cultured adherent splenocytes isolated from young and old mice 
after 2hr in vitro pHrodo treatment. SIGN-R1
+
 MZM were targeted using the antibodies 
CD11b and SIGN-R1.  The CD11b
 
low fraction was gated from all viable cells in the 
spleen and the MZM population revealed in the CD11b
 
low and SIGN-R1
+
 fraction.  Top 
panels are media treated control and pHrodo treated sample of one representative young 
mouse and bottom panels are media treated control and pHrodo treated sample of one 
representative old mouse.   
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Summary of the functional studies on MZM (part I) 
 From the initial series of experiments, confocal microscopy revealed that less 
dextran-FITC was bound in the MZM tissue compartments of old mice when compared 
to young mice.  Yet, it remains to be clarified if the presence of less dextran-FITC on 
MZM is a result of fewer MZM present in the old tissue or the result of an alteration in 
MZM function with age.  Flow cytometry studies attempted to quantify the percentages 
of dextran
+
 MZM of young and old mice but proved to be limiting with the current 
instrument filters.  Phagocytic differences of young and old MZM using flow cytometry 
was attempted using pHrodo bioparticles, but this also proved to have limitations.  This 
time, the fluorescence of pHrodo was clearly higher than the control background, but 
whether the pHrodo
+
 phagocytic cells were exclusively MZM was unclear.  The next 
series of experiments built on the positives gained from these initial experiments to 
directly determine whether MZM from old mice differ in function when compared to 
young mice.  
Measuring the phagocytic differences of MZM from young and old mice using live 
cell confocal microscopy 
To quantify and visualize the phagocytosis of pHrodo by MZM, MZM treated 
with pHrodo were examined by confocal microscopy.  MZM make up 1-2% of total 
splenocytes and to target this rare population of macrophages for functional analysis can 
be difficult.  Immunocytochemistry showed that MZM bind dextran-FITC in vivo in both 
young and old mice (Fig. 26). Therefore, I next sought to determine if I would be able to 
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use this experimental approach to mark MZM and distinguish these cells via confocal 
microcopy in culture.  Studies done in the last section also established the in vitro 
culturing and treatment of pHrodo on adherent splenocytes.  Once adhered in culture, 
dextran
+
 MZM can be co-cultured with pHrodo and the dextran
+
pHrodo
+ 
MZM can be 
visually identified by Leica TCS SP5 confocal microscopy (Fig. 33).  The Leica TCS SP5 
confocal microscope, like the flow cytometer, uses lasers to excite fluorophores; 
however, the Leica TCS SP5 uses a prism to separate the fluorophore emission.  This use 
of a prism generates a single peak of intensity that is only seen by the flow cytometer 
through the use of precise optical filters. Therefore, using the Leica TCS SP5 confocal 
microscope the FITC fluorophore can be differentiated from the natural autofluoresence 
of the MZM.  The phagocytosis of pHrodo (and in turn dextran) can be quantified on a 
per cell basis using image analysis.   
Briefly, results by confocal microscopy revealed fields of dextran
+
cells, 
pHrodo
+
cells, and a small fraction of dextran
+
pHrodo
+
 MZM observed by confocal 
microscopy.  Each image taken of these fields targeted the dextran
+
pHrodo
+
 MZM (due 
to the small frequency of MZM present in culture) while including the single positive 
dextran and pHrodo cells. The pHrodo
+
 cells showed numerous pHrodo
+
 phagocytic 
compartments within each cell – confirming visually that pHrodo was being efficiently 
phagocytized.  A phagocytic compartment is defined as any one compartment of the 
endocytic pathway: early endosome, late endosome, or the lysosome. Since pHrodo starts 
118 
 
 
 
to emit fluorescence at a pH of 6 it is difficult to discern the different compartments of 
the endocytic pathway.  
By image analysis the mean fluorescence intensity (MFI) of the pHrodo
+ 
phagocytic compartments and the dextran-FITC captured by MZM were assessed per cell 
to determine any differences in phagocytic function between young and old MZM.  In 
addition, the numbers of pHrodo
+
 phagocytic compartments/cell-image were compared 
between age groups. Image analysis was also used to determine differences in size of 
adherent MZM.  Finally, the imaged fields were analyzed for the frequency of pHrodo
+
 
cells of the total dextran
+
 MZM.  
Establishment of the concentration and time of the in vitro pHrodo treatment of 
dextran marked MZM 
  In order to view dextran
+
pHrodo
+
 MZM live by confocal, the correct 
concentration and time of pHrodo incubation needed to be determined.  Splenocytes 
obtained from dextran-FITC injected mice were harvested and allowed to adhere onto 4-
well chamber slides.  The surface area of the chamber slides was significantly smaller 
than the area of 35 mm culture plates used previously for adherence in the flow 
cytometry analysis.  Therefore, a series of titrations were performed and plating 4 x 10
6 
splenocytes/well (non-adherent cells were removed to yield approximately 400,000 
adherent splenocytes) with 100 µg of pHrodo was determined to be optimal for 
visualizing individual pHrodo
+
 cells by confocal microscopy.  Low numbers 
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(approximately 100,000/well) of adherent splenocytes took longer to identify 
dextran
+
pHrodo
+
 MZM and high numbers (approximately 600,000/well) of adherent 
splenocytes over saturated the chamber.  In addition, pHrodo was examined after 
incubation at 1hr, 1.5 hr, 2 hr, and 3 hr.  The 1.5 hr time point was sufficient to observe 
phagocytic compartments in individual MZM by confocal microscopy and still detect 
dextran associated with the MZM.  It was found that if tissue processing took more than 6 
hr, dextran was no longer observed within MZM (data not shown).  To assure effective 
dextran injections, half the spleens removed 45 min post dextran injection were saved for 
sectioning to once again reveal positioning of dextran to the MZ.   
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Figure 33.  Experimental paradigm of pHrodo treatment of dextran-FITC marked 
MZM.  Young and old BALB/c mice were injected with 100 µg of dextran-FITC and 
sacrificed after 45 min. The spleens were removed and splenocytes dispersed and adhered 
onto 2 ml chamber wells for 1 hr.  Non-adherent cells were removed and 100 µg of 
pHrodo was administered to approximately 400,000
 
adherent splenocytes for 1.5 hr.  
After 1.5 hr incubation with pHrodo, cells were visualized live via a Lecia TC5 SP5 
confocal microscopy.  
 
 
 
 
100 µg dextran –FITC  
was administered via 
tail vein into young 
and aged mice.
After 45 min mice 
are sacrificed and 
splenocytes
cultured for 1hr.  
Non-adherent cells  
are removed. Flow 
Cytometry
Experimental Design:
100µg/400,000 adherent 
splenocytes of pHrodo
added for 1.5 hour at 37C 
Adherent cells were 
visualized using 
confocal microscopy 
for dextran+ 
pHrodo+ MZM
dextran-FITC
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Imaging pHrodo
+
 dextran
+
 MZM  
 Once pHrodo
+
 dextran
+
 MZM were identified by confocal microscopy, a 
standardized regimen of imaging was captured for analysis using the Lecia TC5 SP5 
confocal microscope.  For each animal, approximately15 different pHrodo
+
 dextran
+
 
MZM were identified and imaged.  Images taken targeted the pHrodo
+
 dextran
+
 MZM, 
but also captured single dextran
+
 and pHrodo
+
 cells.  The images captured of these cells 
were taken near the middle of the cell at a thickness of 1 micron.  The MFI of dextran and 
pHrodo within each MZM was determined using ImageJ software.  Gates were drawn 
around the perimeter of the MZM and the MFI measured and recorded. 
To confirm that images taken near the middle of the cell at 1 micron in thickness 
give an accurate representation of pHrodo within the MZM, a series of z-stack 
measurements were done.  Z-stack measurements are taken by going through a cell slice 
by slice from top to bottom.  Approximately 34 slices are imaged at 1 micron in thickness 
(an adherent macrophage is approximately 8 microns in thickness; therefore there is some 
overlap within the corresponding z-stack sections imaged).  For each animal, 2 separate 
z-stack measurements were done and the MFI of each of the 34 slices was obtained.  The 
average value of the 34 slices imaged was compared to the MFI obtained by taking an 
image near the middle of the cell.  Results show that the values were nearly identical 
(Table VII); therefore, imaging MZM near the middle of the cell at 1 micron in thickness 
gave an accurate representation of the live cell.  In addition, images of MZM were 
captured at 1, 2, 3, 4, and 5 microns in thickness by opening up the pinhole of the 
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microscope.  Opening the pinhole of the microscope draws in more light allowing greater 
depth of capture of the image. However, imaging the MZM at increasing thicknesses 
resulted in decreased resolution and contrast of the cell; therefore, a thickness of 1 micron 
was optimal for imaging live MZM.  
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Table 8.  Values represent the MFI obtained from either the average of 34 images (Z-
stack) or the MFI obtained when the image is taken near the middle of the cell.  Shown 
are values obtained from 2 separate experiments.  
 
 
 
 
Animal Z-Stack 
Avg
Standard                         
Image
Y-419
Y-420
Y-422
O-421
O-423
268 230
104 109
560 592
135 158
522 592
Table 8.  Avg Z-stack vs standard image of MFI of pHrodo+
phagocytic compartments/MZM 
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pHrodo phagocytic compartments over time 
 Each MZM imaged contained numerous pHrodo phagocytic compartments at 
various stages in the endocytic pathway.  To determine if there were drastic changes in 
the quantity of phagocytic compartments and the MFI over time, two separate time lapse 
experiments for 60 and 120 minute time points (time 0 = pHrodo administration) were 
conducted (Fig. 34).  Images were taken once every minute for a total of 60 images (for 
the 60 minute time lapse) and once every 2 minutes for a total of 60 images (for the 120 
minute time lapse).  Results show for both the 60 and 120 minute time lapse experiments 
there is an initial peak 10 min post pHrodo administration in pHrodo fluorescence within 
the MZM before the MFI starts to gradually decline with time.    
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Figure 34.  The MFI of pHrodo
+
 phagocytic compartments over time.  Top graph 
shows the range in MFI of pHrodo
+
 phagocytic compartments in a MZM over 60 
minutes.  Bottom graph shows the range in MFI in a MZM over 120 minutes.  Each 
symbol represents an image taken every 5 minutes for the 60 minute time lapse 
experiment and every 10 minutes for the 120 minute time lapse experiment.   
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Quantification of pHrodo in dextran
+
 MZM 
Results obtained from confocal microscopy revealed numerous pHrodo
+
 
phagocytic compartments within MZM (Fig. 35).  To determine differences in the 
phagocytosis of pHrodo between MZM from young and old mice, dextran
+
 pHrodo
+
 
MZM were first distinguished from dextran only and pHrodo only single positive cells. 
The MFI of pHrodo from the double positive MZM was then determined.  The MFI was 
taken to reflect the amount of pHrodo phagocytized.  Results showed that the MZM from 
old mice had no differences in the amount of pHrodo phagocytized when compared to 
MZM from young mice (Fig. 36B) (n = 10 young and n = 9 old, p = 0.2689).  To rule out 
differences in size of adherent MZM in young versus old affecting the data obtained for 
MFI, the area of the MZM from young and old were also determined and found not to be 
significantly different between age groups (Fig. 36C) (n = 10 young and n = 9 old,  
p = 0.1317).  Individual phagocytic compartments were also counted in young and old 
MZM.  Data show that there were also no differences in the number of phagocytic 
compartments between age groups (Fig. 36E) (n = 8 young and n = 7 old, p = 0.5989). 
Notably, after imaging numerous pHrodo
+
dextran
+
 MZM (15/animal) from both 
young and old adherent splenocytes that only a fraction of the imaged adherent cells from 
old mice met the criteria for evaluation of phagocytosis by MZM (macrophage in 
morphology, dextran
+
 and pHrodo
+
) when compared to adherent MZM  from young 
mice.  The young mice had roughly 40% more pHrodo
+
 dextran
+ 
MZM present in culture 
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compared to old mice.  These results are consistent previous findings that the 
frequency/number of MZM decline with age (Fig. 10; Table III).   
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Figure 35.   Comparison of the phagocytosis of MZM isolated from old and young 
mice. Confocal images of live adherent MZM administered pHrodo for 1.5 hr after 
harvested from young and old mice administered dextran-FITC (green) intravenously.  
Photos show typical dextran
+ 
pHrodo
+
 MZM taken live at 5000x magnification at cell 
thickness of 1 micron.  Photos are representative of MZM isolated from 1 young of 10 
(top panels) and 1 of 9 old (bottom panels).  Dextran (green) only uptake can be 
visualized in the left panels, pHrodo only visualized in the middle panels, and an overlay 
of the dextran
+
 pHrodo
+
 MZM in the right panels.   
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Figure 36.  Quantification of pHrodo in dextran
+
 MZM.  (A) and (B)  Comparison of 
the MFI of pHrodo
+
 phagocytized compartments by MZM from young and old mice.  
Using ImageJ software a perimeter was drawn around the area of each MZM analyzed 
and the MFI was determined for pHrodo (top graph depicts the raw data from 2 separate 
experiments).  p = 0.2689, Mann Whitney test; n = 10 young mice (2-3 mo); n = 9 old 
mice (19-23 mo).  (C) Comparison of the area of adherent MZM from young and old 
mice.  p = 0.1317, Unpaired t-test; n = 10 young mice (2-3 mo); n = 9 old mice (19-23 
mo).  (D) and (E) Comparison of the number of phagocytic compartments in MZM from 
young and old mice (top graph depicts the raw data from 2 separate experiments).  p = 
0.5989, Unpaired t-test; n = 8 young mice (2-3 mo); n = 7 old mice (19-23 mo).   All data 
in figures (B), (C), and (E) are expressed as mean ± SEM and are representative of six 
separate experiments.   
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Percent pHrodo
+
 of the dextran
+
 MZM 
 It is possible that the pHrodo
+
 dextran
+
 MZM of old mice that were evaluated 
were from a pool of functional MZM and that non-functional MZM were not imaged 
because of their inability to phagocytize pHrodo.  To test this hypothesis, I determined 
the proportion of pHrodo
+
 cells of the dextran
+
 adherent MZM.  As previously 
mentioned, 15 separate images of pHrodo
+
dextran
+
 MZM /animal were captured.  Each 
of these images contained multiple cells that were both single positive for dextran and 
pHrodo or double positive for dextran and pHrodo (Fig. 37A). The ratios of pHrodo
+ 
cells: dextran
+
 cells per image were determined and an average of all the images 
analyzed/animal was reported as a percentage.  Results show that there were no 
differences in the percentage of pHrodo
+ 
cells within the dextran
+
 MZM population in 
young and old (Fig. 37B) (n = 9 young and n = 9 old, p = 0.9456).  From these results, I 
conclude that the pHrodo
+
dextran
+
 MZM evaluated for phagocytosis in old were from a 
pool of functional MZM and were a true representation of the old MZM population.   
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Figure 37.  The percentage of pHrodo
+
 cells of the dextran
+
 MZM.  (A) Confocal 
images taken live of young (left) and old (right) adherent splenocytes isolated from mice 
given i.v. delivery of dextran-FITC.  Splenocytes were harvested and given100 µg 
pHrodo for 1.5 hr incubated at 37 C.  Cells were imaged live at 5000x magnification at 
cell thickness of 1 micron.  The total number of pHrodo
+ 
cells in a single image was 
quantified over the total number of dextran
+
 MZM.  (B) The ratio of pHrodo
+
 cells: 
dextran
+
 MZM/field determined and presented as a percentage.  Results are expressed as 
mean ± SEM and are representative of six separate experiments n = 9 young mice (2-3 
mo); n = 9 old mice (19-23 mo).  No significant differences present between young and 
old mice. p = 0.9456, Unpaired t-test.   
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Comparison of dextran-FITC phagocytized by MZM from young and old mice in 
vivo as revealed by confocal microscopy 
 Tissue sections of spleens revealed that there was reduced dextran-FITC localized 
on the MZM of old mice when compared to young mice (Fig. 26) and prior data also 
revealed that there are decreases in the MZM pool with age.  Perhaps the reason for 
reduced MZM capture of dextran-FITC in old mice is a result of less MZM present in old 
tissue and not a predictor of decreases in the phagocytic function of MZM with age.  
Initially, the percentage of dextran
+
 MZM from young and old mice was quantified using 
flow cytometry techniques (Fig. 27).  Results showed a high level of background in the 
control groups suggesting that the use of flow cytometry is limiting to determine 
differences in MZM function.   
Although cellular fluorescence prevented an accurate assessment of the quantity 
of dextran bound by MZM by flow cytometry, dextran
+
 MZM could be visualized 
live/cell at 5000x magnification under confocal microscopy without interference of 
background fluorescence.  The MFI of dextran-FITC in young and old MZM was 
measured using confocal microscopy and image analysis.  Images of pHrodo
+
 dextran
+ 
MZM previously captured for measurement of pHrodo phagocytosis were again used to 
determine the differences in phagocytosis of dextran between young and old MZM.  Prior 
data by Geijtenbeek et al. have reported that after initial dextran capture (observed in 45 
min), MZM will phagocytosis dextran (17).  Results showed that there were no 
differences in the phagocytosis of dextran by MZM between age groups (Fig. 38).  This 
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data again shows that there are no functional differences between MZM from young and 
old mice.   
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Figure 38.  Quantification of dextran-FITC in MZM from young and old mice as 
revealed by confocal microscopy.  Comparison of the MFI of dextran captured by MZM 
from young and old mice.  Using ImageJ software areas was drawn around the perimeter 
of MZM and the MFI of dextran-FITC was determined.  (A)  Raw data gathered from 
two separate experiments.  Each point corresponds to the MFI of dextran captured by 
MZM (B) Data are presented as a ratio of the sample MFI over the average MFI of young 
per experimental group.  p = 0.4256, Mann Whitney test.  Data are expressed as mean ± 
SEM and are representative of six separate experiments n = 9 young mice (2-3 mo); n = 9 
old mice (19-23 mo).   
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Summary of the functional studies on MZM  
 In order to determine the functional differences of MZM of young and old mice 
these rare macrophages needed to be targeted.  Currently there are no studies that have 
reported the ability to isolate MZM without severe manipulation to the cell.  Here I have 
shown that MZM can be marked and its functional properties can be assessed.  Initial 
studies presented aimed to determine functional differences by the capture of dextran-
FITC upon i.v. injection.  Results showed reduced dextran-FITC localized in MZM of 
tissue sections of old mice when compared to young mice.  However, I was not able to 
quantify the amount of dextran-FITC capture.  Using this experimental paradigm to mark 
MZM I was able to target MZM while preserving cell viability.  Once MZM were 
targeted pHrodo was administered in order to determine differences in phagocytosis of 
MZM from young and old mice.  Results revealed that there were no differences in 
phagocytosis between age groups.  Therefore, the reduced dextran-FITC observed in 
tissue sections of old mice are a result of fewer MZM present in old mice and not a result 
of reduced cellular function.     
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                                                      CHAPTER VII 
                                                       DISCUSSION 
The MZ of the spleen is known to be the site where blood-borne antigens first 
enter the spleen at the porous MZ sinus.  In this dissertation, the age-related changes in 
the overall architecture of the MZ compartment were described.  Specific reductions in 
MZM and MZ B cells were observed. The MZ of young adult mice have a characteristic 
uniform dense appearance around the white pulp and follicles; in contrast, the MZ of old 
mice have a statistically significant cellular disruption when compared to young mice.  
Alterations to the MZ included 1) reduction in abundance of MZM with no differences in 
the phagocytic function of MZM, 2) a reduction in the frequency of MZ B cells that 
correlated with the reductions observed with MZM, and 3) unusual staining patterns for 
MAdCAM-1 sinus lining cells and MMM that may indicate positional changes.  
Collectively, work from this dissertation showed that with advanced age there is a gross 
anatomical breakdown of the MZ with decreases particularly striking in the MZM and 
MZ B cell populations. Therefore, if the spleen architecture in humans suffers a similar 
decline with advanced age, one consequence may be less efficient clearing and response 
to bacteria, as has been reported in splenectomized and asplenic patients (112). 
In humans, the MZ of the spleen is a clearly defined zone that is divided into 
outer and inner parts by fibroblasts that are MAdCAM-1
+
 (112, 113).   The MZ sinus is 
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not present as a component of the human MZ and lymphocytes and antigens enter the 
spleen via the splenic open circulation into the outer MZ area.  This outer MZ area is 
referred to as the perifollicular zone.  The perifollicular zone of the human spleen 
contains MZ B cells and sialoadhesin-positive macrophages, postulated to be the “human 
equivalent” of MMM and MZM (113).  Although differences in microanatomy are 
present within the rodent and human splenic MZ areas, the human spleen is also 
important in the immune response to infection with S. pneumoniae and its importance can 
best be seen in epidemiological reports of splenectomized patients.  A study showed a 5% 
lifetime risk of “overwhelming infection syndrome” in these patients, which is lethal in 
almost 50% (114).  Studies have shown that when sepsis occurred in postsplenectomized 
patients, in 80-90% of reported cases it resulted due to infection with S. pneumoniae 
(115).  S. pneumoniae are gram-positive bacteria that have a cell wall whose degradation 
is achieved through phagocytosis (116).  Antibody and complement coated S. 
pneumoniae are believed to filter to the human spleen for removal.  The phagocytes 
present in the human splenic MZ are the sialoadhesin-positive macrophages; therefore, 
future studies can examine these cells to determine if they are the primary phagocytes 
involved in the removal of S. pneumoniae.  
Functional abnormalities of the human spleen have been reported in the elderly 
population.  A condition termed hyposplenism in which the spleen has reduced function 
has been reported in the elderly and in newborn infants (117).  Patients with 
hyposplenism have a reported increased mortality rate as a result of pneumococcal sepsis 
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(118).  Studies have also shown that vaccines that utilize T cell dependent mechanisms 
are more effective in the prevention of pneumococcal disease in hyposplenic and asplenic 
patients.  Therefore, I believe that the elderly population would too benefit from T cell 
dependent vaccines.  
Alteration in the structure of the splenic marginal zone 
 At the MZ region of the spleen there is continuous migration of lymphocytes, self 
antigens, and blood borne pathogens (7, 30, 82).  The MZ can be seen as a major 
intersection for the homing of lymphocytes to their respective zones and the sorting 
station for TI and TD pathogens.  Therefore, the positioning of the cellular components 
that make up this MZ region can be seen as critical in its maintenance. The structure of 
the MZ is highly ordered in young mice, with definitive boundaries at the white pulp and 
red pulp regions.   Examination of H&E tissue sections of young spleens revealed MZ 
regions with minimal interface distortion and percent radius involvement.  However, the 
MZ regions of old mice were significantly more disrupted with a high degree of 
variability.  In many old mice, the interface distortion and percent radius involvement 
was severe; however, in ~20 % of old mice the MZ regions appeared young-like in 
morphology.  What factors could contribute to this young-like morphology, given that 
these old mice are inbred?   An environmental stimulus is one answer.  The mice in my 
studies were housed 4 to a cage, and it is possible that natural dominance leads to chronic 
stress contributing to the rapid aging of the submissive mice.  Studies have shown that 
chronic social defeat as a result of exposure to an aggressor mouse each day for 10 min 
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for a total of 10 days leads to chronic stress (119).   Chronic stress has been shown to be 
accompanied by chromatin remodeling of the brain-derived neurotrophic factor gene 
(BDNF), which has been shown to be important for the hippocampus to deal with stress 
(120, 121).  It may be possible that chronic social defeat may also contribute to damage 
of immune system cells.  The alteration in the morphology of the MZ in old mice 
appeared to be due to an alteration of the cellular components that make up this zone.  
The next sections will go through the cells that exhibited an alteration in age.  
Decreases in marginal zone macrophages in old mice 
Decreases in MZM in old mice were seen both semi-qualitatively (in tissue 
sections) and quantitatively (via flow cytometry).  An age related decrease in MZM may 
have consequences on the immunity of aged individuals.  For example, pneumonia 
caused by S. pneumoniae is one of the leading causes of mortality in advanced age (2, 3).  
SIGN-R1 [the murine homologue of human DC-SIGN (16)] on MZM binds the capsular 
polysaccharide of S. pneumoniae (19, 20).  It is possible that a decrease in the SIGN-R1
+
 
MZM pool may allow for increased susceptibility to S. pneumoniae reported in the 
elderly.  Very little is known about the homeostasis of the MZM compartment.  Three 
possible mechanisms may contribute to the reductions in MZM with advanced age 
include: decreased MZ B cells, decreased chemotactic factors important for MZM 
homing to the MZ, or decreased MZM turnover.  
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Evidence supports the first mechanism since decreases in MZ B cells in old mice, 
when present, correlate with decreases in MZM (Fig. 14).   In addition, a report by Kraal 
et al. observed that recovery of MZM correlated with full restoration of the B cell 
population in the MZ of mice after in vivo liposome treatment that led to depletion of all 
splenic macrophages and most MZ B cells (39).  Furthermore, it is important to point out 
that although there was a significant decrease in MZM in old mice when compared to 
young mice, there were approximately ~20% of old mice that had young like MZM 
distributions in tissue and as revealed by flow cytometry.   Data that revealed a 
correlation between MZM and MZ B cells also showed that there are three separate 
groups of MZM and MZ B correlates: one group having poor amounts of both cells, a 
second group having moderate amounts of both cells, and a third group having 
good/young-like amounts of MZM and MZ B cells.  This separation is particularly 
meaningfully because perhaps it reflects a gradual loss of the “young-like” phenotype in 
old mice.  It is possible that at some point all mice will have a loss of both cell 
populations.   Nolte et al. reported that overexpression of CD70 (a TNF family member) 
specifically in B cells led to a gradual loss of the splenic B cell pool with a subsequent 
gradual loss of MZM (40).  In advanced age, this same phenomenon of a gradual loss 
may occur and is represented by the moderate group seen here.   
It is reasonable to propose that decreases in MZM with age can be influenced by 
chemotactic factors important for MZM homing to the MZ.  The chemokine CCL21 
(protein) (Fig. 19A) was found in lesser amounts in the PALS region of old mice when 
143 
 
 
 
compared to young mice.  In addition, I determined that there was no co-localization of 
CCL21 with MZM, rather CCL21 when present was localized outside the MZ, as 
revealed by confocal microscopy (Fig. 20B).  Preliminary observations also showed that 
in some mice that have poor levels of MARCO
+
 MZM also have an abundance of CCL21 
proteins in splenic tissue (Fig. 20C).  It may be possible that in these mice there is an over 
production of CCL21 in order to attract precursor MZM (if present) to the MZ to refill 
the reduced MZM population.  Whether this loss is due to the inability of newly made 
MZM to home to the MZ or a result of loss of the resident MZM remains to be clear.  It 
has yet to be established if MZM are continuously made throughout the lifetime of the 
animal or if the MZM observed 10 days post birth are maintained throughout a lifetime.   
If the former is true, then MZM are continuously made every few days, weeks, or 
months.   It is possible in this scenario that the MZM of old mice may have a slower 
turnover.  Kraal et al. showed that new MZM will replenish a macrophage-depleted 
young spleen by 30 days, implying that MZM precursors exist in young animals (39).  
Therefore, it is possible that with advancement in age there is a decrease in MZM 
replenishment and/or precursors that is responsible for the age related decrease in MZM.    
Decreases in marginal zone B cells in old mice 
The decrease in MZ B cell frequency in old mice is puzzling because an age-
related increase toward maintenance of existing MZ B cells has been predicted by 
Allman and Miller (67).  Moreover, certain conditions in old mice are more aligned with 
MZ B cell development than follicular (FO) B cell development, such as low levels of 
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E2A and IL-7 [reviewed in (11, 67, 68, 122) (69, 70, 75-77)].   A shift towards expanded 
MZ B cell differentiation at the expense of FO B cell production was age is an attractive 
hypothesis, and as previously mentioned in the background section of this dissertation, 
increases in MZ B cell numbers were reported by one group using aged B10.D2 mice 
(78).  Furthermore, it may be possible that MZ B cells are being produced at expanded 
levels in age; however, because of the collapse in the MZ micro-architecture in age, the 
newly formed MZ B cells may not home effectively to the aged MZ compartment.  
Adoptive transfer experiments presented in this dissertation (Chapter five)  showed that 
donor MZ B cells from young mice had a decreased ability to home to spleens of old 
mice when compared to young mice.  Moreover, when other lymphoid organs were 
examined a MZ B cell phenotype was observed in both the lymph nodes and bone 
marrow of a very few old mice (Table V).  Experiments by Cariappa et al. have shown a 
subset of recirculating mature B cells in the bone marrow able to respond to TI antigens 
(123).  It may be possible that these recirculating B cells that were identified were in fact 
MZ B cells that were displaced to the bone marrow. Data from adoptive transfer 
experiment suggests that the microenvironment of old mice is altered preventing homing 
of MZ B cells.  Another consideration is suggested by recent studies that have shown that 
MZ B cells are lost during chronic inflammation (124, 125).  Traggiai et al. report 
changes in B-lineage subpopulations that appear similar to those reported in old mice (88, 
89, 124).  Chronic inflammation has been viewed by many investigators as part of 
immunosenescence [reviewed in (98, 101)], raising the possibility that increased 
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inflammation with age promotes gradual loss of MZ B cells, and perhaps, subsequent 
decline of MZM.  Lastly, it may also be that donor MZ B cells were not able to home to 
the spleens of old mice because of the decreases in the MZM pool with age. 
Yet, there are other factors important for the maintenance of MZ B cells to the 
MZ. Reports by Cinamon et al. have demonstrated that S1P1 is needed for MZ B cells to 
maintain localization in the MZ (64, 65), and reduction in receptor expression causes MZ 
B cells to leave the MZ and move into the follicle in a CXCL13-dependent manner.  If 
decreases in S1P or its receptors are present in spleens of old mice, a displacement of MZ 
B cells would be expected, perhaps not only to the follicular area, since CXCL13 
expression has been shown to be disrupted with age (27), but near the MAdCAM1
+
 sinus 
lining cells at the boundary of the MZ and white pulp interface where CXCL13 is 
localized with age.  Furthermore, recent work has shown that B cells from SHEP1-
deficient mice have a reduction in mature MZ B cells and fail to migrate towards 
CXCL13 and S1P (126).  Therefore, it may also be possible that there is an alteration in 
the SHEP1 with age. SHEP1 is an adaptor molecule shown to partner with the 
scaffolding protein CasL (important for integrin activation), which leads to the 
phosphorylation of the serine/threonine of CasL allowing for MZ B cell retainment to the 
MZ.   
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The marginal zone sinus and metallophilic macrophages in old mice  
The marginal zones in old mice also showed alterations in the MAdCAM-1
+
 MZ 
sinus lining cells, which are part of the reticular family of cells (127, 128).  Moreover, 
these cells act as a “polarized” barrier to overt penetration of antigen from the MZ sinus 
into the follicles; whereas, antigen readily moves from the sinus outward toward the 
MZM and MZ B cell layer (64, 129).  Results showed that the expression of MAdCAM-1
 
was diffused into the white pulp and less organized in old mice when compared to young 
mice, and MMM were found to be similarly disrupted in old when compared to young 
spleens.  Changes in the morphology of MAdCAM-1
+ 
and MMM compartments 
appeared consistently disrupted in the majority of spleens from old mice.  Strikingly 
similar morphological disruptions in the MAdCAM-1
+
 sinus lining cells and MMM were 
observed by Girkontaite et al. in sphingosine-1-phosphate receptor 3 (S1P3) deficient 
mice (84).  S1P3 is necessary for the positioning of MAdCAM-1
+
 sinus lining cells and 
MMM along the continuity of the MZ sinus (84).  It is possible that in old mice there is a 
downregulation of S1P3, which is responsible for the morphological disruptions of the 
MZ sinus and MMM.  Furthermore, in the MZ compartment, S1P1 and S1P3 are highly 
expressed on MZ B cells and FO B cells (65).  Therefore, it is possible that S1P and/or its 
receptors provide a link between reduced MZM/MZ B cells and dispositioning of 
MAdCAM-1
+
 cells/MMM (Fig. 8).   S1P has also been implicated in the induction of 
proteins found in junctional complexes, and at least one receptor (S1P1) was found on the 
surface of reticular stromal cells, as well as endothelial cells, in lymph nodes (130).  
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Recently, Katakai et al. provided evidence that the MAdCAM-1
+
 sinus lining cells derive 
from a type of reticular stromal cell that requires constant LTβR stimulation for survival 
and production of CXCL13 (128). These observations, along with the previous finding 
that MZ sinus lining cells of aged spleens had less CXCL13 (27) could indicate a 
problem in LTβR stimulation.  It is also possible that either S1P and its receptors or 
LT/LTβR provide a link between reduced MZM/MZ B cells and dispositioning of 
MAdCAM-1
+
 cells. 
No difference in marginal zone macrophage function in old mice 
To determine whether reduced MZM affected antigen clearance in the MZ, 
fluorescently labeled polysaccharide dextran that is known to bind SIGN-R1 (17, 18), 
was administered via tail vein into both young and old mice.  Less bound dextran in the 
MZ of old mice was found when compared to young mice as revealed by confocal 
microscopy (Chapter VI).  Less bound dextran in old tissue sections could be a result of 
fewer MZM available to bind blood-borne dextran.  To answer this question, an approach 
was needed to specifically identify MZM in order to measure functional differences in 
age.  MZM comprise 1-2% of the total splenic population and prior studies have had 
limited success in isolating these cells for functional analysis ex vivo.  Using a novel 
approach, I was able to target MZM of young and old mice and administer pHrodo to 
measure differences in phagocytosis of live cells using a Leica TCS SP5 confocal 
microscope.   Results showed that the phagocytic function of individual MZM was not 
different between young and old mice, suggesting that it is this loss in the MZM 
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population with age that contributes to the reduction in pathogen clearance reported in the 
elderly.   
Chronic inflammation in age 
It is believed that in aging there is a low level of chronic inflammation as a result 
of underlying disease a phenomenon termed “Inflam-aging” (101).  It is believed that 
chronic inflammation produces a heightened proinflammatory state.  “Inflam-aging” is 
characterized by a decrease in adaptive immunity and an increase in innate immunity.  It 
has been suggested that cells of the mononuclear phagocyte cell lineage are responsible 
for the increase production of proinflammatory cytokines in age.  Recently, Di Paolo et 
al. showed that macrophages in the MZ trapped blood-borne adenovirus and rapidly 
produced an IL-1α dependent pro-inflammatory response (131).  It is conceivable that a 
lifetime of repeated exposure and uptake of viruses and bacteria causes repeated 
production of pro-inflammatory cytokines and chemokines, leading to overall damage to 
the microenvironment and decrease in immune cells (Fig. 39).  Yet, whether a hyper-
proinflammatory state or repeated exposure to viruses and bacteria can lead to a 
hindrance in normal cell frequencies and function still remains to be elucidated for 
immune cells.   
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Figure 39.  Model of the Microenvironmental alterations of the Splenic Marginal 
Zone.  Factors that may contribute to decreases in the cellular components of the MZ.  
(1) There is a correlation between decreases in MZM and MZ B cells in old mice.  
Decreases in MZM can be a result of decreases in MZ B cells.  Furthermore, it may be 
possible that the chemokine CCL21 is over produced in the spleens of old mice to home 
precursor MZM to MZ that have a reduction in MZM.  On the contrary, decreases in MZ 
B cells may be due to decreases in MZM or downregulation of S1P3.    (2) MAdCAM1
+
 
MZ sinus lining cells are observed in multiple cell layers and MMM are not continuous 
with the MZ sinus.  This alteration may also be due to a reduction in S1P3.  (3) MZ B 
cells may also exit the spleen and home to the bone marrow or the lymph nodes.  (4)  It is 
also possible that as a result of “Inflam-aging” there is an over production of 
proinflammatory cytokines such as TNFα leading to damage and loss of the MZ cells.  
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Significance  
Understanding the alterations that occur with age in lymphoid tissues such as the 
spleen is important for developing more efficient therapies for the prevention of diseases 
such as bacterial pneumonia that have shown to be highly detrimental in the elderly (2).  
The cells that contribute to framework of the MZ of the spleen are largely responsible for 
initiating an effective immune response to the vaccine components for the prevention of 
S. pneumoniae and other TI antigens.  The goal of this study was to determine if there 
were age-related changes in the cellular components of the MZ in old versus young mice.   
Results show changes throughout the components of the MZ, including the: MZ sinus 
lining cells, MMM, MZM, and MZ B cells.  Furthermore, reductions in MZM in 
individual old mice correlated with reductions in MZ B cell populations with some of the 
old mice exhibiting young-like MZM and MZ B cell phenotypes.  Future studies can 
examine old mice in order to determine what attributes to these young-like phenotypes, 
and perhaps insights gained from these studies can pave the way for a modern day 
fountain-of-youth.  In terms of vaccine efficacy, vaccines can target the deficient MZM 
and MZ B cell populations in aging individuals to heighten the immune response against 
the TI components that constitute current vaccines. 
 151 
 
 
 
 
 
             
   REFERENCES  
 
1.     Bureau, U. S. C. 2010. USA Quickfacts. In  
 
2      . Artz, A. S., W. B. Ershler, and D. L. Longo. 2003. Pneumococcal vaccination and 
revaccination of older adults. Clin Microbiol Rev 16:308-318. 
 
3      . van der Poll, T., and S. M. Opal. 2009. Pathogenesis, treatment, and prevention of 
pneumococcal pneumonia. Lancet 374:1543-1556. 
 
4.    Bondada, S., H. Wu, D. A. Robertson, and R. L. Chelvarajan. 2000. Accessory cell 
defect in unresponsiveness of neonates and aged to polysaccharide vaccines. 
Vaccine 19:557-565. 
 
5.    Butler, J. C., E. D. Shapiro, and G. M. Carlone. 1999. Pneumococcal vaccines: 
history, current status, and future directions. Am J Med 107:69S-76S. 
 
6.    Kirby, A. C., L. Beattie, A. Maroof, N. van Rooijen, and P. M. Kaye. 2009. 
SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis 
after Leishmania donovani-induced loss of marginal zone macrophages. Am J 
Pathol 175:1107-1115. 
 
7.     Kraal, G., and R. Mebius. 2006. New insights into the cell biology of the marginal 
zone of the spleen. Int Rev Cytol 250:175-215. 
 
8.    Mebius, R. E., M. A. Nolte, and G. Kraal. 2004. Development and function of the 
splenic marginal zone. Crit Rev Immunol 24:449-464. 
 
9     Dijkstra, C. D., E. Van Vliet, E. A. Dopp, A. A. van der Lelij, and G. Kraal. 1985. 
Marginal zone macrophages identified by a monoclonal antibody: characterization 
of immuno- and enzyme-histochemical properties and functional capacities. 
Immunology 55:23-30. 
 
10.    Gunn, K. E., and J. W. Brewer. 2006. Evidence that marginal zone B cells possess  
an enhanced secretory apparatus and exhibit superior secretory activity. J 
Immunol 177:3791-3798. 
 
152 
 
 
11.     Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr Opin Immunol 
20:149-157. 
 
12.    Vos, Q., A. Lees, Z. Q. Wu, C. M. Snapper, and J. J. Mond. 2000. B-cell activation 
by T-cell-independent type 2 antigens as an integral part of the humoral immune 
response to pathogenic microorganisms. Immunol Rev 176:154-170. 
 
13.    Chelvarajan, R. L., S. M. Collins, J. M. Van Willigen, and S. Bondada. 2005. The 
unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in 
macrophage function. J Leukoc Biol 77:503-512. 
 
14.     Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. 
Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding 
receptor structurally related to scavenger receptors and expressed in a subset of 
macrophages. Cell 80:603-609. 
 
15.     Karlsson, M. C., R. Guinamard, S. Bolland, M. Sankala, R. M. Steinman, and J. V. 
Ravetch. 2003. Macrophages control the retention and trafficking of B 
lymphocytes in the splenic marginal zone. J Exp Med 198:333-340. 
 
16.     Koppel, E. A., E. Saeland, D. J. de Cooker, Y. van Kooyk, and T. B. Geijtenbeek. 
2005. DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 
and 14. Immunobiology 210:203-210. 
 
17.    Geijtenbeek, T. B., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-
Panday, G. C. van Duijnhoven, G. Kraal, A. J. van Oosterhout, and Y. van 
Kooyk. 2002. Marginal zone macrophages express a murine homologue of DC-
SIGN that captures blood-borne antigens in vivo. Blood 100:2908-2916. 
 
18.    Kang, Y. S., S. Yamazaki, T. Iyoda, M. Pack, S. A. Bruening, J. Y. Kim, K. 
Takahara, K. Inaba, R. M. Steinman, and C. G. Park. 2003. SIGN-R1, a novel C-
type lectin expressed by marginal zone macrophages in spleen, mediates uptake of 
the polysaccharide dextran. Int Immunol 15:177-186. 
 
19.    Kang, Y. S., J. Y. Kim, S. A. Bruening, M. Pack, A. Charalambous, A. Pritsker, T. 
M. Moran, J. M. Loeffler, R. M. Steinman, and C. G. Park. 2004. The C-type 
lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus 
pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci U S A 
101:215-220. 
 
20.     Koppel, E. A., C. W. Wieland, V. C. van den Berg, M. Litjens, S. Florquin, Y. van 
Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2005. Specific ICAM-3 grabbing 
nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is 
153 
 
 
essential for defense against pulmonary Streptococcus pneumoniae infection. Eur 
J Immunol 35:2962-2969. 
 
21.    Koppel, E. A., M. Litjens, V. C. van den Berg, Y. van Kooyk, and T. B. 
Geijtenbeek. 2008. Interaction of SIGNR1 expressed by marginal zone 
macrophages with marginal zone B cells is essential to early IgM responses 
against Streptococcus pneumoniae. Mol Immunol 45:2881-2887. 
 
22.     Chen, Y., T. Pikkarainen, O. Elomaa, R. Soininen, T. Kodama, G. Kraal, and K. 
Tryggvason. 2005. Defective microarchitecture of the spleen marginal zone and 
impaired response to a thymus-independent type 2 antigen in mice lacking 
scavenger receptors MARCO and SR-A. J Immunol 175:8173-8180. 
 
23.     Gebe, J. A., M. Llewellyn, H. Hoggatt, and A. Aruffo. 2000. Molecular cloning, 
genomic organization and cell-binding characteristics of mouse Spalpha. 
Immunology 99:78-86. 
 
24.     Yokota, T., B. Ehlin-Henriksson, and G. K. Hansson. 1998. Scavenger receptors 
mediate adhesion of activated B lymphocytes. Exp Cell Res 239:16-22. 
 
25.     Szakal, A. K., Y. Aydar, P. Balogh, and J. G. Tew. 2002. Molecular interactions of 
FDCs with B cells in aging. Semin Immunol 14:267-274. 
 
 
26.     Eaton-Bassiri, A. S., L. Mandik-Nayak, S. J. Seo, M. P. Madaio, M. P. Cancro, and 
J. Erikson. 2000. Alterations in splenic architecture and the localization of anti-
double-stranded DNA B cells in aged mice. Int Immunol 12:915-926. 
 
27.     Minges Wols, H. A., K. M. Johnson, J. A. Ippolito, S. Z. Birjandi, Y. Su, P. T. Le, 
and P. L. Witte. 2009. Migration of immature and mature B cells in the aged 
microenvironment. Immunology. 
 
28.     Cheung, H. T., and M. J. Nadakavukaren. 1983. Age-dependent changes in the 
cellularity and ultrastructure of the spleen of Fischer F344 rats. Mech Ageing Dev 
22:23-33. 
 
29.     Zheng, B., S. Han, Y. Takahashi, and G. Kelsoe. 1997. Immunosenescence and 
germinal center reaction. Immunol Rev 160:63-77. 
 
30.     Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat Rev 
Immunol 5:606-616. 
 
154 
 
 
31.    Allen, C. D., and J. G. Cyster. 2008. Follicular dendritic cell networks of primary 
follicles and germinal centers: phenotype and function. Semin Immunol 20:14-25. 
 
32.     Allman, D., B. Srivastava, and R. C. Lindsley. 2004. Alternative routes to maturity: 
branch points and pathways for generating follicular and marginal zone B cells. 
Immunol Rev 197:147-160. 
 
33.     Johnston, B., and E. C. Butcher. 2002. Chemokines in rapid leukocyte adhesion 
triggering and migration. Semin Immunol 14:83-92. 
 
34.     Campbell, D. J., C. H. Kim, and E. C. Butcher. 2003. Chemokines in the systemic 
organization of immunity. Immunol Rev 195:58-71. 
 
35.     Lu, T. T., and J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in 
the splenic marginal zone. Science 297:409-412. 
 
36.     Sasou, S., R. Satodate, and S. Katsura. 1976. The marginal sinus in the 
perifollicular region of the rat spleen. Cell Tissue Res 172:195-203. 
 
37.    Richard A. Goldsby, T. J. K., Barbara A. Osborne, and Janis Kuby. 2003. 
Immunology. Freeman, W.H., Publishers. 
 
38.     Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. 
Annu Rev Immunol 13:655-692. 
 
39.     van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in 
the spleen: differential kinetics after liposome-mediated elimination. J Leukoc 
Biol 45:97-104. 
 
40.     Nolte, M. A., R. Arens, M. Kraus, M. H. van Oers, G. Kraal, R. A. van Lier, and R. 
E. Mebius. 2004. B cells are crucial for both development and maintenance of the 
splenic marginal zone. J Immunol 172:3620-3627. 
 
41.    You, Y., H. Zhao, Y. Wang, and R. H. Carter. 2009. Cutting edge: Primary and 
secondary effects of CD19 deficiency on cells of the marginal zone. J Immunol 
182:7343-7347. 
 
42.    Takeya, M., and K. Takahashi. 1992. Ontogenic development of macrophage 
subpopulations and Ia-positive dendritic cells in fetal and neonatal rat spleen. J 
Leukoc Biol 52:516-523. 
 
155 
 
 
43.     Ato, M., H. Nakano, T. Kakiuchi, and P. M. Kaye. 2004. Localization of marginal 
zone macrophages is regulated by C-C chemokine ligands 21/19. J Immunol 
173:4815-4820. 
 
44.     Platt, N., R. P. da Silva, and S. Gordon. 1999. Class A scavenger receptors and the 
phagocytosis of apoptotic cells. Immunol Lett 65:15-19. 
 
45.     Elomaa, O., M. Sankala, T. Pikkarainen, U. Bergmann, A. Tuuttila, A. 
Raatikainen-Ahokas, H. Sariola, and K. Tryggvason. 1998. Structure of the 
human macrophage MARCO receptor and characterization of its bacteria-binding 
region. J Biol Chem 273:4530-4538. 
 
46.    Pikkarainen, T., A. Brannstrom, and K. Tryggvason. 1999. Expression of 
macrophage MARCO receptor induces formation of dendritic plasma membrane 
processes. J Biol Chem 274:10975-10982. 
 
47.     Underhill, D. M., and A. Ozinsky. 2002. Phagocytosis of microbes: complexity in 
action. Annu Rev Immunol 20:825-852. 
 
48.     Nagaoka, K., K. Takahara, K. Tanaka, H. Yoshida, R. M. Steinman, S. Saitoh, S. 
Akashi-Takamura, K. Miyake, Y. S. Kang, C. G. Park, and K. Inaba. 2005. 
Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by 
recognition of LPS in gram-negative bacteria. Int Immunol 17:827-836. 
 
49.     Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human 
homologue of the Drosophila Toll protein signals activation of adaptive 
immunity. Nature 388:394-397. 
 
50.   Netea, M. G., C. van der Graaf, J. W. Van der Meer, and B. J. Kullberg. 2004. Toll-
like receptors and the host defense against microbial pathogens: bringing 
specificity to the innate-immune system. J Leukoc Biol 75:749-755. 
 
51.    Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: impact on the 
adaptive immune response. Curr Opin Immunol 9:4-9. 
 
52.   Bennett, I. L., Jr., and P. B. Beeson. 1953. Studies on the pathogenesis of fever. II. 
Characterization of fever-producing substances from polymorphonuclear 
leukocytes and from the fluid of sterile exudates. J Exp Med 98:493-508. 
 
53.     Cundell, D. R., N. P. Gerard, C. Gerard, I. Idanpaan-Heikkila, and E. I. Tuomanen. 
1995. Streptococcus pneumoniae anchor to activated human cells by the receptor 
for platelet-activating factor. Nature 377:435-438. 
156 
 
 
54.     Prescott, S. M., G. A. Zimmerman, and T. M. McIntyre. 1990. Platelet-activating 
factor. J Biol Chem 265:17381-17384. 
 
55.     Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in 
macrophages. Annu Rev Immunol 17:593-623. 
 
56.     Pillay, C. S., E. Elliott, and C. Dennison. 2002. Endolysosomal proteolysis and its 
regulation. Biochem J 363:417-429. 
 
57.     Gruenberg, J. 2001. The endocytic pathway: a mosaic of domains. Nat Rev Mol 
Cell Biol 2:721-730. 
 
58.     Clague, M. J. 1998. Molecular aspects of the endocytic pathway. Biochem J 336 ( 
Pt 2):271-282. 
 
59.     Tjelle, T. E., A. Brech, L. K. Juvet, G. Griffiths, and T. Berg. 1996. Isolation and 
characterization of early endosomes, late endosomes and terminal lysosomes: 
their role in protein degradation. J Cell Sci 109 ( Pt 12):2905-2914. 
 
60.     Bright, N. A., B. J. Reaves, B. M. Mullock, and J. P. Luzio. 1997. Dense core 
lysosomes can fuse with late endosomes and are re-formed from the resultant 
hybrid organelles. J Cell Sci 110 ( Pt 17):2027-2040. 
 
61.     Herzenberg, L. A. 1989. Toward a layered immune system. Cell 59:953-954. 
 
62.     Herzenberg, L. A., and A. B. Kantor. 1992. Layered evolution in the immune 
system. A model for the ontogeny and development of multiple lymphocyte 
lineages. Ann N Y Acad Sci 651:1-9. 
 
63.     Ferguson, A. R., M. E. Youd, and R. B. Corley. 2004. Marginal zone B cells 
transport and deposit IgM-containing immune complexes onto follicular dendritic 
cells. Int Immunol 16:1411-1422. 
 
64.     Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. 
Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat 
Immunol 9:54-62. 
 
65.     Cinamon, G., M. Matloubian, M. J. Lesneski, Y. Xu, C. Low, T. Lu, R. L. Proia, 
and J. G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell 
localization in the splenic marginal zone. Nat Immunol 5:713-720. 
 
66.     Allman, D., and J. P. Miller. 2005. The aging of early B-cell precursors. Immunol 
Rev 205:18-29. 
157 
 
 
 
67.    Allman, D., and J. P. Miller. 2005. B cell development and receptor diversity during 
aging. Curr Opin Immunol 17:463-467. 
 
68.     Lopes-Carvalho, T., and J. F. Kearney. 2004. Development and selection of 
marginal zone B cells. Immunol Rev 197:192-205. 
 
69.     Stephan, R. P., C. R. Reilly, and P. L. Witte. 1998. Impaired ability of bone 
marrow stromal cells to support B-lymphopoiesis with age. Blood 91:75-88. 
 
70.     Stephan, R. P., D. A. Lill-Elghanian, and P. L. Witte. 1997. Development of B 
cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not 
to other growth factors. J Immunol 158:1598-1609. 
 
71.     LeMaoult, J., S. Delassus, R. Dyall, J. Nikolic-Zugic, P. Kourilsky, and M. E. 
Weksler. 1997. Clonal expansions of B lymphocytes in old mice. J Immunol 
159:3866-3874. 
 
72.     Riley, S. C., B. G. Froscher, P. J. Linton, D. Zharhary, K. Marcu, and N. R. 
Klinman. 1989. Altered VH gene segment utilization in the response to 
phosphorylcholine by aged mice. J Immunol 143:3798-3805. 
 
73.      Nicoletti, C., X. Yang, and J. Cerny. 1993. Repertoire diversity of antibody 
response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from 
young and aged mice differ in structure and protective activity against infection 
with Streptococcus pneumoniae. J Immunol 150:543-549. 
 
74.     Nicoletti, C., C. Borghesi-Nicoletti, X. H. Yang, D. H. Schulze, and J. Cerny. 
1991. Repertoire diversity of antibody response to bacterial antigens in aged mice. 
II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL 
gene repertoire and in specificity. J Immunol 147:2750-2755. 
 
75.     Frasca, D., D. Nguyen, R. L. Riley, and B. B. Blomberg. 2004. Effects of aging on 
DNA-binding activity of the E47 transcription factor in splenic B cells. Mech 
Ageing Dev 125:111-112. 
 
76.     Frasca, D., D. Nguyen, R. L. Riley, and B. B. Blomberg. 2003. Effects of aging on 
proliferation and E47 transcription factor activity induced by different stimuli in 
murine splenic B cells. Mech Ageing Dev 124:361-369. 
 
77.     Frasca, D., D. Nguyen, E. Van der Put, R. L. Riley, and B. B. Blomberg. 2003. The 
age-related decrease in E47 DNA-binding does not depend on increased Id 
158 
 
 
inhibitory proteins in bone marrow-derived B cell precursors. Front Biosci 
8:a110-116. 
 
78.     Johnson, S. A., S. J. Rozzo, and J. C. Cambier. 2002. Aging-dependent exclusion 
of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol 
168:5014-5023. 
 
79.     Frasca, D., A. M. Landin, S. C. Lechner, J. G. Ryan, R. Schwartz, R. L. Riley, and 
B. B. Blomberg. 2008. Aging down-regulates the transcription factor E2A, 
activation-induced cytidine deaminase, and Ig class switch in human B cells. J 
Immunol 180:5283-5290. 
 
80.     Streeter, P. R., E. L. Berg, B. T. Rouse, R. F. Bargatze, and E. C. Butcher. 1988. A 
tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 
331:41-46. 
 
81.     Nakache, M., E. L. Berg, P. R. Streeter, and E. C. Butcher. 1989. The mucosal 
vascular addressin is a tissue-specific endothelial cell adhesion molecule for 
circulating lymphocytes. Nature 337:179-181. 
 
82.     Kraal, G., K. Schornagel, P. R. Streeter, B. Holzmann, and E. C. Butcher. 1995. 
Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells 
in the spleen. Am J Pathol 147:763-771. 
 
83.     Tada, T., N. Inoue, D. T. Widayati, and K. Fukuta. 2008. Role of MAdCAM-1 and 
its ligand on the homing of transplanted hematopoietic cells in irradiated mice. 
Exp Anim 57:347-356. 
 
84.     Girkontaite, I., V. Sakk, M. Wagner, T. Borggrefe, K. Tedford, J. Chun, and K. D. 
Fischer. 2004. The sphingosine-1-phosphate (S1P) lysophospholipid receptor 
S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus 
organization. J Exp Med 200:1491-1501. 
 
85.     Eikelenboom, P., C. D. Dijkstra, D. M. Boorsma, and N. van Rooijen. 1985. 
Characterization of lymphoid and nonlymphoid cells in the white pulp of the 
spleen using immunohistoperoxidase techniques and enzyme-histochemistry. 
Experientia 41:209-215. 
 
86.     Yan, J., J. M. Greer, R. Hull, J. D. O'Sullivan, R. D. Henderson, S. J. Read, and P. 
A. McCombe. The effect of ageing on human lymphocyte subsets: comparison of 
males and females. Immun Ageing 7:4. 
 
159 
 
 
87.     Lerner, A., T. Yamada, and R. A. Miller. 1989. Pgp-1hi T lymphocytes accumulate 
with age in mice and respond poorly to concanavalin A. Eur J Immunol 19:977-
982. 
 
88.     Stephan, R. P., V. M. Sanders, and P. L. Witte. 1996. Stage-specific alterations in 
murine B lymphopoiesis with age. Int Immunol 8:509-518. 
 
89.     Johnson, K. M., K. Owen, and P. L. Witte. 2002. Aging and developmental 
transitions in the B cell lineage. Int Immunol 14:1313-1323. 
 
90.     Kline, G. H., T. A. Hayden, and N. R. Klinman. 1999. B cell maintenance in aged 
mice reflects both increased B cell longevity and decreased B cell generation. J 
Immunol 162:3342-3349. 
 
91.     Kishimoto, S., S. Tomino, H. Mitsuya, H. Fujiwara, and H. Tsuda. 1980. Age-
related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody 
in humans. J Immunol 125:2347-2352. 
 
92.    Burns, E. A., L. G. Lum, M. C. Seigneuret, B. R. Giddings, and J. S. Goodwin. 
1990. Decreased specific antibody synthesis in old adults: decreased potency of 
antigen-specific B cells with aging. Mech Ageing Dev 53:229-241. 
 
93.     Weksler, M. E., and T. H. Hutteroth. 1974. Impaired lymphocyte function in aged 
humans. J Clin Invest 53:99-104. 
 
94.     Kishimoto, S., T. Takahama, and H. Mizumachi. 1976. In vitro immune response 
to the 2,4,6-trinitrophenyl determinant in aged C57BL/6J mice:changes in the 
humoral immune response to, avidity for the TNP determinant and responsiveness 
to LPS effect with aging. J Immunol 116:294-300. 
 
95.     Doria, G., G. D'Agostaro, and A. Poretti. 1978. Age-dependent variations of 
antibody avidity. Immunology 35:601-611. 
 
96.     Zharhary, D., Y. Segev, and H. Gershon. 1977. The affinity and spectrum of cross 
reactivity of antibody production in senescent mice: the IgM response. Mech 
Ageing Dev 6:385-392. 
 
97.     Shi, Y., T. Yamazaki, Y. Okubo, Y. Uehara, K. Sugane, and K. Agematsu. 2005. 
Regulation of aged humoral immune defense against pneumococcal bacteria by 
IgM memory B cell. J Immunol 175:3262-3267. 
 
160 
 
 
98.     Boehmer, E. D., J. Goral, D. E. Faunce, and E. J. Kovacs. 2004. Age-dependent 
decrease in Toll-like receptor 4-mediated proinflammatory cytokine production 
and mitogen-activated protein kinase expression. J Leukoc Biol 75:342-349. 
 
99.     Swift, M. E., A. L. Burns, K. L. Gray, and L. A. DiPietro. 2001. Age-related 
alterations in the inflammatory response to dermal injury. J Invest Dermatol 
117:1027-1035. 
 
100.   Tasat, D. R., R. Mancuso, S. O'Connor, and B. Molinari. 2003. Age-dependent 
change in reactive oxygen species and nitric oxide generation by rat alveolar 
macrophages. Aging Cell 2:159-164. 
 
101.   Franceschi, C., M. Bonafe, S. Valensin, F. Olivieri, M. De Luca, E. Ottaviani, and 
G. De Benedictis. 2000. Inflamm-aging. An evolutionary perspective on 
immunosenescence. Ann N Y Acad Sci 908:244-254. 
 
102.   Bruunsgaard, H., and B. K. Pedersen. 2003. Age-related inflammatory cytokines 
and disease. Immunol Allergy Clin North Am 23:15-39. 
 
103.   Ormerod, M. G. 2000. Flow Cytometry. Oxford University Press, U.K. 
 
104.   Herzenberg, L. A., J. Tung, W. A. Moore, and D. R. Parks. 2006. Interpreting flow 
cytometry data: a guide for the perplexed. Nat Immunol 7:681-685. 
 
105.   Won, W. J., J. B. Foote, M. R. Odom, J. Pan, J. F. Kearney, and R. S. Davis. 2006. 
Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and 
B1 B cells. J Immunol 177:6815-6823. 
 
106.   Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu Rev 
Immunol 23:161-196. 
 
107.   Jablonska, J., K. E. Dittmar, T. Kleinke, J. Buer, and S. Weiss. 2007. Essential role 
of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of 
BALB/c mice by Listeria monocytogenes. Infect Immun 75:462-470. 
 
108.   Lo, C. G., T. T. Lu, and J. G. Cyster. 2003. Integrin-dependence of lymphocyte 
entry into the splenic white pulp. J Exp Med 197:353-361. 
 
109.   Manjunath, N., P. Shankar, J. Wan, W. Weninger, M. A. Crowley, K. Hieshima, T. 
A. Springer, X. Fan, H. Shen, J. Lieberman, and U. H. von Andrian. 2001. 
Effector differentiation is not prerequisite for generation of memory cytotoxic T 
lymphocytes. J Clin Invest 108:871-878. 
 
161 
 
 
110.   van der Laan, L. J., E. A. Dopp, R. Haworth, T. Pikkarainen, M. Kangas, O. 
Elomaa, C. D. Dijkstra, S. Gordon, K. Tryggvason, and G. Kraal. 1999. 
Regulation and functional involvement of macrophage scavenger receptor 
MARCO in clearance of bacteria in vivo. J Immunol 162:939-947. 
 
111.   van der Laan, L. J., M. Kangas, E. A. Dopp, E. Broug-Holub, O. Elomaa, K. 
Tryggvason, and G. Kraal. 1997. Macrophage scavenger receptor MARCO: in 
vitro and in vivo regulation and involvement in the anti-bacterial host defense. 
Immunol Lett 57:203-208. 
 
112.   Weill, J. C., S. Weller, and C. A. Reynaud. 2009. Human marginal zone B cells. 
Annu Rev Immunol 27:267-285. 
 
113.   Steiniger, B., P. Barth, and A. Hellinger. 2001. The perifollicular and marginal 
zones of the human splenic white pulp : do fibroblasts guide lymphocyte 
immigration? Am J Pathol 159:501-512. 
 
114.   Lynch, A. M., and R. Kapila. 1996. Overwhelming postsplenectomy infection. 
Infect Dis Clin North Am 10:693-707. 
 
115.   Waghorn, D. J. 2001. Overwhelming infection in asplenic patients: current best 
practice preventive measures are not being followed. J Clin Pathol 54:214-218. 
 
116.   Ram, S., L. A. Lewis, and P. A. Rice. Infections of people with complement 
deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 
23:740-780. 
 
117.   Zago, M. A. 1989. The evaluation of spleen function in man. Braz J Med Biol Res 
22:159-169. 
 
118.   William, B. M., and G. R. Corazza. 2007. Hyposplenism: a comprehensive review. 
Part I: basic concepts and causes. Hematology 12:1-13. 
 
119.   Tsankova, N. M., O. Berton, W. Renthal, A. Kumar, R. L. Neve, and E. J. Nestler. 
2006. Sustained hippocampal chromatin regulation in a mouse model of 
depression and antidepressant action. Nat Neurosci 9:519-525. 
 
120.   Nestler, E. J., M. Barrot, R. J. DiLeone, A. J. Eisch, S. J. Gold, and L. M. 
Monteggia. 2002. Neurobiology of depression. Neuron 34:13-25. 
 
121.   Duman, R. S. 2004. Depression: a case of neuronal life and death? Biol Psychiatry 
56:140-145. 
 
162 
 
 
122.   Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B 
lymphocyte cell fate decision. Nat Rev Immunol 9:767-777. 
 
123.   Cariappa, A., I. B. Mazo, C. Chase, H. N. Shi, H. Liu, Q. Li, H. Rose, H. Leung, B. 
J. Cherayil, P. Russell, U. von Andrian, and S. Pillai. 2005. Perisinusoidal B cells 
in the bone marrow participate in T-independent responses to blood-borne 
microbes. Immunity 23:397-407. 
 
124.   Traggiai, E., A. Casati, M. Frascoli, S. Porcellini, M. Ponzoni, F. Sanvito, L. Leng, 
R. Bucala, L. Moretta, and F. Grassi. Selective preservation of bone marrow 
mature recirculating but not marginal zone B cells in murine models of chronic 
inflammation. PLoS One 5:e11262. 
 
125.   Tortola, L., K. Yadava, M. F. Bachmann, C. Muller, J. Kisielow, and M. Kopf. IL-
21 induces death of marginal zone B cells during chronic inflammation. Blood. 
 
126.   Browne, C. D., M. M. Hoefer, S. K. Chintalapati, M. H. Cato, Y. Wallez, D. V. 
Ostertag, E. B. Pasquale, and R. C. Rickert. SHEP1 partners with CasL to 
promote marginal zone B-cell maturation. Proc Natl Acad Sci U S A 107:18944-
18949. 
 
127.   Wang, S. L., M. Kutsche, G. DiSciullo, M. Schachner, and S. A. Bogen. 2000. 
Selective malformation of the splenic white pulp border in L1-deficient mice. J 
Immunol 165:2465-2473. 
 
128.   Katakai, T., H. Suto, M. Sugai, H. Gonda, A. Togawa, S. Suematsu, Y. Ebisuno, K. 
Katagiri, T. Kinashi, and A. Shimizu. 2008. Organizer-like reticular stromal cell 
layer common to adult secondary lymphoid organs. J Immunol 181:6189-6200. 
 
129.   Hoek, K. L., L. E. Gordy, P. L. Collins, V. V. Parekh, T. M. Aune, S. Joyce, J. W. 
Thomas, L. Van Kaer, and E. Sebzda. Follicular B cell trafficking within the 
spleen actively restricts humoral immune responses. Immunity 33:254-265. 
 
130.   Singer, II, M. Tian, L. A. Wickham, J. Lin, S. S. Matheravidathu, M. J. Forrest, 
S.Mandala, and E. J. Quackenbush. 2005. Sphingosine-1-phosphate agonists 
increase macrophage homing, lymphocyte contacts, and endothelial junctional 
complex formation in murine lymph nodes. J Immunol 175:7151-7161. 
 
131.   Di Paolo, N. C., E. A. Miao, Y. Iwakura, K. Murali-Krishna, A. Aderem, R. A. 
Flavell, T. Papayannopoulou, and D. M. Shayakhmetov. 2009. Virus binding to a 
plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory 
macrophage response in vivo. Immunity 31:110-121. 
 
 163 
 
 
 
 
 VITA 
The author, Shirin Birjandi, was born in Chicago, IL on April 30, 1978 to Hossein 
Birjandi and Nahid Zahedi.  She received a Bachelor of Science in Biology from Loyola 
University Chicago in May 2001 and a Master’s of Science in Cell Biology, 
Neurobiology and Anatomy from Loyola University Chicago Medical Center in May 
2005. The focus of her master’s thesis work was on neuroplasticity after middle cerebral 
artery occlusion in rats. 
In August 2005, Shirin joined the Ph.D. Program of Cell Biology, Neurobiology and 
Anatomy at Loyola University Chicago Medical Center.  Shortly thereafter, she joined 
the laboratory of Dr. Pamela L. Witte, where she studied the age related alterations in the 
splenic marginal zone and function of marginal zone macrophages using a murine model.  
While at Loyola, Shirin was appointed to a pre-doctoral training grant from the National 
Institute on Aging, served on the Graduate Student Association Council, and was a 
Graduate Student department representative.  Shirin also was the recipient of travel 
awards to present her work at the Society for Leukocyte Biology and the American 
Association of Immunologists national conferences. 
Shirin is engaged to be married to Morteza Dehghani, a research assistant professor at 
University of Southern California.  After completing her Ph.D., Shirin will go onto a 
post-doctoral position at the University of California, Los Angeles.  
